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Abstract
Development of the placenta and embryo is a highly orchestrated process that is vulnerable to
changes in the in utero environment. Maternal immune activation (MIA) during pregnancy is
a major risk factor for many obstetric complications and predisposes offspring to growth
restriction as well as cognitive and neurobehavioral deficits; however, the mechanisms
underlying these risks remain unknown. In this thesis, I aimed to determine the effect of MIA
on development of the placenta and fetal brain. By administering the viral mimetic
polyinosinic:polycytidylic acid to pregnant rats as a model of MIA, I demonstrated that a
maternal antiviral response is associated with impaired placental and fetal growth and altered
fetal brain structure. Specifically, I showed that intraperitoneal injection of
polyinosinic:polycytidylic acid into pregnant rats results in MIA, decreased placental and
fetal size, and reduced expression of several paternally-expressed imprinted genes.
Moreover, I determined that type I interferons impair differentiation of rat trophoblast stem
cells. Secondly, by analyzing the cerebral cortex of midgestation rat fetuses one week
following maternal injection of polyinosinic:polycytidylic acid or saline, I found that fetuses
exposed to MIA had increased neural precursor cell self-renewal. This finding was
recapitulated using neurospheres generated from these fetal brains and was associated with
altered expression of Notch signaling components. Lastly, I found that uterine natural killer
cells, the most prevalent immune cells in rat decidua in early pregnancy, produce the
multifunctional protein osteopontin, which may contribute to decidual and placental
development. Collectively, this work provides insight into the role of MIA and decidual
immune cells in modulating development of the placenta and fetal brain.
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Summary for Lay Audience
The placenta is a necessity of human reproduction. Connecting a mother to her developing
baby, the placenta sustains pregnancy by ensuring nutrients and oxygen reach the baby and
by acting as a protective barrier. When the placenta does not develop properly, dangerous
pregnancy complications can occur which put both mother and baby at risk of developing
short and long-term illness or death. Factors that cause high risk of placental maldevelopment
include infection and inflammation, and I believe that the mother’s immune cells (which
fight infections) play a role in the development of these complications during pregnancy.
Using rats, I found that inflammation during early pregnancy altered the way the placenta
forms and reduced the size of pups. Moreover, I found that inflammation during rat
pregnancy changed the pups’ brain structure, which could help explain why individuals
exposed to infection while they are in the womb have an increased chance of problems with
brain function. Additionally, I found that a protein called osteopontin is produced by immune
cells close to the placenta and may have an important role in how the placenta forms.
Collectively, these findings can help us understand how infections and inflammation lead to
poor placental development and smaller babies.
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Chapter 1

1

Introduction

1.1 The Placenta
The placenta is an intricate organ that connects a mother to the embryo during pregnancy
playing a critical role in maintaining and protecting the developing baby. Functionally,
the placenta ensures the transfer of nutrients and oxygen between maternal and fetal
circulations, the removal of wastes from fetal circulation, as well as the synthesis and
secretion of growth factors, hormones, and cytokines. In addition, it also acts as both a
physical and endocrine barrier between maternal and fetal circulations, providing
protection against pathogens, maternal hormones, and the maternal immune system.
Impairments in placental development can result in fetal growth restriction (FGR) and
other severe obstetric complications for both mother and baby (Brosens et al. 2011).
While negative outcomes on fetal development are often observed during late gestation,
the underlying causes of placental maldevelopment are thought to be due to events during
early pregnancy.
Placentation is a complex process that begins prior to implantation of the blastocyst; early
placental development is carried out primarily by trophoblast cells which originate from
the trophectoderm (the outer layer) of the blastocyst. The trophectoderm can differentiate
into several specialized trophoblast lineages which are involved in invasion, remodelling,
endocrine functions, and immunity (Napso et al. 2018). Various animal models have been
used to characterize and model placentation; in particular, the use of mice and rats has
improved our understanding of early placentation since they exhibit a similar type of
placentation as humans, they are multiparous with short gestations, and they are readily
manipulated in laboratory settings.

1.1.1

Human Placental Development
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In humans, the placenta is anatomically organized into specialized tree-like structures
known as chorionic villi. Chorionic villi are comprised of a mesenchymal core containing
fetal blood vessels, macrophages, and fibroblasts, and are surrounded by a layer of villous
cytotrophoblast cells and an outer layer of fused trophoblast called syncytiotrophoblast
(Figure 1-1). Within the mesenchymal core, fetal blood vessels develop and connect to
fetal circulation through the umbilical vasculature, a process that does not complete until
approximately three weeks into gestation (Knöfler et al. 2019). Chorionic villi can be
classified into floating chorionic or anchoring villi, where floating villi emanate from
anchoring villi and are small tree-like structures bathed in maternal blood – facilitating
the majority of nutrient and gas exchange to take place. At the tips of anchoring villi, a
stratified layer of extravillous cytotrophoblasts forms, which differentiate and invade into
the maternal decidua and inner myometrium. Invading extravillous cytotrophoblasts play
an important role in the remodelling of maternal spiral arteries, which is described below
(Meekins et al. 1994). This process is essential for attachment of the placenta into the
uterus as well as ensuring that an unimpeded supply of maternal blood reaches the
placenta.
As pregnancy progresses, maternal spiral arteries need to be remodeled into large
diameter, low resistance conduits which allows the space between floating villi
(intervillous space) to fill with maternal blood (Brosens et al. 1967). This process is
largely accomplished by extravillous trophoblast cells, which proliferate up into the distal
columns of the anchoring villi and develop invasive properties (Weiss et al. 2016). As
extravillous trophoblast cells become more invasive, they invade deep into the decidua
basalis and through the uterine stroma or through the lumen of the maternal spiral arteries
up into the inner third of the myometrium. During this early development of the placenta,
extravillous trophoblasts plug the spiral arteries to allow blood plasma to seep into the
intervillous space without red blood cells entering (Jauniaux et al. 2000). This plugging
process creates a hypoxic environment which is essential to the regulation of trophoblast
proliferation and invasion, and also protection of the placenta and fetus during critical
phases of development (James et al. 2018). Trophoblast plugs disappear towards the end
of the first trimester to allow for the increased volume of blood, which is required to
create an environment capable of sustaining a growing fetus. As the structure of villi

3

develop and progress, unimpeded blood flow to the placenta is established around ten to
twelve weeks of pregnancy (Burton et al. 2002). Poor placental development – a product
of impaired trophoblast invasion and deficient spiral artery remodelling – results in the
poor exchange of nutrients, oxygen, and hormones between maternal and fetal
circulations and has been implicated in several obstetric complications including
preeclampsia, FGR, placenta accreta, and stillbirth (Barrientos et al. 2017; Cotechini et
al. 2014; Lyall et al. 2013; Kumer et al. 2021).

1.1.2

Preeclampsia, Fetal Growth Restriction, and Placenta
Accreta

Numerous obstetric diseases have been linked to placental maldevelopment, including
preeclampsia, FGR, and PA. In healthy pregnancies the maternal spiral arteries are
remodeled into low-resistance high-flow conduits, however in pregnancies with impaired
spiral artery remodelling there is reduced transfer of oxygen and nutrients to the fetus,
resulting in placental insufficiency. Placental insufficiency can result from a number of
factors including genetics, maternal undernutrition, and maternal hypertension, however
over 60% of cases of placental insufficiency are idiopathic (Ghidini 1996).
Despite the advancements of modern medicine in the management of pregnancy,
preeclampsia affected approximately 5% of pregnancies in Canada in 2012 (Auger et al.
2016). Women diagnosed with preeclampsia have higher mortality rates and are at an
increased risk of developing cardiac, respiratory, renal, and hepatic failure (Abalos et al.
2014; Nerenberg et al. 2014). Additionally, offspring from pregnancies complicated by
preeclampsia are at a disproportionate risk for further complications including a
requirement for emergency caesarean section, pre-term birth, FGR, admission to
intensive care, and long-term chronic morbidities (Abalos et al. 2014; Nerenberg et al.
2014; Bakker et al. 2011; Lisonkova et al. 2014). Preeclampsia is diagnosed as the
sudden onset of new hypertension, in addition to at least one of: proteinuria, endothelial
dysfunction, swelling, or headaches after the 20th week of pregnancy in mothers (Roberts
et al. 1989; Williams et al. 2010). In many cases, delivery of the placenta is the only cure
for preeclampsia and mothers remain at risk for long-term complications including
diabetes, cardiovascular disease, and kidney disease (Williams et al. 2010). Placentas

4

from preeclamptic pregnancies have shown disruptions in the syncytial architecture as
well as decreased size (Sankar et al. 2012; Chen et al. 2004; Chen et al. 2006). Mouse
models of preeclampsia further show decreased vascular remodelling and increased
vascular resistance indicating possible underlying mechanisms for the pathogenesis of
preeclampsia (Dokras et al. 2006). Furthermore, in a subset of preeclampsia cases, the
fetus stops growing in response to a lack of blood flow and results in growth deficiencies
in the offspring.
Growth of the fetus is dependent on genetic and environmental factors and the ability of
the placenta to transfer nutrients and oxygen between maternal and fetal circulations
(Gardosi et al. 1992). Growth restriction is the failure of a fetus to achieve its predetermined growth potential due to environmental or genetic factors, which manifests as
suboptimal growth, and can develop with or without the presence of maternal
preeclampsia (Figueras and Gratacos 2017; Mitani et al. 2009; Khalil et al. 2019). Several
factors have been linked to the development of FGR including aneuploidies, maternal use
of nicotine, infections, metabolic disorders, and placental maldevelopment or
insufficiencies (Burton and Jauniaux 2018; Sharma, Shastri, et al. 2016; McCowan et al.
2009; Odibo et al. 2006; Shah and Knowledge Synthesis Group on Determinants of
LBW/PT births 2010). In adulthood, offspring born with low birthweights face an
increased risk for developing cardiovascular diseases, hypertension, diabetes, and
metabolic and renal diseases (Murphy et al. 2006).
FGR is often defined as being born below the 10th percentile in weight for that
gestational age, but this is not predictive of perinatal mortality as this definition
encompasses many constitutionally small fetuses (considered small for gestational age).
Current definitions of early onset FGR is defined as reduced growth before 32 weeks of
gestation, with an estimated fetal weight (EFW) or fetal abdominal circumference (FAC)
below the 3rd percentile with absent end diastolic flow, or EFW and FAC below the 10th
percentile and a Doppler pulsatility index above the 95th percentile (Gordijn et al. 2016).
Similarly, the definition of late gestation FGR includes a diagnosis of FAC or EFW
below the 3rd percentile after 32 weeks of gestation or FAC and EFW below the 10th
percentile with an impaired umbilical doppler flow or cerebro-placental ratio below the
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5th percentile (Gordijn et al. 2016). Early onset FGR is considered to be the more severe
phenotype and is associated with impairments in placental perfusion and subsequent fetal
hypoxia, and offspring face an increased risk of preterm birth, morbidity, and mortality
(Weiler et al. 2011; Lackman et al. 2001). FGR pregnancies with fetal weights below the
3rd percentile are at an increased risk of fetal mortality that correlates to the severity of
the growth restriction observed at birth (McIntire et al. 1999). Doppler ultrasounds used
throughout pregnancy can give a predictive value for poor outcomes per growth
percentile, and those with diminished fetal arterial and venous doppler blood flow can be
delivered early to prevent in utero fetal demise; however, premature birth introduces risks
of perinatal morbidity and mortality (Zeitlin et al. 2000; Larkin et al. 2015).
Growth restriction is defined as an impairment in growth of the body, and therefore
estimates of fetal growth throughout pregnancy can determine the possibility of organ
sparing (asymmetrical FGR) or not (symmetrical FGR) (Briana and Malamitsi-Puchner
2018). Asymmetrical FGR accounts for the majority of FGR cases (~70%) and is
typically linked to insults during mid or late gestation resulting in severe decreases in
body size (Sharma, Shastri, et al. 2016; Sharma, Farahbakhsh, et al. 2016). The
asymmetry results from a “brain-sparing effect,” where blood is redirected towards the
brain to preserve its functions while development of the other organs is compromised
(Wu et al. 2006). Symmetrical FGR is associated with genetic abnormalities or placental
insults during early pregnancy, accounting for the other 30% of FGR cases and is
characterized by a proportional decrease in organ size (Sharma, Farahbakhsh, et al. 2016;
Sharma, Shastri, et al. 2016).
Placenta accreta applies to conditions in pregnancy when the placenta attached
abnormally into the maternal myometrium. The abnormal attachment of the placenta can
be further broken down into three grades based on the degree of invasion, which include
accreta (attachment to the myometrium), increta (invasion of trophoblast into
myometrium), and percreta (invasion of trophoblasts through the myometrium) (Miller et
al. 1997). In mice, hyper-invasive trophoblasts can be observed in a surgical model of PA
(Burke et al. 2020). The excessive invasion of trophoblast past the decidua basalis and
into the myometrium puts mothers at risk of severe bleeding following detachment of the
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Figure 1-1: Placental development in the rat and human.
Following fertilization, implantation of the blastocyst occurs by gestational day (GD) 4.5
in the rat and embryonic day (E) 6 in humans. The blastocyst gives rise to the
trophectoderm (TE) and inner cell mass which will differentiate into the epiblast (EPI).
By GD 8.5, the trophectoderm differentiates and gives rise to the ectoplacental cone
(EPC) in rat placentation. In humans, the TE will develop into the syncytiotrophoblast
(STB) and underlying proliferative cytotrophoblasts (CTB) around E 12. As the placenta
develops a population of rat trophoblast stem (rTS) cells can be isolated from the TE and
EPC, whereas human trophoblast stem (hTS) cells are isolated from the TE or CTB layer.
From early in gestation uterine natural killer cells (uNK) can be found within the decidua
basalis (DB) in both rat and human placentation. Around gestational day 10.5 in rats, the
structure of the labyrinth begins to form, housing the syncytiotrophoblast (STB), and
facilitating nutrient and gas exchange between maternal and fetal circulations.
Trophoblast giant cells (TGC) line the interface between the (DB) and developing
placenta. The structure of the definitive placenta is completed by GD 10 in rats, and E 35
in humans however it continues to grow throughout gestation until term.
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placenta, which can lead to hemorrhage, multisystem organ failure, and death (Bailit et
al. 2015; Warshak et al. 2010). Variations in the number of immune cells in placentas
from PA pregnancies compared to healthy controls have been reported, in addition to an
increase in the presence of inflammation, warranting further investigation (Ernst et al.
2017; Schwede et al. 2014; Hecht et al. 2020).

1.1.3

Rodent Placental Development

A variety of animal models have been studied to improve our understanding of the
processes of implantation, placentation, and early pregnancy. Humans, primates, and
rodents all feature hemochorial placentation which is characterized by the direct contact
of maternal blood with trophoblast cells. Over the past decades, mice have been the
preferred model for placental research due to their ease of use in transgenic approaches
and have therefore greatly expanded our knowledge of genes essential for placental
development, however more recently genetic editing tools have become available for rat
work as well. Featuring spiral artery remodelling, humans, mice, and in particular rats,
exhibit trophoblast invasion into the uterine lining (Soares et al. 2012). In addition, the
recent development of rat TS cell models has enabled in vitro experimentation to
complement in vivo models, furthering their use for experimental models (Asanoma et al.
2011). Despite their similarities, there are some differences in placental structure between
humans and rats (Soncin et al. 2018). Even with these differences, their short gestations,
large litter sizes, and deep trophoblast invasion make rats an excellent model for the
study of placental development.
Following implantation in the rodent, the trophectoderm gives rise to the extra-embryonic
ectoderm and the ectoplacental cone (Figure 1-1). The trophectoderm and subsequently
the extraembryonic ectoderm and ectoplacental cone (EPC) differentiates into rat TS
(rTS) cells, a self-renewing population of placental precursor cells that can be cultured in
vitro (Asanoma et al. 2011). Further differentiation of the EPC forms the unique barrier
that forms between the maternal decidua and the trophoblast layer in rodent placentation,
known as the junctional zone. Positioned between the decidua and the underlying
labyrinth layer, it primarily arises from the ectoplacental cone and together with the
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labyrinth zone forms the fetal component of the mature rodent placenta. The junctional
zone is comprised of three subtypes of trophoblast: spongiotrophoblast cells, glycogen
cells, and trophoblast giant cells (TGC). Spongiotrophoblast cells comprise the bulk of
the junctional zone and can be found between the giant cells and the labyrinth zone.
While spongiotrophoblast may have an important endocrinological role and promote
maternal physiological adaptations to pregnancy, their function is not entirely understood
(Salbaum et al. 2011). The second specialized trophoblast subtype found within the
junctional zone are termed glycogen trophoblast cells and they accumulate and
metabolize large stores of glycogen, as well as invade into the decidua throughout
gestation (Bouillot et al. 2006; Coan et al. 2006). The EPC also differentiates into TGC –
cells known for their continuous endoreduplication (polyploidy) combined with the lack
of cell division causing their large size (Simmons and Cross 2005). During early
development, TGCs line the outside of the developing conceptus and are in direct contact
with the maternal decidua. Along with spongiotrophoblast cells and glycogen trophoblast
cells, TGCs provide the major endocrine functions of the placenta.
The site of gas and nutrient exchange in rodent placentas is functionally equivalent to
human chorionic villi and termed the labyrinth zone due to its maze-like network of
blood vessels (Baines and Renaud 2017). The labyrinth zone in rodents consists of three
layers of trophoblast cells (two layers of syncytiotrophoblast and an outer mononucleated
trophoblast layer termed sinusoidal trophoblast giant cells) (Hu and Cross 2010; Baines
and Renaud 2017). The proximity of fetal trophoblast cells with maternal blood in the
labyrinth layer of rodents ensures efficient nutrient and gas exchange between mother and
developing fetus.

1.1.4

Uterine NK cells

The maternal portion of the maternal-placental interface in both rats and humans is
comprised of the decidua basalis. There are variety of cell types within the decidua
basalis including decidual stromal cells (from differentiation of endometrial stromal
cells), blood vessels, glands, and a variety of immune cells. Immune cells comprise 3040% of all decidual cells, which include uterine natural killer (uNK) cells, macrophages,
dendritic cells, and T cells, each with unique functions and cytokine productions that

10

contribute to the maintenance of a successful pregnancy (Faas and de Vos 2017; Lash et
al. 2010). Within the uterus the leukocyte population is primarily comprised of
macrophages (20-25%) and uNK cells (70%) (Ander et al. 2019). In blood, peripheral
NK cells are short-lived cells of the innate immune system which have the ability to
eliminate cells through cytotoxic actions (Cerwenka and Lanier 2001). Healthy host cells
are immune from the cytotoxic actions of NK cells by the interaction of their major
histocompatibility complex (MHC) class I molecules with the inhibitory receptors on NK
cells (Schmidt et al. 2004). While NK cells are found throughout the body, a unique
subset is found within the mucosal tissues of the uterus, known as uterine NK (uNK) cells
(King et al. 1996; Koopman et al. 2003; Whitelaw and Croy 1996). These uNK cells are
unique from those found in blood, displaying a distinct CD56brightCD16dim phenotype, and
acting less cytotoxic than their peripheral NK counterparts (Cerdeira et al. 2013; Yang et
al. 2019; Koopman et al. 2003).
While high in number during early pregnancy, uNK cells decline in number around midgestation (Jabrane-Ferrat 2019). Close in proximity to the uterine spiral arteries and
invasive trophoblast cells, uNK cells are embedded in the decidua basalis and are thought
to provide support for the process of trophoblast invasion and spiral artery remodelling
(Smith et al. 2009). Co-culture experiments with uterine spiral artery segments implicate
uNK cells in the restructuring of spiral arteries through loss of integrity of the tunica
media (Robson et al. 2012), however the exact mechanism through which this process
occurs remains unknown. Recent research has highlighted the wide range of factors that
uNK cells can secrete – including the growth promoting factors: pleiotrophin,
osteoglycin, and osteopontin, which each contribute to healthy fetal development (Fu et
al. 2017). Changes in the number or activity of uNK cells has been associated with
several pregnancy complications including FGR, preeclampsia, and spontaneous
recurrent abortion (Wallace et al. 2013; Wallace et al. 2014), further implicating them as
regulators of placental development.

1.1.4.1

uNK cells in Mouse
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In mouse pregnancy, two distinct populations of uNK cells have been identified, which
are most commonly defined by their reactivity to Dolichos biflorous agglutinin (DBA)
(Paffaro et al. 2003). DBA+ uNK cells express high transcript levels of angiogenic
factors, whereas DBA- uNK cells express a higher transcript level of interferon-gamma
(IFN-γ) (Chen et al. 2012; A. A. Ashkar et al. 2000; Paffaro et al. 2003). Throughout
murine pregnancy, mature uNK cells remain poorly cytotoxic despite containing poreforming proteins such as perforin and granzymes (Parr et al. 1990). Murine uNK cells
express lectin-like Ly49 receptors, which recognize MHC class I as well as killer-cell
lectin like receptor G1 (Madeja et al. 2011; Kieckbusch et al. 2014). These two subsets
have differing roles throughout murine pregnancy, with uNK IFN-γ playing a key role in
the remodelling of maternal spiral arteries (Monk et al. 2005; Greenwood et al. 2000;
Ashkar and Croy 1999)
Strong evidence that uNK cells contribute to spiral artery remodelling has come from
studies using NK cell-deficient pregnant mice (Koopman et al. 2003; Kennedy et al.
2000; Mazurier et al. 1999; Kim et al. 2000; Gascoyne et al. 2009). Specifically, mouse
models genetically lacking uNK cells consistently exhibit narrow spiral artery lumens
(Ashkar and Croy 2001; Guimond et al. 1997; Hofmann et al. 2014). Impairments in
spiral artery remodelling has also been associated with decreased blood flow and
compromised fetal growth in mouse models genetically devoid of NK cells and those
with reduced NK cell numbers or function (Barber and Pollard 2003; Ashkar et al. 2003;
Kieckbusch et al. 2014). Together, these studies implicate the role of uNK cells in the
initial stages of spiral artery remodelling and their importance in creating unimpeded
blood flow to the developing mouse placenta.

1.1.4.2

uNK cells in Rat

Mice feature shallow trophoblast invasion with limited trophoblast-mediated spiral artery
remodelling, whereas rats (like humans) have deep trophoblast invasion and extensive
trophoblast-mediated spiral artery remodelling (Caluwaerts et al. 2005; Ain et al. 2003).
The use of rats therefore provides an advantage to study this aspect of placental
development. Like in mice, uNK cells comprise the majority of leukocytes within the
decidua in rats, where they increase in number in the mesometrial compartment until
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approximately midgestation (Acar et al. 2011; Gaynor and Colucci 2017). uNK cells
accumulate around the spiral arteries prior to the onset of trophoblast invasion, and then
subsequently decrease in number towards the end of pregnancy (Kusakabe et al. 1999). In
both human and rat placentation, uNK cells initiate angiogenesis and a ‘first wave’ of
spiral artery remodelling, since there is evidence of early spiral artery dilation without the
presence of invasive trophoblast cells (Chakraborty et al. 2011; Smith et al. 2009).
Depletion of NK cells in rats results in a transient delay in early aspects of spiral artery
remodelling, and ultimately a compensatory over-invasive trophoblast phenotype
(Chakraborty et al. 2011). Recent work has shown that a genetic knockout of interleukin15 (IL-15) in rats, a cytokine required for NK cell survival, results in drastic alterations in
placental structure. This includes an expanded junctional zone and early-onset and
exacerbated trophoblast invasion and spiral artery remodelling (Renaud et al. 2017).
Despite the underlying importance of uNK cells in spiral artery remodelling, studies in
both rats and mice indicate that Il-15 deficiencies do not impair implantation, pregnancy
success, or fetal growth (Renaud et al. 2017; Bany et al. 2012).

1.1.4.3

Interleukin-15

Interleukin-15 (IL-15) is a pleiotropic cytokine that can stimulate the growth of mature T,
B, and NK cells, as well as act as a chemoattractant for T lymphocytes and promote the
activation of NK cells (Armitage et al. 1995; Bamford et al. 1994; Carson et al. 1994).
Therefore, the development of NK cells is reliant on the expression of IL-15. IL-15 is
produced in bone marrow stromal cells (Ashkar et al. 2003; Grabstein et al. 1994),
thymic epithelium (Leclercq et al. 1996), and fetal intestinal epithelium (Murray et al.
1998). Il15 mRNA has been found in a wide range of tissues including placenta, skeletal
muscle, kidney, lung, heart, and macrophages (Grabstein et al. 1994). The IL-15 receptor
(IL-15R) is a heterotrimer composed of a unique α subunit that mediates specific and
high affinity binding to IL-15, as well as a β and common γ subunit that transduce
intracellular signals and are shared with several other interleukins such as IL-2 and IL-4
(Giri et al. 1995). Using adoptive transfer techniques, peripheral NK cells have been
isolated from wild-type mice and transferred into IL-15-/- mice, however these cells did
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not survive more than a few days in their new hosts, confirming the importance of IL-15
for NK cell survival (Ranson et al. 2003).
NK cells are dependent on IL-15 for their development and survival (Fehniger and
Caligiuri 2001). In the uterus, endometrial IL-15 transcript levels are increased in the
secretory phase of the menstrual cycle compared with the proliferative phase, reaching
peak expression levels in the mid-secretory phase (Kitaya et al. 2000; Okada et al. 2000).
This corresponds with an increased number of CD16- CD56bright NK cells in the
endometrium during the secretory phase and early stages of pregnancy as well as in the
early pregnant decidua (King et al. 1991). Trophoblasts inhibit IL-15 mediated uNK cell
survival, proliferation, and cytotoxicity in in vitro studies using trophoblast conditioned
media, by negatively regulating IL-15R signaling in uNK cells (Park et al. 2017).
Inhibition of IL-15 gene expression results in a complete NK cell deficiency in animal
models, including peripheral NK cells, tissue resident NK cells, and uNK cells, however
IL-15 is not required for pregnancy success (Barber and Pollard 2003).
It has been suggested that uNK cells play a key role in regulating placental development
through interactions with trophoblast cells and their purported involvement in spiral
artery remodelling. In IL-15 deficient mice, spiral arteries have thicker walls and
narrower lumens compared to wildtype animals (Renaud et al. 2017; Barber and Pollard
2003). Mice lacking IL-15 have no uNK cells in implantation sites in addition to a
hypocellular decidua basalis, an absent metrial gland, and failed spiral artery remodelling
(Ashkar et al. 2003; Mori et al. 2016). Despite poor placentation in mice devoid of uNK
cells, there appears to be no impairments in pregnancy progression and no long term
effects on offspring (Greenwood et al. 2000). Rats possessing a mutation in the gene
encoding IL-15 have no detectable uNK cells and exhibit robust expansion of the
junctional zone and precocious trophoblast invasion into spiral arteries. Interestingly,
there is no observable change in fetal growth or litter size in these rats, suggesting that
the placental adaptations that take place are sufficient to compensate for the lack of uNK
cells (Renaud et al. 2017). These placental adaptations observed in uNK cell deficient
rats may result from compensatory leukocytes or changes in the expression of various
growth factors, cytokines or extracellular matrix proteins secreted by uNK cells.
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1.1.5

Osteopontin

Osteopontin (OPN) is an extracellular matrix protein that is expressed in many tissues
including teeth, brain, kidney, bone, muscle, chorionic villi, and decidua (Mazzali et al.
2002; Chen et al. 2014). In addition to structural functions, OPN can act as a cytokine
and chemoattractant for macrophages and T-cells during inflammatory responses (S.
Ashkar et al. 2000; Mazzali et al. 2002). OPN can also mediate many cellular functions
including adhesion, migration, and cell survival (Wang and Denhardt 2008). OPN is a
negatively charged protein encoded by a single gene on chromosome 4 with a promoter
region that responds to several transcription factors (Fisher et al. 2001). While OPN is
comprised of 314 amino acids, there are several cleaved products and splice variants. It is
commonly expressed as a 33 kDa protein, but after post-translational modifications it can
increase to 44 kDa (Sodek et al. 2000). The various post-translational modifications and
cell sources of OPN provide a means for its numerous functions (Kazanecki, Uzwiak, et
al. 2007; Kazanecki, Kowalski, et al. 2007). For example, tumor-derived OPN can inhibit
the function of macrophages, while host-derived OPN acts as a chemoattractant
(Crawford et al. 1998). OPN can interact with a variety of cell surface receptors, most
notably integrins (αvβ1, αvβ3, αvβ5, αvβ6, and α5β1) (Barry et al. 2000; Yokosaki et al.
2005). Additionally, OPN can also be detected intracellularly on the inner surface of
plasma membranes (iOPN), where it plays a role in motility, cell fusion, cell survival, and
migration of fibroblasts, macrophages, and metastatic cells (Suzuki et al. 2002; Zohar et
al. 2000). IFN-α expression may also be mediated by iOPN in dendritic cells, as observed
in OPN deficient mice with impaired NK cell responses to tumors and decreased
responses following herpes simplex virus 1 infection (Shinohara et al. 2006). Together,
these studies implicate a role for OPN in mediating immune function.
OPN is produced by several immune cells including NK cells, though as an extracellular
matrix protein it’s primary roles are in tissue growth and regeneration through it’s
interactions with various cell surface receptors, growth factors, and cytokines (Fu et al.
2017). Increased levels of OPN have been implicated in pathological conditions such as
cancer and inflammatory diseases and result in increased cellular apoptosis (Lund et al.
2009; Icer and Gezmen-Karadag 2018). However, contradicting reports note that OPN
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can also act as a survival factor by inhibiting apoptosis as observed in stressed endothelial
cells or in tumor development (Hsieh et al. 2006; Khan et al. 2002). Signalling through
αvβ3 integrin allows OPN to modulate NFκB signaling, promoting endothelial cell
survival in stress conditions, perhaps accounting for this variability (Figure 1-2) (Scatena
et al. 1998; Rice et al. 2006). Interacting with MyD88 and TLR9, iOPN can activate
interferon regulatory factor 7 and induce the production of IFN-α (Shinohara et al. 2006).
Increased gene expression of OPN was observed in mouse intestines and epithelial cells
infected with Listeria monocytogenes and rotavirus, however OPN-deficient mice
exhibited prolonged symptoms of infection, leaving the role of OPN in immunological
processes unclear (Rollo et al. 2005; S. Ashkar et al. 2000).
In pregnancy, OPN plays a role in several processes including: implantation (Nomura et
al. 1988), acting as a component of histiotroph, decidualization, and immune regulation
(Burton et al. 2002; Johnson et al. 2003). OPN has been found throughout the pregnant
uterus in animal models, including in the glandular epithelium, metrial gland, and
trophoblast cells (Johnson et al. 2003). Detectable throughout gestation at the transcript
level in the mouse decidua (GD7.5-18.5), it is hypothesized that OPN is essential for
proper placental progression (Nomura et al. 1988). In extravillous trophoblast cell lines,
OPN is constitutively expressed, and inhibition of OPN hinders their proliferative and
invasive capacity (Wu et al. 2015). Furthermore, inhibition of OPN compromises
angiogenesis and decidualization, and decreased levels of OPN are found in cases of
implantation failure (Wang et al. 2018). In pregnancy complications like preeclampsia,
OPN plays a role in aberrant trophoblast invasion leading to pathogenic placental
development (Gabinskaya et al. 1998). With possible implications in immunological
functions and it’s presence in the uterus, OPN has been localized within uNK cells and
found to be absent in mice lacking NK cells (Herington and Bany 2007).
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Figure 1-2: Schematic of osteopontin and receptor.
OPN is secreted by activated immune cells and has been shown to play a role in
regulating early immune responses and inflammation. Upon binding to integrin αvβ3,
OPN mediates the recruitment and activation of leukocytes at the sites of inflammation
by inducing a pro-inflammatory response. OPN, osteopontin.
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1.2 Inflammation and infections in pregnancy
Healthy pregnancies require a delicate immune balance to ensure a functional immune
system capable of fighting pathogens while minimizing damage to the host and protecting
the developing offspring. The unique cellular milieu within the pregnant decidua consists
of a variety of immune cells, decidual stromal cells, glands, blood and lymph vessels, and
trophoblast cells. These various cells must all interact with each other to ensure
successful placental and fetal development. Mild inflammation is essential for the
progression of a healthy pregnancy, including during implantation and parturition,
however this process is tightly regulated by immunomodulatory mechanisms. Common
to pregnancy complications such as preeclampsia, FGR, and preterm birth is an aberrant
maternal immune response and impaired placental development (Kaufmann et al. 2003;
Redman 1991). Increased maternal serum levels of the pro-inflammatory cytokines IL-6,
IL-8, IL-12, and IFN-γ have been associated with recurrent pregnancy loss (Comba et al.
2015), however the relationship between inflammation and pregnancy loss remains
elusive. Conditions associated with chronic low-level inflammation (e.g. diabetes and
hypertension) have also been linked to increased hypoxia/ischemia, oxidative stress, and
inflammation within the placenta as well as trophoblast cell death (Maxwell et al. 2015).
While FGR has been associated with placental dysfunction, studies have found high
levels of pro-inflammatory cytokines in maternal serum from women with FGR, and their
offspring had a higher risk of brain morbidity (Gazzolo et al. 2006).

1.2.1

Viral Infections and Pregnancy

The effects of maternal viral infection during pregnancy can range from no impact on the
fetus to pregnancy loss or congenital infection. Epidemiological data implicates pregnant
women as a high risk for serious illness and mortality from viral infections, including
influenza, Ebola, Lassa fever, and most recently, COVID-19 (Gervasi et al. 2012; Price et
al. 1988; Moltner et al. 2021; Jamieson et al. 2014; Kwon et al. 2014). Including the wellknown teratogenic TORCH infections (toxoplasmosis, others, rubella, cytomegalovirus,
and herpes simplex virus), there remains no true standard of care for maternal or prenatal

18

management of infections, leaving pregnant women vulnerable to a wide range of
symptoms and illnesses. For several decades researchers have been linking viral
infections with pregnancy complications including preterm labor, preeclampsia and FGR,
however the mechanisms of how infections can affect the progression of a healthy
pregnancy remain poorly understood (Aldo et al. 2010; Gervasi et al. 2012; ArechavaletaVelasco et al. 2008; Koga, Cardenas, et al. 2009).
The increase in inflammation seen with infections can lead to both systemic symptoms
for mothers and fetal complications like preterm birth and miscarriage (Pazos et al. 2012;
Fell et al. 2017). Infections like CMV, Zika virus, and Dengue have been associated with
placental abnormalities including villi enlargement, intravillous hemosiderin deposition,
and intervillositis (Ribeiro et al. 2017; Krauer et al. 2017; Martinez 2016; VillamilGómez et al. 2016). Respiratory infections like Middle East respiratory syndrome
(MERS), while understudied, show records of stillbirths at 5 months of gestation
(Alserehi et al. 2016). Additionally, congenital infections acquired during development
may lead to disabilities later in life, like those seen due to congenital TORCH infections.
The relatively recent outbreaks of Zika virus resulted in ZIKV syndrome, with offspring
exhibiting microcephaly and lesions within the brain comparable to those seen in
congenital CMV infections (de Vries 2019).
More recently, SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2; COVID19), a virus of the coronaviridae family, emerged in December 2019 and continues to
grow as one of the most significant public health threats of this century. Swiftly
spreading around the world, COVID-19 has caused over 250 million infections and over
5 million deaths as of November 2021. Presenting from asymptomatic cases to symptoms
of fever, cough, pneumonia, acute respiratory distress syndrome, multisystem organ
failure, and a cytokine storm, the case fatality rate of COVID-19 is approximately 2%
(Wu and McGoogan 2020; Huang et al. 2020; Chen et al. 2020; Ye et al. 2020). Although
the majority of pregnant women with COVID-19 have mild symptoms, women testing
positive for COVID-19 during their pregnancy are at an increased risk of being admitted
to the intensive care unit or requiring invasive ventilation, as well as delivering
prematurely or maternal death (Allotey et al. 2020; Elsaddig and Khalil 2021;
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Andrikopoulou et al. 2020; Wu and McGoogan 2020; Breslin et al. 2020). Vertical
transmission of SARS-CoV-2 is uncommon, although there is some evidence that
placental and fetal infection can occur (Kirtsman et al. 2020; Patanè et al. 2020; Dong et
al. 2020; Mattar et al. 2020). The possibility of the intense cytokine storm produced by
COVID-19 that could possibly pass through the placental barrier and the risk of severe
symptoms in pregnant women may have future implications in fetal development that
should continue to be monitored.
The maternal-fetal interface acts as an effective barrier against foreign pathogens while
permitting oxygen, hormones, and nutrients to pass to the developing baby (Brett et al.
2014; Wong and Cox 2017). Viral infections can disturb the delicate immune balance that
exists at the maternal-fetal interface, and aberrations in the immune cell population and
function in the uterus may lead to fetal damage even without direct contact with the virus
(Koga, Aldo, et al. 2009). Trophoblast cells (syncytiotrophoblast, cytotrophoblasts, and
extravillous trophoblasts) express various pattern recognition receptors which can
recognize a wide range of molecules common to many pathogens and are important for
immune surveillance (Abrahams and Mor 2005; Abrahams 2008). These pattern
recognition receptors stimulate distinct downstream pathways and, in the case of viral
infections, can mediate a rapid antiviral response (Alexopoulou et al. 2001), and produce
both type I and type III interferons (Bayer et al. 2016). An antiviral immune response has
the ability to interrupt fetal and placental growth (Yockey and Iwasaki 2018) and has
been associated with pregnancy complications like preeclampsia and FGR (Mor et al.
2011).
Viral infections and/or inflammation may affect the ability of trophoblasts to enter into
and invade the uterine tissue and spiral arteries, thereby leading to placental dysfunction
and pregnancy complications (Gierman et al. 2021; Chatterjee et al. 2012). Viruses
require a living host where they recruit host machinery to replicate and create an
infectious cycle of generating new viral particles. Viruses can enter cells through fusion
with the plasma membrane or through cellular internalization, whereby viruses are
encapsulated by endosomes and further release into the cytoplasm (Yamauchi and Greber
2016; Schneider-Schaulies 2000).
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Double-hit rodent models of murine herpes virus (HPV) and lipopolysaccharide (LPS),
detected no (HPV) infection in the placenta but observed robust increases in maternal
levels of proinflammatory cytokines that correlated with an increased risk of preterm
labor (Cardenas et al. 2011). The authors hypothesized that these results may stem from
the maternal pro-inflammatory response to infection rather than from the response to the
infectious agent itself (Cardenas et al. 2011). As shown in animal models, maternal
immune activation (MIA) during pregnancy can lead to alterations in offspring behavior
(Bakos et al. 2004), brain development (Patterson 2002; Wischhof et al. 2015; Urakubo et
al. 2001), and metabolic health (Niklasson et al. 2006; Yu et al. 2017). Maternal fever
alone has been linked to increased risk of neural disorders in offspring (Zerbo et al.
2013). By using single or double stranded-RNA, a potent type I interferon response can
be generated in human first trimester trophoblast cell lines through TLR3 and TLR8, both
of which are detectable in cells at the maternal fetal interface (Potter et al. 2015; Aldo et
al. 2010). The cytokine storm associated with infections and proinflammatory events in
pregnancy can result in increased maternal IL-2 and IL-17 levels which have been
implicated in the pathogenesis of preeclampsia and miscarriage (Romero-Adrián et al.
2002; Wilson et al. 2003; Wu et al. 2014). Although TNF-α and its receptor are
detectable throughout reproductive tissues, increased TNF-α levels can be used to
diagnose possible health outcome depending upon gestational age, and can lead to tissue
necrosis as well as hypoxia within the placenta (Azizieh and Raghupathy 2015;
Carpentier et al. 2011).

1.2.2

Toll-Like Receptors in Pregnancy
Infections are commonly recognized through pathogen-associated molecular

patterns (PAMPs), notably the TLRs (Kawai and Akira 2009). Ten of these receptors
have been identified and described in humans, each recognizing distinct patterns present
in bacteria, viruses, and other pathogens (Janeway and Medzhitov 2002). For example,
TLR4 binds to LPS found on the outer membrane of invading gram-negative bacteria,
while TLR2 responds to lipoteichoic acid within the cell wall of gram-positive bacteria.
Within the endosome of infected cells, TLR3 is activated by double-stranded RNA
(dsRNA), a common product of many viral replication pathways that does not exist in
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uninfected mammalian cells (Muzio et al. 2000; Karikó et al. 2004; Cavassani et al.
2008). Once activated, TLRs employ various intracellular signaling cascades to initiate
the production of pro-inflammatory cytokines or type I interferons (Akira and Takeda
2004). While commonly found on innate immune cells, mRNA expression of all 10 TLRs
have been found within first trimester trophoblasts, and mRNA expression of TLRs 1-9
have been found within uterine epithelial cells (Tangerås et al. 2014; Schaefer et al.
2004). Several reports note that TLR3 had the highest expression across various
gestational time points in the decidua and placenta (Pudney et al. 2016; Zarember and
Godowski 2002; Gierman et al. 2021), which may indicate the ability of the placenta to
recognize viral pathogens and initiate an immune response.
TLR3 is specifically activated by viral dsRNA and is expressed by a variety of cells,
notably epithelial cells and innate immune cells like NK cells, dendritic cells, and
macrophages (Muzio et al. 2000). TLR3 contains an extracellular domain and an
intracellular domain, forming a horseshoe-like structure. Upon activation by dsRNA,
TLR3 homodimerizes and initiates a signal transduction cascade by recruiting the adaptor
protein TRIF at the intracellular domain (Gosu et al. 2019). Activation of TLR3 leads to
the downstream activation of the NF-κB pathway, activator protein 1 (AP-1), or
interferon regulatory factor (IRF3) pathways resulting in the production of proinflammatory cytokines and an antiviral response (Figure 1-3) (Yamamoto et al. 2003;
Alexopoulou et al. 2001; Schmidt et al. 2004). TLR3 has the ability to activate NK cells
with or without stimulation of a MHC molecule on an antigen presenting cell (Schmidt et
al. 2004). In pregnant women, TLR3 is present on human endometrial epithelial cells,
uterine primary epithelial cells, and trophoblast cells (Jorgenson et al. 2005; Schaefer et
al. 2005; Abrahams et al. 2005). Studies looking at the differential expression of TLRs in
the placenta throughout pregnancy highlighted that TLR3 has the highest expression
compared to other TLRs in both first and second trimesters (Pudney et al. 2016).
Increased TLR3 levels have been described in placentas from preeclampsia complicated
pregnancies compared to healthy controls and in mouse models of preeclampsia
(Chatterjee et al. 2012; Gierman et al. 2021; Pineda et al. 2011). The high expression of
TLR3 in healthy placentas and increased expression in preeclampsia complicated
pregnancies suggests that TLR3 mediates low-grade inflammation during normal
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Figure 1-3: Activation of TLR by PolyI:C.
Upon dsRNA binding to TLR3 within the endosome of cells, TLR3 recruits the adaptor
protein TRIF, which further activates NFκB, AP-1, to generate a proinflammatory
response. Additionally, TRIF can activate IRF3 to stimulate the production of type I
interferons. PolyI:C, polyinosinic:polycytidylic acid; TLR3, toll-like receptor 3; TRIF,
TIR-domain-containing adapter-inducing interferon-β; IRF3, interferon regulatory factor
3; NFκB, nuclear factor kappa B; AP-1, activator protein 1.
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pregnancy and may play a role in the increased inflammation and placental dysfunction
seen in pregnancy complications such as preeclampsia.
In many animal models, inflammation is sufficient to cause symptoms similar to those
seen in common obstetric complications (Scharfe-Nugent et al. 2012; Gomez-Lopez et al.
2016). Polyinosinic:polycytidylic acid (PolyI:C) is a known TLR3 agonist (Zhang et al.
2007) and a synthetic dsRNA molecule (Field et al. 1967). In addition to TLR3, PolyI:C
can also activate retinoic acid-inducible gene 1 (RIG-1) and melanoma differentiationassociated protein 5 (MDA5), to initiate antiviral responses and the production of
interferons (Kato et al. 2006). PolyI:C is often used to activate immune functions of cells
both in vivo and in vitro (Sivori et al. 2004). The pro-inflammatory effects of PolyI:C are
acute, with cytokine responses peaking rapidly and declining within 48 hours of
exposure, depending on the dosage and route of administration (Fortier et al. 2007).
Cytokines observed in this antiviral response include IL-6, IL-1β, TNF-α, as well as
various type I interferons (Gitlin et al. 2006; Duluc et al. 2009; Fortier et al. 2007; Smith
et al. 2007; Murray et al. 2015). Studies using human trophoblast cells in vitro have
shown that exposure to PolyI:C results in an increase in secretion of chemokines,
specifically chemokine (c-c motif) ligand 5 (CCL5) (Abrahams et al. 2005). In mice,
injection of PolyI:C at GD 16.5 results in an increase in the production of proinflammatory chemokines and cytokines (such as CCL2 and IL-6) and causes preterm
birth within 24 hours of injection (Koga, Cardenas, et al. 2009). Lower doses of PolyI:C
did not appear to affect maternal wellbeing at all, however at a dose high enough to cause
100% preterm delivery and a significant increase in the number of deceased pups, and
dams exhibited piloerection, tachypnea, and decreased movement (Koga, Cardenas, et al.
2009). Zhang et al. (2007) determined that when pregnant mice were injected with
PolyI:C at GD 6.5, not only was there an increase in the secretion of TNF-α but there was
also increased TLR3 expression, vessel to lumen ratios of spiral arteries, and fetal loss. In
a study conducted by Tinsley et al. (2009), rats injected with PolyI:C at gestational day
10 experienced preeclampsia like symptoms with high systolic blood pressures and
protein in the urine. Together, these results indicate PolyI:C elicits a potent immune
response that leads to pregnancy complications in animal models.
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1.3 Maternal Inflammation and Fetal Brain Development
Suboptimal in utero environments, including those affected by maternal inflammation,
infection, hypoxia, diet, and age may have detrimental consequences on the development
of the fetal brain as well as long-lasting effects on functioning of the adult brain (Knuesel
et al. 2014). Mounting evidence has linked maternal infections during pregnancy to
increased risk of psychiatric disorders with developmental origins, such as autism
spectrum disorder (ASD) and schizophrenia (Brown et al. 2004; Han et al. 2021; Goines
et al. 2011). Acquired infections or activation of the maternal immune system during
early pregnancy may interfere with fundamental neurodevelopmental events leading to
psychiatric illness in adulthood. Due to the complicated nature of studying prenatal
neurodevelopment, preclinical animal models can provide mechanistic links to
understanding possible in utero origins of disease. Using rodent models, research has
shown that maternal inflammation during pregnancy can impede development of the
hippocampus and skew stress responses, learning, and memory, key impairments seen in
psychiatric illnesses (Ratnayake et al. 2012; Lins et al. 2019; Rasmussen et al. 2019).
There is little known, however, about how activation of the maternal immune system can
result in alteration in early brain development, resulting in neural dysfunction and
psychiatric illnesses in adults.

1.3.1

Early Neural Development in Rats

Development of the brain is a highly orchestrated process and variations in the maternal
environment due to factors such as inflammation can lead to long term consequences on
neurodevelopmental outcomes of the offspring. The cerebral cortex is primarily involved
in higher order processes like attention, awareness, memory, and behavior (Shipp 2007).
Development of the fetal cortex occurs in an inside out fashion, initiating from a pool of
neural precursor cells (NPCs) that resides in the ventricular zone (Van Essen et al. 2018).
As these cells divide from NPCs to glial cells and definitive neurons, they migrate
outwards to the cortical plate where they accumulate to form the cerebral cortex (Noctor
et al. 2001). Many factors play a role in the successful progression of neurogenesis,
including environmental, molecular, and genetic factors. Insults that disrupt neurogenesis
can cause deficiencies in cortical development and lead to changes in brain volume.
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Neurogenesis is responsible for the development of all definitive neurons in the brain.
The timing of neurogenesis, however, varies quite widely between species. Rodents begin
embryonic cortical neurogenesis around gestational day 12, peaking at gestational day
15.5, with expansive proliferation diminishing by gestational day 18.5 (Rice and Barone
2000). In humans, pre-natal cortical neurogenesis begins around gestational week 5, and
ends around gestational week 15 (Rice and Barone 2000); however, in both species
neurogenesis continues throughout adult life as NPC continually differentiate into
functional neurons. The differentiation of neurons in the developing brain requires a large
number of signaling pathways initiated at the correct time and intensity to ensure
functional plasticity of neurons and limit the risk of neurodevelopmental disorders.

1.3.2

Notch Pathway in Neurogenesis

The Notch signaling pathway is an evolutionarily conserved signaling system found in
most animals. There are four Notch receptors (NOTCH1, NOTCH2, NOTCH3,
NOTCH4) and six ligands (DLL1, DLL2, DLL3, DLL4, JAG1, JAG2) (Fiúza and Arias
2007; Bray 2006). Important for cell-cell communication, the Notch signaling pathway
offers a wide variety of cellular functions. Notch pathways play a critical role in
developmental processes, controlling cell fate decisions, cell death, and maintaining cells
in the stem state (Fiúza and Arias 2007; Ohishi et al. 2000). Activation of NOTCH by
one of its ligands results in the cleavage of its intracellular domain (NICD), where it
translocates to the nucleus to repress or activate transcription (Figure 1-4) (Lathia et al.
2008). The main target genes of NOTCH include two families of transcription factors,
Hes and Hey, which have been implicated in neurodevelopment (Jalali et al. 2011;
Sakamoto et al. 2003; Kandasamy et al. 2010). NOTCH proteins are highly prevalent in
the telencephalon during early embryogenesis but can also be found in post-mitotic
neurons in the adult CNS (Yoon et al. 2004). High levels of NOTCH1 and DLL1 have
been localized to the neural tube of developing mouse fetuses (Dang et al. 2006; Gaiano
et al. 2000), while human embryos show high expression of NOTCH1 and minimal
NOTCH3 staining in the forebrain and spinal cord (Kostyszyn et al. 2004).
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Figure 1-4: Schematic of NOTCH activation.
Binding of NOTCH ligands (Delta, Jagged) on one cell to the NOTCH receptor on
another cell results in the cleavage of the Notch intracellular domain (NICD). NICD
enters the nucleus and interacts with DNA to result in the activation of various target
genes.
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In neurodevelopment, NOTCH signaling has been implicated in maintenance of neural
precursor cell populations within the ventricular zone, as well as controlling the balance
between gliogenesis and neurogenesis. In mice, expression of all four NOTCH proteins
can be found throughout various stages of CNS development, but their expression is
predominantly found in undifferentiated cells (Lindsell et al. 1996; de la Pompa et al.
1997). Knockout of NOTCH1 leads to embryonic lethality at GD 9.5 and 11.5 in mice,
with null embryos exhibiting exacerbated neuronal differentiation (Swiatek et al. 1994;
de la Pompa et al. 1997). Loss of function models of NOTCH components can cause
depletion of the neural precursor cell pools while simultaneously increasing neuronal
differentiation (Bolós et al. 2007). Additionally, in vitro models demonstrate that
expression of NOTCH1 can block neurogenesis but not gliogenesis (Nye et al. 1994),
further indicating the importance of balanced NOTCH expression in neurogenesis.

1.3.3

Infections, Inflammation, and Neurodevelopment

There is mounting evidence that inflammation plays a role in central nervous system
injuries in both the fetal and adult brain. During fetal life and infancy, the brain is
vulnerable to insults, and several neurodevelopmental disorders have been linked to MIA
including ASD, schizophrenia, epilepsy, and depression (Knuesel et al. 2014).
Neurodevelopmental disorders include a wide range of conditions that emerge in early
childhood and adolescence that are primarily associated with abnormal brain function.
These disorders often result in persistent impairments in cognitive, social, academic, and
occupational functioning, and can include ASD, schizophrenia, intellectual disabilities,
attention-deficit/hyperactivity disorder, conduct disorders, cerebral palsy, as well as
vision and hearing impairments. While there is considerable overlap in phenotypes
between various disorders, there is considerable sexual dimorphism that is skewed
towards males for neurodevelopmental disorders like ASD, while depression is more
common in women (Motlagh et al. 2010; Weissman et al. 1996; Kessler et al. 1994).
Exposure to maternal infections during in utero development is associated with offspring
exhibiting cognitive impairments later in life (Brown et al. 2001; Selten et al. 2010;
Chess 1971; Lubinsky 1979; O’Callaghan et al. 1991; Sham et al. 1992). This hypothesis
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dates back to the 1918 Spanish influenza pandemic where researchers documented
evidence of the development of psychiatric disorders in offspring from mothers with
influenza exposure during their pregnancy (Menninger 1926; Yudofsky 2009). Similar
effects were observed following an outbreak of Rubella in the USA in 1964, where there
was a 19% increase in cases of schizophrenia and a 12% increase in cases of ASD (Estes
and McAllister 2016; Li et al. 2009). Additionally, maternal exposure to parasites (i.e.,
toxoplasma gondii) during early gestation leads neurological impairments in offspring
like microencephaly, blindness, and developmental delays (Gleason and Back 2005;
McAuley 2014). Administration of viruses like influenza to pregnant mice during early
gestation results in an increase in the volume of the adult offspring brain, however
exposure during late gestation results in decreased brain volumes (Fatemi et al. 2002; Shi
et al. 2003). While there are varying reports of viruses causing brain overgrowth and
undergrowth, it is important to note that route of administration, dose and duration, as
well gestational timing may be responsible for these differing results (Meyer et al. 2006;
Meyer et al. 2008).
Activation of the maternal immune system by infections, stress, smoking, obesity,
autoimmunity, or inflammation during early pregnancy can affect both innate and
adaptive immune systems. Inflammatory mediators, like cytokines and chemokines can
influence the function, development, and maintenance of neurons within the brain
(Zalcman et al. 1994; Ling et al. 1998; Dunn 2006). Cytokines play an essential role in
the development of the central nervous system, acting as signaling molecules while
maintaining their immunomodulatory roles, resulting in the developing CNS remaining
susceptible to perturbations in cytokine levels (Ling et al. 1998; Dunn 2006). Animal
models in which MIA is induced, such as injection of PolyI:C or LPS into pregnant
rodents, has allowed for a deeper understanding of the impact of the maternal immune
response on fetal brain development. Early studies of MIA and its effects on fetal
neurodevelopment in rodents linked increased rates of behavioral abnormalities (similar
to those seen in human ASD and schizophrenia cases) in offspring to mothers with
prenatal influenza infections (Fatemi et al. 2002; Fatemi et al. 1999). Several animal
studies utilize the effects of MIA to induce a wide range of brain and behavioral
dysfunctions, including symptoms observed in ASD and schizophrenia (Meyer et al.
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2007; Traynor et al. 2004). Similarity like exposing animals to true pathogens, the use of
MIA methods allows for the potent activation of the maternal immune system, including
proinflammatory cytokines. Both methods result in impairments in social behaviors and
sensorimotor gating as well as increases in anxiety-like behaviors which are correlated to
the similar phenotypes of altered neuronal migration, synaptic function and structure
observed in cases of ASD and schizophrenia (Choi et al. 2016; Wu et al. 2017).
Studies using animal models have further shown that the maternal immune response is
primarily responsible for the behavioral changes observed in offspring, rather than the
pathogen itself (Meyer et al. 2005; Shi et al. 2003; Zuckerman et al. 2003). Additionally,
animal models have indicated that variations in timing, intensity, and type of immune
activation can result in a broad spectrum of behavioral phenotypes in offspring. It has
been well documented that the effects of MIA on neurodevelopment can vary between
strains of animal, the dosage given, and administration route of the MIA-inducing agent
(Arsenault et al. 2014; Schwartzer et al. 2013).
Studies using PolyI:C as a model of MIA in mouse and rat models have consistently
reported that offspring present with anxiety like behaviors coupled with disrupted growth
in offspring, as well changes in the cerebral vasculature and decreases in brain volumes
(Piontkewitz et al. 2011). As neural precursor cells differentiate and divide from the
ventricular zone, they migrate outwards towards the cortical plate, a process that has been
shown to be hindered by administration of PolyI:C and influenza (Fatemi et al. 1999;
Meyer et al. 2006). Additionally, elevations in pro-inflammatory cytokines like IL-6 can
drive neural precursor cells from neurogenic pathways to the gliogenic state (Nakanishi et
al. 2007). While migration of cortical interneurons is delayed following PolyI:C
administration in mice, inhibition of IL-6 does not rescue this effect (Gumusoglu et al.
2017). MIA from polyI:C has also demonstrated increased cell death in hippocampal and
cortical neurons in neonatal pups (Zuckerman et al. 2003). Several studies have also
shown the MIA at mid-gestation can lead to decreased synaptic transmission, impaired
cortical connectivity, and an increase in the activity and number of microglia in postnatal
rats (Coiro et al. 2015; Dean et al. 2011; Girard et al. 2010; Juckel et al. 2011). Microglia
are the resident macrophages found throughout the brain not only serving immune
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defense roles but also participating in normal neurodevelopmental functions. Changes in
microglial activity and number following MIA may lead to decreased NPC cell numbers
in the fetal brain and result in pathological behaviors later in life (Cunningham et al.
2013; Paolicelli and Gross 2011). It is possible, therefore, that changes in fetal brain
morphology may result from the effects of MIA directly or through impairments in
neurodevelopmental processes.
ASD is a complex neurodevelopmental disorder that is primarily characterized by
impairments in social behaviors and the presence of repetitive behaviors (American
Psychiatric Association 2013). According to the Canadian medical association journal
approximately 1-2% of the population is on the autistic spectrum, and 1 in 66 children
will be diagnosed with ASD (Anagnostou et al. 2014; Anon n.d.). Genetic disorders
account for approximately 10% of ASD cases, while the other 90% have an unknown
etiology (Muhle et al. 2004). Researchers noticed neurological abnormalities similar to
those in ASD in MIA models, highlighting a possible link between maternal
inflammation and early exposure to proinflammatory cytokines (Croonenberghs et al.
2002; Fatemi et al. 2008; Smith et al. 2007).
The association between maternal PolyI:C exposure and behavioral deficits in offspring
are similar to the behavioral phenotypes observed in offspring exposed to viruses (i.e.,
influenza) during pregnancy (Reisinger et al. 2015). Pups exposed to PolyI:C in utero
exhibit increased anxiety-like behaviors and decreased post-natal weights and decreased
motor function (Arsenault et al. 2014). Administration of PolyI:C to pregnant mice
results in transcriptional changes in the fetal brain and perturbations in key neurological
developmental processes which can contribute to inflammation-associated
neurodevelopmental disorders (Kalish et al. 2021). Many MIA studies have focused on
male offspring in part due to the male predominance of human ASD (Coiro and Pollak
2019; Klein and Corwin 2002; Brown and Meyer 2018), but it is important to consider
both sexes as a biological variable in MIA-associated responses.
It is of interest that many neurodevelopmental disorders affect a larger proportion of
males. In autism diagnoses the incidence ratio of male-to-females is 4:1, schizophrenia
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was 2:3, and the incidence of Parkinson’s disease is a 2:1 ratio (Baird et al. 2000; Scott et
al. 2002; Kirkbride et al. 2006; Van Den Eeden et al. 2003). It is believed that the
regulation of cerebellar development varies between biological sexes, with various genes
and proteins being expressed at different levels between sexes; however, the mechanisms
in which environmental and genetic factors can affect CNS development remain poorly
understood (Suárez et al. 1992; Ramírez and Jiménez 2002). Therefore, recognition of
sex-related differences in development and function of the CNS is required to further
understand the possible molecular mechanisms leading to a disproportionate incidence
rate of neurodevelopmental disorder diagnoses in males.

1.4 Rationale & Study Aims
There is a strong association between infections during pregnancy and the development
of placenta-associated disorders and obstetric complications like preeclampsia, FGR,
preterm labor, and spontaneous abortion (Brown et al. 2000; Pereira et al. 2014; CondeAgudelo et al. 2008). There are pathogen-specific immune responses responsible for
impairments in both placenta and fetal development, however, epidemiological data
implicates the maternal immune response as an increased risk factor for developing
obstetric complications and impairments in fetal neurodevelopment (Scharfe-Nugent et
al. 2012; Gomez-Lopez et al. 2016; Buka et al. 2008; Buka et al. 2001). The similar
effects on fetal and placental development between infections and pathogen-free proinflammatory immune responses indicate a common underlying mechanism where the
maternal immune response is the likely cause; however, the relationship between
impaired fetal and placental development due to MIA is not yet known.
Thus, the overall hypothesis of my thesis is that MIA during pregnancy will disrupt
normal placental and fetal development.
The specific objectives of this project were:
1)

To determine the effects of a systemic maternal pro-inflammatory response on

development of the placenta, and if this affects growth of the fetus.
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2)

To investigate the effects of early-gestation maternal immune activation on

neurodevelopment of the offspring.
3)

To compare gene expression profiles of IL15Δ/Δ and WT rat deciduas, in order to

uncover novel regulatory factors produced by uNK cells.
Together, my work will further our understanding of the role of the maternal immune
system in healthy and pro-inflammatory conditions on the progression of pregnancy at
both the placental and fetal level.
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Chapter 2

2

Antiviral Inflammation during Early Pregnancy Reduces
Placental and Fetal Growth Trajectories

Many viruses are detrimental to pregnancy and negatively affect fetal growth and
development. What is not well understood is how virus-induced inflammation impacts
fetal–placental growth and developmental trajectories, particularly when inflammation
occurs in early pregnancy during nascent placental and embryo development. To address
this issue, we simulated a systemic virus exposure in early pregnant rats (gestational day
8.5) by administering the viral dsRNA mimic polyinosinic:polycytidylic acid (PolyI:C).
Maternal exposure to PolyI:C induced a potent antiviral response and hypoxia in the early
pregnant uterus, containing the primordial placenta and embryo. Maternal PolyI:C
exposure was associated with decreased expression of the maternally imprinted genes
Mest, Sfrp2, and Dlk1, which encode proteins critical for placental growth. Exposure of
pregnant dams to PolyI:C during early pregnancy reduced fetal growth trajectories
throughout gestation, concomitant with smaller placentas, and altered placental structure
at midgestation. No detectable changes in placental hemodynamics were observed, as
determined by ultrasound biomicroscopy. An antiviral response was not evident in rat
trophoblast stem (TS) cells following exposure to PolyI:C, or to certain PolyI:C-induced
cytokines including IL-6. However, TS cells expressed high levels of type I IFNR
subunits (Ifnar1 and Ifnar2) and responded to IFN-⍺ by increasing expression of IFNstimulated genes and decreasing expression of genes associated with the TS stem state,
including Mest. IFN-⍺ also impaired the differentiation capacity of TS cells. These
results suggest that an antiviral inflammatory response in the conceptus during early
pregnancy impacts TS cell developmental potential and causes latent placental
development and reduced fetal growth.

2.1 Introduction
Successful pregnancy requires a delicate balance between proinflammatory and antiinflammatory pathways. Pathological inflammation disrupts this balance and is an
underlying feature of a spectrum of prevalent pregnancy complications (Romero et al.
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2007). In humans, it is difficult to discern whether inflammation is a cause or
consequence of a compromised pregnancy, but circumstantial and epidemiological
evidence implicate inflammation as a component of disease pathogenesis (Cotechini and
Graham 2015; Mor et al. 2011). A direct link between inflammation and various
pregnancy pathological conditions has been demonstrated in animal models in which
dams are exposed to microbial products called pathogen-associated molecular patterns,
resulting in changes in labor onset and alterations in fetal survival, growth, and
developmental trajectories (Renaud et al. 2011; Chatterjee et al. 2012; Cotechini et al.
2014; Bakos et al. 2004). However, the underlying mechanisms through which
inflammation compromises fetal growth and development are still unknown.
Fetal growth restriction (FGR; also known as intrauterine growth restriction) is a serious
pregnancy complication associated with failure of a fetus to grow to its full potential.
Although an accepted definition and consensus diagnosis of FGR are lacking, it is
generally defined as fetal weight below the 10th percentile for that population and
gestational age while considering sex, race, and genetic growth potential (Anon 2019).
Identifying cases of morbid FGR versus healthy fetuses that are constitutionally small
remains a significant problem. In general, FGR is one of the most important indicators of
pregnancy outcome including prematurity, stillbirth, intrapartum fetal distress,
hypoglycemia, and meconium aspiration pneumonia (Brodsky and Christou 2004), as
well as long-term growth impairments and permanent pulmonary, metabolic, endocrine,
and neurobehavioral sequelae (Sharma et al. 2016). FGR may be caused by multiple
factors, including chromosomal aberrations, vascular abnormalities, and infections and in
many cases is associated with inflammation as an underlying feature (Raghupathy et al.
2012). In 40–50% of cases, the cause of FGR is idiopathic and attributed to
maldevelopment or dysfunction of the placenta.
The placenta is the extraembryonic organ that ensures an adequate nutrient and gas
supply for the fetus and as such is a critical regulator of fetal growth and development.
The efficiency of transferring substrates needed for fetal growth, including oxygen,
amino acids, glucose, and fatty acids, to the fetal circulation is dependent on placental
size, morphology, and blood flow (Sibley et al. 2010). Formation of the placenta begins
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shortly after blastocyst implantation and is contingent on proper proliferation and
differentiation of trophoblast stem (TS) cells. TS cells are multipotent progenitor cells
that specialize into heterogeneous trophoblast subtypes that form the bulk of the placenta
and perform various functions required for fetal growth and pregnancy success. In
humans, TS cells differentiate into extravillous trophoblasts, which direct maternal
resources to the conceptus, and villous trophoblasts, which specialize in nutrient transfer
between maternal and fetal blood. A similar dichotomous organization of the placenta
occurs in rodents, in which junctional zone and labyrinth zone trophoblasts perform
analogous functions to extravillous and villous trophoblasts, respectively (Baines and
Renaud 2017). TS cell development and differentiation are adaptable and respond to
changes in the surrounding environment, including cellular stress and changes in oxygen
and nutrient delivery, providing the placenta a degree of plasticity during its early
development to facilitate embryo survival during extrinsic challenges (Soares et al.
2018). Trophoblasts cultured from rodent blastocysts and ectoplacental cones alter their
survival and differentiation potential in response to IFNs (Ain et al. 2003; Athanassakis et
al. 2000; Hoshida et al. 2007; Buchrieser et al. 2019), indicating that inflammation may
be an additional extrinsic challenge that can impact placental morphology and fetal
growth.
To determine the effect of systemic inflammation on placental development and fetal
growth, we injected rats with the viral mimic polyinosinic:polycytidylic acid (PolyI:C)
during early pregnancy. PolyI:C is a synthetic analogue of dsRNA: a molecular pattern
produced by many viruses, either as the genetic material for some RNA viruses or as an
intermediate for viral RNA synthesis. PolyI:C is a ligand for the pattern recognition
receptors TLR3, retinoid acid inducible gene-1 (RIG1), and melanoma differentiationassociated gene 5, which enables mammalian cells to detect the presence of viruses and
initiate cellular antiviral responses, such as production of IFNs (Palchetti et al. 2015).
Given the purported immune tolerance mechanisms evident within the conceptus during
early pregnancy, we were uncertain whether an antiviral response would be evident at
this site. We found that PolyI:C exposure during early pregnancy induced a robust
antiviral response and hypoxia within the conceptus, close to the location of placental
development. The antiviral response was associated with reduced placental and fetal size
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during middle and late pregnancy. Furthermore, we provide evidence that rat TS cells are
responsive to IFN-α, and IFN-α exposure decreased expression of stem-related genes in
these cells and reduced their differentiation capacity. Our results suggest that an IFNmediated intrauterine antiviral response during early pregnancy causes transient placental
dormancy by inhibiting TS cell developmental potential, resulting in smaller-than-normal
placentas and fetuses.

2.2 Materials and Methods
2.2.1

Animals

Female (6–8 wk) and male (8–10 wk) Sprague Dawley rats were obtained from Charles
River Laboratories and maintained in a 12-h light/12-h dark cycle with food and water
available ad libitum. Females were cycled by daily inspection of cells within a vaginal
lavage and mated when in proestrus with a fertile male. Gestational day (GD) 0.5 was
defined as the day immediately following mating if spermatozoa were detected within the
vaginal lavage. All protocols involving the use of rats were approved by the University of
Western Ontario Animal Care and Use Committee.

2.2.2

Experimental protocol and tissue collection

In the first set of experiments, pregnant rats received PolyI:C (1, 5, or 10 mg/kg; SigmaAldrich) or sterile saline i.p. on GD8.5. Dams were sacrificed on GD13.5 to assess for
fetal viability. Based on these results, 10 mg/kg PolyI:C was used in all subsequent
experiments because there was no difference in litter size or number of resorptions with
any of the doses tested, and it is a dose that has been previously used in pregnant dams to
elicit longterm metabolic and neurodevelopmental problems in offspring (20–24). For
experiments in which fetal and placental growth were analyzed, dams were sacrificed on
GD8.5 (6 h after maternal saline or PolyI:C injection), GD13.5 (5 d after maternal saline
or PolyI:C injection), or GD18.5 (10 d after maternal saline or PolyI:C injection) using
mild carbon dioxide inhalation until respiratory failure, followed by cardiac puncture or
decapitation. For tissues collected on GD8.5, whole conceptuses (containing decidua,
placenta, and embryo) were isolated and either snap-frozen in liquid nitrogen or fixed in
10% neutral buffered formalin. For analysis of placental and fetal weights on GD13.5 or
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GD18.5, uterine horns were dissected to isolate whole conceptuses, preserved in 10%
neutral buffered formalin for 24 h, and then dissected to isolate and independently weigh
the fetus and placenta. Preservation was used to enhance the structural integrity of fetal
tissue, particularly for tissues isolated on GD13.5, and ensure that residual fetal
membranes were completely removed. Fetal weights were consistent between fresh and
fixed specimens. Fetal crown-rump length was also measured using a digital caliper. For
cryosections, whole conceptuses were placed in dry ice–cooled heptane and stored at
−80˚C until sectioned. For paraffin-embedded sections, whole conceptuses were fixed in
10% neutral buffered formalin for at least 24 h, then transferred to 70% ethanol and
stored at 4˚C prior to sectioning.

2.2.3

RT-PCR

RNA was extracted from tissue by homogenizing in TRIzol (Thermo Fisher Scientific).
The aqueous phase was then diluted with 70% ethanol, placed on RNeasy columns
(Qiagen), treated with DNase I, and purified. RNA was extracted from cells by lysing in
TRIzol and proceeding as directed by the manufacturer. cDNA was generated from
purified RNA (50 ng/μl) using High-Capacity cDNA Reverse Transcription kit (Thermo
Fisher Scientific), diluted 1:10, and used for conventional RT-PCR or quantitative RTPCR (qRT-PCR). Conventional RT-PCR was conducted using primers described in Table
I, and DreamTaq DNA Polymerase (Thermo Fisher Scientific) to amplify cDNA. Cycling
conditions involved an initial holding step (95˚C for 3 min), followed by 34 cycles of
PCR (95˚C for 30 s, 55˚C for 30 s, and 72˚C for 1 min), and a final elongation phase at
72˚C for 5 min. PCR products were resolved on 2% agarose gels and imaged using a
ChemiDoc imaging system (Bio-Rad Laboratories). For qRT-PCR, cDNA was mixed
with SensiFAST SYBR green PCR Master Mix (FroggaBio) and primers described in
Table 2-1. A CFX Connect Real-Time PCR system (Bio-Rad Laboratories) was used for
amplification and fluorescence detection. Cycling conditions were as follows: an initial
holding step (95˚C for 3 min), followed by 40 cycles of two-step PCR (95˚C for 10 s,
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Table 2-1: List of Primers used for RT-PCR.
Gene
Actb
Cdx2
Cxcl10
Dio3
Dlk1
Ddx58
Eef2
Gapdh
Gcm1
Id2
Ido1
Ifna
Ifnar1
Ifnar2
Igf2
Il1b
Il6
Il6r
Irf7
Isg15
Isg20
Magel2
Mest
Mx1
Plagl1
Peg3
Peg10
Pgf
Prl3b1
Rn18s
Rsad2
Sfrp2
Tlr3
Vegfa
Ywhaz

Accession Number
NM_031144.3
NM_023963.1
NM_139089.1
NM_017210.4
NM_053744.1
NM_001106645.1
NM_017245.2
NM_017008.4
NM_017186.2
NM_013060.3
NM_023973.1
NM_001014786.1
NM_001105893.1
XM_006248107.3
NM_001190162.1
NM_031512.2
NM_012589.2
NM_017020.3
NM_001033691.1
NM_001106700.1
NM_001008510.1
XM_001054803.6
NM_001009617.1
NM_001271058.1
NM_012760.3
NM_001304816.1
XM_008762737.1
NM_053595.2
NM_012535.3
NM_046237.1
NM_138881.1
NM_001276712.1
NM_198791.1
NM_001110333.2
NM_013011.3

Forward Sequence
5’-agccatgtacgtagccatcc-3’
5’-gagcacggacactgtgagaa-3’
5’-tgtccgcatgttgagatcat-3’
5’-gcctctacgtcatccagagc-3’
5’-gagctggcggtcaatatcat-3’
5’-tcctcccacctgtttgagac-3’
5’-cgcttctatgccttcggtag-3’
5’-agacagccgcatcttcttgt-3’
5’-cctcaatgattgcctgtcct-3’
5’-tgaaagccttcagtccggtg-3’
5’-cgtggatccagacacctttt-3’
5’-ggtggtggtgagctactggt-3’
5’-attacgtgttctccccacca-3’
5’-tggcccacaaatgttcttct-3’
5’-cggacgacttccccagatac-3’
5’-aggcttccttgtgcaagtgt-3’
5’-gccagagtcattcagagcaa-3’
5’-agggtgtctgcttcctgcta-3’
5’-cctctgctttctggtgatgc-3’
5’-gccatgacctggaacctaaa-3’
5’-tctgaaaggcaagctggtg-3’
5’-tccagcctgcctctactgat-3’
5’-ccatcgtcctctccttctcc-3’
5’-cctgaggtaaggctgtggaa-3’
5’-ggtgctgccttttcagagtc-3’
5’-cagaatgaactggcagacga-3’
5’-gttgaccgtgtccgtgtatg-3’
5’-agacgacaaaggcagaaagg-3’
5’-acctggagctgttggaagtg-3’
5’-gcaattattccccatgaacg-3’
5’-gggatgctagtgcctactgc-3’
5’-tgtccgatagggacctgaag-3’
5’-ggtggcccttaaaagtgtgg-3’
5’-caatgatgaagccctggagt-3’
5’-ttgagcagaagacggaaggt-3’

Reverse Sequence
5’-ctctcagctgtggtggtgaa-3’
5’-agaagccccaggaatcactt-3’
5’-gggtaaagggaggtggagag-3’
5’-gcccaccaattcagtcactt-3’
5’-gcatagagggagctgtgagg-3’
5’-acaagccatgttaggggatg-3’
5’-gtagtgatggtgccggtctt-3’
5’-cttgccgtgggtagagtcat-3’
5’-tccaggtttgtgcttcatca-3’
5’-gagcttggagtagcagtcgt-3’
5’-ggctggaggcatgtactctc-3’
5’-ttgagccttctggatctgct-3’
5’-cgattctcctctccagcaac-3’
5’-gtgcaccctaatgctgtcct-3’
5’-ctgaacgcttcgagctcttt-3’
5’-tgagtgacactgccttcctg-3’
5’-cattggaagttggggtagga-3’
5’-ttgtgaaaaggcaagctcct-3’
5’-gcgctcagtcatcagaactg-3’
5’-ctgcctgataagggcaacac-3’
5’-tggacgtgtcgtagatggtg-3’
5’-gacttggaagcctctgcatc-3’
5’-tcccgtcattgttgcgaatc-3’
5’-aatacggccccacaaaacac-3’
5’-ccacactcagtcttggagca-3’
5’-ggtgtaggagggcccatatt-3’
5’-gacgtctgatcttgcgtttg-3’
5’-tctcctctgagtggctggtt-3’
5’-gacagggatggctactcagc-3’
5’-ggcctcactaaaccatccaa-3’
5’-ctgagtctccttgggctcac-3’
5’-cgagaagccactccactagg-3’
5’-ggtttgcgtgtttccagagt-3’
5’-tttcttgcgctttcgttttt-3’
5’-cctcagccaagtagcggtag-3’
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60˚C for 45 s), then a dissociation step (65˚C for 5 s and a sequential increase to 95˚C).
Relative mRNA expression was calculated using the comparative cycle threshold (Ct)
(ΔΔCt) method. The geometric mean of Ct values obtained from amplification of five
constitutively expressed genes (Rn18s, Ywhaz, Eef2, Gapdh, and Actb) was used as
reference RNA. Ct values from each of these genes were stable among the conditions
tested.

2.2.4

Ultrasound

Ultrasound imaging and Doppler waveform recordings were used to compare blood flow
patterns in the maternal uterine artery and fetal umbilical vessels. Dams were
anesthetized with inhaled isoflurane (4% induction, 1-3% maintenance). Body
temperature was maintained at 36-38˚C with a heating pad. Heart rate and respiratory
physiology were monitored throughout the imaging procedure. Hair was removed from
the abdomen by shaving, followed by application of a depilatory cream, after which a
coupling gel (37˚C) was applied. Rats were imaged transcutaneously using a preclinical
ultrasound imaging system (model Vevo 2100; FujiFilm VisualSonics) coupled with MS250 (20 MHz, uterine artery) and MS-400 (30 MHz, umbilical artery) MicroScan
transducers. The transducer beam angle was set to <45˚ for all measurements. Doppler
waveforms were obtained from the uterine artery near the utero-cervical junction and
from the umbilical artery spanning the fetal–placental junction. Peak systolic velocity
(PSV) and end diastolic velocity (EDV) were manually measured from three sequential
cardiac cycles, and data were averaged. The resistance index (RI) (RI = [PSV −
EDV]/PSV) was then calculated to quantify the resistance of arterial blood velocity
waveforms. Uterine artery measurements were recorded from nine dams per group;
umbilical artery measurements were conducted in at least two conceptuses from each of
these dams. The duration of anesthesia was limited to no more than 45 min. During this
time, maternal and fetal circulatory parameters were not noticeably affected.

2.2.5

Western blotting

Protein expression was evaluated by Western blotting. Total protein in tissues was
isolated by homogenizing snap-frozen GD 8.5 conceptuses in radioimmunoprecipitation
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assay lysis buffer (50 mM Tris, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% SDS, pH 7.2) supplemented with protease inhibitor mixture (SigmaAldrich) and then sonicated (Sonic Dismembrator Model 100; Thermo Fisher Scientific).
A modified bicinchoninic acid assay (Bio-Rad Laboratories) was used to measure total
protein concentrations. Approximately 25 μg of tissue lysates were mixed with 4✕
loading buffer (final volume: 62.5 mM Tris, pH 6.8, 2% SDS, 10% glycerol, 0.025%
bromophenol blue, 50 mM DTT), boiled for 5 min, and subjected to SDS-PAGE.
Proteins were then transferred to polyvinylidene difluoride (PVDF) membranes, blocked
with 3% BSA in TBS containing 0.1% Tween-20, and probed with primary Abs specific
for STAT1 (catalog no. 14994, 1:1000; Cell Signaling Technology), VIPERIN (catalog
no. MABF106, 1:1000; Sigma-Aldrich), and IFN regulatory factor (IRF) 1 (catalog no.
8478, 1:1000; Cell Signaling Technology). Expression of GAPDH (catalog no. 5174,
1:1000; Cell Signaling Technology) was used as a loading control. Following incubation
with species-appropriate, infrared-conjugated secondary Abs (Cell Signaling
Technology), protein signals were detected using a LI-COR Odyssey imaging system
(LI-COR Biotechnology).

2.2.6

Immunohistochemistry

Frozen conceptuses were embedded in Optimal Cutting Temperature compound and
cryosectioned at 10-mm thickness. Sections were fixed in 10% neutral buffered formalin,
permeabilized using 0.3% Triton-X and 1% BSA in PBS, and blocked in 10% normal
goat serum (Thermo Fisher Scientific). Sections were immersed in primary Abs specific
for cytokeratin (catalog no. 628602, 1:400; BioLegend) and vimentin (catalog no. MA511883, 1:50; Invitrogen) overnight at 4˚C. After washing, sections were immersed in
species-appropriate biotin-conjugated secondary IgG Abs followed by Vectastain ABC
Elite reagent (Vector Laboratories), and color was developed using 3-amino-9ethylcarbazole (AEC) red (Thermo Fisher Scientific). Sections were counterstained with
Gill No. 1 hematoxylin (Sigma-Aldrich) and mounted using Fluoromount-G mounting
medium (SouthernBiotech). Images were acquired using a Nikon ECLIPSE Ni Series
microscope equipped with a Ds-Qi2 camera. Placental sections that were immunostained
using vimentin (which is detectable in labyrinth zone and uterine tissue but not in
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junctional zone and is therefore useful for demarcating different placental zones) were
subjected to morphometric analysis using ImageJ software (25). The mean thickness of
the conceptus, placenta (junctional zone and labyrinth zone), and each zone was
calculated following three independent measurements within the middle of the placenta.
The mean area of each placenta and zone was calculated following three independent
measurements of the perimeter. All measurements were conducted by two researchers
who were blinded to the experimental treatments, and results between observers were
averaged.
To detect localization of perforin-containing cells on GD8.5, whole conceptuses were
collected, fixed in 10% neutral buffered formalin, embedded with paraffin, and sectioned
at 5-mm thickness. Sections were dewaxed in Histo-clear and rehydrated using increasing
dilutions of ethanol. Formaldehyde crosslinks were broken by immersing sections in a
retrieval solution (Reveal Decloaker; BioCare Medical) heated to 95˚C for 20 min.
Sections were then permeabilized using 0.3% Triton-X and 1% BSA in PBS and blocked
in 10% normal goat serum. Samples were immersed in primary Ab specific for rat
perforin (catalog TP251, 1:400; Torrey Pines Biolabs) overnight at 4˚C, followed by
Alexa 555–conjugated anti-rabbit secondary Ab for 1 h at room temperature. Sections
were then immersed in an Ab specific for cytokeratin (BioLegend) for 1 h, then exposed
to Alexa 488–conjugated anti-mouse secondary Abs, and mounted using Fluoromount-G.
Images were acquired using a Nikon ECLIPSE Ni Series microscope equipped with a DsQi2 camera. Sections were subjected to localization analysis using ImageJ software (25).
The distance between the bulk of perforin-positive cells and the tip of the ectoplacental
cone was measured in arbitrary units (pixels) and calculated relative to the length of the
ectoplacental cone.

2.2.7

Detection of hypoxia

To assess hypoxia in uterine and placental tissue after maternal PolyI:C exposure,
immunohistochemical staining for pimonidazole was performed. Pimonidazole
covalently binds to thiol groups in proteins of cells exposed to hypoxia (PO2 < 10 mm
Hg). Pimonidazole adducts can then be detected immunohistochemically to denote tissue
areas exposed to hypoxic conditions. Rats were i.p. injected with pimonidazole
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hydrochloride (hypoxyprobe-1, 60 mg/kg; Natural Pharmacia) 2.5 h before sacrifice.
After euthanasia, whole conceptuses were collected, fixed in 10% neutral buffered
formalin, and embedded with paraffin. Paraffin-embedded tissues were then sectioned at
5-μm thickness. Sections were dewaxed in Histo-clear and rehydrated using increasing
dilutions of ethanol. Formaldehyde crosslinks were broken by immersing sections in
Reveal Decloaker, as described above. Endogenous peroxidases were then inhibited using
3% hydrogen peroxide in PBS, and tissues were blocked in 10% normal goat serum.
Sections were incubated in hypoxyprobe-1 mouse mAb (clone 4.3.11.3, 1:50; Natural
Pharmacia), followed by biotin-conjugated anti-mouse secondary IgG Ab. Following
wash, samples were then immersed in Vectastain (Vector Laboratories) for 30 min at
room temperature, and color was developed using AEC red (Thermo Fisher Scientific).
Samples were counterstained with Gill No. 1 hematoxylin (Sigma-Aldrich), mounted,
and imaged as above.

2.2.8

Rat TS cell cultures

Blastocyst-derived rat TS cells (Asanoma et al. 2011) were used to evaluate the effects of
PolyI:C, or selected PolyI:C-induced cytokines, on trophoblast cell behavior. Rat TS cells
were generously provided by Michael Soares (University of Kansas Medical Center,
Kansas City, KS). Cells were cultured in RPMI 1640 media (Life Technologies)
supplemented with 20% (v/v) FBS (Life Technologies), 100 μM 2-ME (Sigma-Aldrich),
1 mM sodium pyruvate (Sigma-Aldrich), 50 μM penicillin, 50 U/ml streptomycin,
fibroblast growth factor 4 (25 ng/ml; R&D Systems), and heparin (1 μg/ml; SigmaAldrich). A total of 70% of the media was preconditioned by mitomycin C–treated mouse
embryonic fibroblasts prior to being added to rat TS cells. PolyI:C (50 mg/ml),
recombinant rat IFN-α1 (100 U/ml or 1000 U/ml; R&D Systems), recombinant rat IL-6
(IL-6, 20 ng/ml; PeproTech), or recombinant rat IFN-γ (100 U/ml; PeproTech) was added
to TS cells for 24 h. Transfection of PolyI:C (50 mg/ml) into rat TS cells was conducted
using lipofectamine 2000 (Thermo Fisher Scientific). To determine the effect of IFN-α on
trophoblast differentiation, rat TS cells were cultured for 3 d as above but without mouse
embryonic fibroblast-conditioned media, fibroblast growth factor 4, activin A, or heparin
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and in the presence or absence of recombinant rat IFN-α1 (1000 U/ml). Media were
replaced daily.

2.2.9

Immunocytochemistry and EdU incorporation

Cells were fixed in 4% paraformaldehyde, permeabilized using 0.3% Triton-X, and
blocked using 10% normal goat serum (Life Technologies). Cells were then immersed in
anti-phospho-histone H3 Ab (1:1000, catalog no. 3377P; Cell Signaling Technology),
followed by goat anti-rabbit Alexa Fluor 488–conjugated secondary Ab. Nuclei were then
counterstained using DAPI (Thermo Fisher Scientific). For EdU, rat TS cells were treated
with 10 μM EdU (ClickiT EdU Proliferation Kit; Thermo Fisher Scientific) for 6 h,
followed by fixation as above. Detection of EdU was performed as per the
manufacturer’s instructions, and nuclei were detected by counterstaining with Hoechst.
Cells were imaged with a Zeiss Axio fluorescence microscope. The total number of cells,
and the number positive for phospho-histone H3 or EdU, was then counted in three
random nonoverlapping fields of view per well. The percentage of phospho-histone H3
and EdU-positive cells was then calculated by dividing the total number of positive cells
by the total number of cells, then multiplying by 100.

2.2.10

Statistical analysis

Values are expressed as mean ± SEM. Unless indicated otherwise, statistical significance
was analyzed by unpaired t test when comparing two groups and one-way ANOVA with
Tukey multiple comparisons test when comparing three or more groups. All statistical
tests were two sided, and differences were considered significant when p < 0.05. All
animal experiments were conducted with a minimum of three dams. The specific number
of dams and conceptuses analyzed is indicated in the figure legends.

2.3 Results
2.3.1

Maternal PolyI:C exposure triggers a potent antiviral
response within the conceptus during early pregnancy

PolyI:C is an analogue of dsRNA, which is a molecular pattern associated with viral
infection and a well-known inducer of antiviral immune responses. The pregnant uterus
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and fetal–placental unit are considered immune-privileged sites, so our first goal was to
determine whether systemic PolyI:C administration to pregnant dams elicited an antiviral
response within the conceptus (referring to decidualized uterine tissue along with
primordial placenta and embryo). Compared with pregnant rats administered saline,
expression of genes encoding various antiviral factors was increased within the conceptus
6 h after injecting pregnant rats with 10 mg/kg PolyI:C, including IFN-α (Ifna, 3.3-fold
increase), Il6 (11-fold increase), Il1a (17-fold increase), Il1b (6-fold increase), c-x-c
motif ligand (Cxcl) 10 (Cxcl10; 323-fold increase), IRF 7 (Irf7, 22-fold increase), IDO
(Ido1, 221-fold increase), radical SAM domain-containing 2 (Rsad2; 166-fold increase),
and Tlr3 (5-fold increase, Figure 2-1A, all p < 0.05, primer sequences provided in Table
I). Myxovirus resistance 1 (Mx1), which is an IFN-inducible gene encoding a dynaminlike GTPase that confers an antiviral state against a wide range of RNA viruses
(including influenza A) and some DNA viruses, was also highly upregulated in the
conceptus following PolyI:C exposure (386-fold increase, Figure 2-1A, p < 0.05). A
similar robust antiviral response was detected when transcript levels were evaluated
within isolated decidua following maternal PolyI:C exposure.
Next, we determined whether PolyI:C altered expression of select proteins associated
with antiviral immune responses. PolyI:C exposure to pregnant dams caused a rapid
increase in RSAD2 (also known as VIPERIN, which is a multifunctional protein that
inhibits viral processes) in the conceptus 2, 6, and 12 h after injection and increased IRF1
expression 2 and 6 h after injection. Both VIPERIN and IRF1 are directly and rapidly
activated by both PolyI:C and IFNs and contribute to the cellular antiviral state
(Stirnweiss et al. 2010). Injection of PolyI:C also increased expression of STAT1 in the
conceptus 12 and 24 h after maternal exposure (Figure 2-1B). The relatively longer time
required for increased STAT1 expression in comparison with VIPERIN and IRF1 likely
relates to the time required for protein stabilization and accumulation following
activation (Wenta et al. 2008). Collectively, these data indicate that maternal exposure to
PolyI:C during early pregnancy provokes a robust antiviral response near the site of
placental and embryonic development.
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Figure 2-1: Exposure of pregnant rats to PolyI:C elicits a robust antiviral response
in the conceptus.
RNA was isolated from the conceptus (containing decidua, primordial placenta, and
embryo) 6 h following maternal injection of 10 mg/kg PolyI:C or saline (0 mg/kg
PolyI:C) on GD8.5. (A) Expression of genes associated with antiviral responses after
saline or PolyI:C exposure. (B) Protein levels of STAT1, VIPERIN, IRF1, and GAPDH
are shown 2, 6, 12, and 24 h following maternal PolyI:C exposure (10 mg/kg) or 2 h
following maternal saline exposure (0 mg/kg). (C) Expression of maternally imprinted
genes associated with fetal and placental growth after saline or PolyI:C exposure. Results
represent means ± SEM. Data significantly different (p < 0.05) from controls are
indicated by an asterisk (*) (n = 9 from three dams per group).

82

We next assessed expression of nine maternally imprinted genes associated with
embryonic and placental growth and development (Piedrahita 2011). In pregnant rats
exposed to PolyI:C, we observed decreased expression of mesoderm-specific transcript
(Mest, 4-fold decrease), a gene highly associated with placental growth, as well as
secreted frizzled-related protein 2 (Sfrp2; 2.4-fold decrease) and d-like noncanonical
notch ligand 1 (Dlk1, 1.7-fold decrease, Figure 2-1C, all p < 0.05). Expression of Dio3
appeared to be decreased, although it did not reach statistical significance (p = 0.10, not
shown). No change in expression of MAGE family member L2 (Magel2; not shown),
paternally expressed gene 3 (Peg3), paternally expressed gene 10 (Peg10), or insulin-like
growth factor 2 (Igf2) was detected in the conceptus after maternal exposure to PolyI:C
(Figure 2-1C). Transcript levels of another maternally imprinted gene, PLAG1-like zinc
finger 1 (Plagl1), did not meet the threshold detection levels (Ct > 30 cycles).

2.3.2

Maternal PolyI:C exposure is associated with acute hypoxia
within the conceptus during early pregnancy

To assess whether maternal administration of PolyI:C increased tissue hypoxia within the
conceptus, immunohistochemical detection of pimonidazole was used. Sections of the
conceptus collected from saline-injected dams showed moderate levels of pimonidazole
immunoreactivity, indicative of hypoxic regions proximate to the primordial placenta
(Figure 2-2). In comparison, following maternal PolyI:C administration, pimonidazole
immunoreactivity was noticeably more intense, suggesting that PolyI:C administration
altered tissue oxygenation (Figure 2-2). Likewise, maternal administration of PolyI:C was
also associated with a 1.7-fold increase in hypoxia-inducible factor 1 a (Hif1a) transcript
levels, and a 2-fold increase in transcript levels of the hypoxia-inducible gene Vegfa
within conceptuses (Figure 2-2C, p < 0.05). The pregnant uterus contains an abundant
population of perforin containing uterine NK cells. PolyI:C alters the activation of uterine
NK cells (Thaxton et al. 2013; Hsiao and Patterson 2011), so we sought to examine
whether maternal PolyI:C exposure during early pregnancy alters localization of these
cells. In dams injected with saline, perforin-containing cells were abundant within the
decidua, but few cells were detectable close to the site of placental development.
Following injection of PolyI:C, there appeared to be an accumulation of perforin-positive
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Figure 2-2: Detection of hypoxia in the conceptus following maternal exposure to
PolyI:C.
(A) Hypoxia was detected in sections of the conceptus collected 6 h following maternal
PolyI:C (10 mg/kg) or saline (0 mg/kg) exposure using hypoxyprobe. The black boxes
surround the ectoplacental cone (part of the primordial placenta), and a higher
magnification image is shown in (B). Scale bar in (A), 1000 μm. Scale bar in (B), 100
μm. (C) Transcript levels of Hif1a and Vegfa 6 h following saline or PolyI:C exposure.
Results represent means ± SEM. Data significantly different (p < 0.05) from controls are
indicated by an asterisk (*) (n = 9 from three dams per group).
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cells adjacent to the nascent placenta in some conceptuses. However, the effect was
variable, and we were unable to detect a statistically significant difference in the distance
separating perforin-positive cells from the nascent placenta. Collectively, these results
indicate that maternal PolyI:C exposure during early pregnancy alters the decidual
microenvironment during development of the nascent placenta and embryo.

2.3.3

Maternal PolyI:C exposure during early pregnancy is
associated with reduced fetal weight at mid and late
gestation

After determining that maternal PolyI:C administration during early pregnancy triggered
robust antiviral response and tissue hypoxia within the conceptus, our next goal was to
examine fetal growth and survival 5 and 10 d after maternal exposure to PolyI:C. On
GD13.5, average fetal weight was decreased by 10% in dams exposed to PolyI:C in early
pregnancy compared with those exposed to saline (Figure 2-3A, p < 0.05). Similarly,
fetal crown-rump length was reduced by 9% following maternal PolyI:C exposure
(Figure 2-3B, p < 0.05). Because fetal growth is often referenced to percentiles for a
given gestational age and babies smaller than the 10th centile are typically considered
small for gestational age, we characterized the distribution of control GD13.5 fetuses
using the saline-treated group to generate percentiles. Fetuses falling below the 10th
percentile (0.068 g weight; 8.17 mm crown-rump length) were considered FGR.
Strikingly, maternal PolyI:C exposure during early pregnancy caused 73% of fetuses to
fall below the FGR threshold in weight and 52% to fall below the FGR threshold in
crown-rump length (Figure 2-3A, 3B, p < 0.05). On GD18.5, fetal body weight and
crown-rump length remained smaller in dams exposed to PolyI:C, although these effects
were more modest in comparison with that which was observed on GD13.5 (decreased by
9 and 2% compared with saline-treated dams, respectively, Figure 2-3C, 2-3D, p < 0.05),
suggesting that these fetuses had some degree of catch-up growth. Using the same
percentile strategy to characterize distribution of control GD18.5 fetuses, we observed a
greater percentage of fetuses with weights and crown-rump lengths below the 10th centile
when dams were exposed to PolyI:C 10 d earlier (43% in weight, 16% in crown-rump
length, Figure 2-3C, 2-3D, p < 0.05). In line with the
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Figure 2-3: Maternal PolyI:C treatment early in pregnancy is associated with
decreased fetal size at mid and late pregnancy.
Following maternal administration of saline (0 mg/kg) or PolyI:C (10 mg/kg) on GD8.5,
litters were collected on GD13.5 (A, B, and F) or GD18.5 (C–E). Fetal weight (A and C)
and crown-rump length (B and D) were analyzed. (E) Fetal brain and liver weights were
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measured. (F) Litter size and number of resorptions are presented. Results represent
means ± SEM. Data significantly different from controls (p < 0.05) are indicated by an
asterisk (*) (n = 35 saline and n = 53 PolyI:C from at least six dams on GD13.5; n = 58
saline and n = 81 PolyI:C from at least six dams on GD 18.5)
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smaller overall fetal size, maternal PolyI:C exposure was associated with smaller fetal
liver weights (9% decrease, p < 0.05) and fetal brain weights (10% decrease, p < 0.05)
compared with saline-injected dams (Figure 2-3E). Surprisingly, we did not observe any
significant difference in litter size, as well as number of viable or resorbed fetuses,
indicating that PolyI:C did not affect fetal survival (Figure 2-3F). Thus, maternal
exposure to PolyI:C during early gestation is associated with delayed or impaired fetal
growth at mid and late gestation without affecting viability.

2.3.4

Maternal PolyI:C exposure results in smaller placentas

Proper development of the placenta is fundamental for supporting fetal growth
throughout pregnancy. Because maternal PolyI:C exposure induced a potent antiviral
response within the conceptus and was associated with reduced fetal growth, we next
evaluated the effect of PolyI:C on placental growth and development. As illustrated
schematically in Figure 2-4A, the rodent placenta is composed of three distinct zones.
The labyrinth zone is situated closest to the chorionic plate (and, hence, the fetus) and is
specialized to promote nutrient and gas transfer between maternal and fetal blood. The
middle layer is the junctional zone, which forms the interface between maternal and fetal
tissue. The maternal portion of the placenta includes the decidua and mesometrial
triangle, which contain a variety of cell types (e.g., stromal cells, blood vessels,
leukocytes) that support placentation and pregnancy outcome. We did not observe a
noticeable difference in the composition of the maternal portion of the placenta 5 d
following exposure to PolyI:C. Specifically, there was no evident change in the area or
thickness of the decidua or mesometrial triangle, number or localization of NK cells,
blood vessels, or the depth of trophoblast invasion between saline- or PolyI:C-exposed
dams on GD13.5. However, in dams exposed to PolyI:C on GD8.5, average placental
weight, area, and thickness were reduced on GD13.5 (15, 10, and 8% decreased
compared with saline-treated dams, respectively; Figure 2-4, p < 0.05 for all),
concomitant with reduced area and thickness of the junctional zone (12 and 17%,
respectively, Figure 2-4, p < 0.05) and labyrinth zone (14 and 6%, Figure 2-4, p < 0.05).
Interestingly, the effects of maternal PolyI:C exposure on placental structure were
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transient, as there were no differences in placental weights, zonal areas, or thicknesses on
GD18.5. Collectively,

Figure 2-4: Changes in placental morphology and size following maternal PolyI:C
exposure.
Representative images of placentas collected on GD13.5 5 d after dams were injected
with saline (0 mg/kg) or PolyI:C (10 mg/kg). Scale bar, 1000 μm. (C) Placentas were
collected on GD13.5 and weighed, and sections were immunostained with vimentin to
analyze area and thickness of the placenta, labyrinth zone (LZ), and junctional zone (JZ).
Results represent means ± SEM. Data significantly different from controls (n ≥ 18
placentas from six dams, p < 0.05) are indicated by an asterisk (*).
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these results suggest that PolyI:C exposure during early pregnancy is associated with a
transient impairment or delay in development of the fetal components of the placenta.
To assess whether placental hemodynamics were altered on GD13.5 following maternal
PolyI:C exposure, ultrasound biomicroscopy was performed to measure blood flow in
uterine and umbilical vasculature. There were no statistically significant differences in
blood flow through the uterine artery 5 d after maternal exposure to PolyI:C, as
determined by average PSV, EDV, RI, and velocity time integral (VTI) (Figure 2-5A). In
the umbilical artery, there was no difference detected when measuring EDV, RI, heart
rate, and VTI. We did note a modest 23% increase in PSV 5 d after maternal exposure to
PolyI:C (Figure 2-5B, p < 0.05), although in the absence of a statistical difference in
other umbilical vessel parameters, we are unable to conclude whether this difference has
important implications for placental function and fetal growth (Kessous et al. 2014).
Collectively, these results demonstrate efficient hemodynamics of the placenta following
early gestational exposure to PolyI:C despite their smaller size.

2.3.5

IFN-a promotes an antiviral response in rat TS cells and
disrupts stem cell traits

PolyI:C is capable of directly inducing expression of genes associated with cellular
antiviral responses. PolyI:C also robustly stimulates production of cytokines, such as type
I IFNs and IL-6, which have pleiotropic effects on various cell types and mediate
antiviral inflammation. Therefore, our next goal was to determine whether PolyI:C, type I
IFNs, or IL-6 induce an antiviral response in TS cells. Treatment of rat TS cells with
PolyI:C or IL-6 did not alter expression of genes associated with antiviral responses,
including Rsad2, Cxcl10, Irf7, Isg15, and Isg20. Because some cell types only respond to
PolyI:C if it is present within the cytosol (Palchetti et al. 2015), we transfected PolyI:C
into rat TS cells but still did not observe any change in expression of these genes (data
not shown). Likewise, exposure of rat TS cells to 100 U/ml IFN-γ (a type II IFN that is
constitutively expressed in the conceptus during early pregnancy, owing to the prevalence
of uterine NK cells) did not affect expression of any of these genes in TS cells.
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Conversely, exposure of rat TS cells to 100 U/ml IFN-⍺ stimulated expression of Cxcl10
(2.6-fold), Rsad2 (7.1-fold), Irf7 (11.6-fold), Isg15 (24-fold), and Isg20 (2-fold, Figure 26A, all p < 0.05). In line with these results, robust expression of type I IFNR subunits
Ifnar1 and Ifnar2 was detected in rat TS cells, whereas expression of IL-6R and the
PolyI:C receptors Tlr3 and Ddx58 (which encodes RIG1) were low or undetectable
(Figure 2-6B). To further evaluate the responsiveness of TS cells to IFN-⍺, cells were
exposed to low-dose (100 U/ml) or high-dose (1000 U/ml) IFN-⍺. IFN-⍺ stimulated
expression of Cxcl10, Rsad2, Irf7, and Isg20 in a dose-dependent manner, with 1000
U/ml IFN-⍺ increasing expression of these genes by 7.34-fold, 39-fold, 38-fold, and 2.97fold, respectively. Both doses of IFN-⍺ stimulated Isg15 expression ∼30-fold (Figure 26C, p < 0.05).
After deducing that IFN-⍺ stimulates an antiviral response in TS cells, our next goal was
to determine whether IFN-⍺ disrupts TS cell behavior. First, we evaluated proliferation in
TS cells and found that there was no statistically significant change in proliferation as
determined by percentage of cells that incorporated EdU (Figure 2-7A, 2-7B) or that were
positive for phospho-histone H3 (data not shown). We next evaluated expression of genes
associated with maintaining the TS cell stem state and found that 1000 U/ml IFN-⍺
decreased transcript levels of Cdx2 (22%) and Mest (14%, Figure 2-7C, p < 0.05). There
was no statistically significant change in the expression of Id2. When TS cells were
cultured in differentiation conditions, expression of the labyrinth-associated gene glial
cells missing-1 (Gcm1) was increased by 5.3-fold, and the trophoblast giant cell–
associated gene prolactin family 3, subfamily b, member 1 (Prl3b1; also called placental
lactogen 2) was increased by 2.4-fold (Figure 2-7D, both p < 0.05). However, in the
presence of IFN-⍺, expression of Gcm1 was reduced by 78%, and Prl3b1 levels were
reduced by 63% compared with cells not exposed to IFN-⍺ (Figure 2-7D, both p < 0.05).
Thus, IFN-⍺ disrupts expression of a subset of genes required to maintain TS cells in a
stem state and inhibits their capacity to undergo differentiation into specialized
trophoblast lineages.
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Figure 2-5: IFN-⍺ promotes an antiviral response in rat TS cells.
(A) Rat TS cells were exposed to 100 U/ml IFN-⍺, 20 ng/ml IL-6, 100 U/ml IFN-γ, and
50 mg/ml PolyI:C for 24 h. The expression of five representative antiviral genes (Cxcl10,
Rsad2, Irf7, Isg15, and Isg20) was analyzed using qRT-PCR. Expression levels were
calculated relative to five transcripts (Rn18S, Ywhaz, Eef2, Gapdh, Actb). The horizontal
dotted line represents control rat TS cells that were not exposed to cytokines. (B)
Expression of receptors that interact with PolyI:C (Tlr3, Ddx58), type I IFNs (Ifnar1,
Ifnar2), and IL-6 (Il6r) were examined in rat TS cells by RT-PCR. (C) Rat TS cells were
exposed to low-dose (100 U/ml) and high-dose (1000 U/ml) IFN-⍺, and expression of
antiviral genes was assessed by qRT-PCR. Results represent means ± SEM. Data
significantly different from controls (n = 3, p < 0.05) are indicated by an asterisk (*).
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Figure 2-6: IFN-⍺ inhibits expression of stem-related genes in rat TS cells.
(A) Representative images of rat TS cells exposed to 1000 U/ml IFN-⍺. Proliferation of
rat TS cells was evaluated by EdU incorporation. Scale bar, 50 μm. (B) Percentage of
cells that incorporated EdU. (C) Expression of transcripts associated with TS cell stem
state after rat TS cells were exposed to IFN-⍺ for 24 h. (D) Expression of Gcm1 and
Prl3b1 in rat TS cells following culture in stem conditions or in differentiation (Diff)
conditions in the presence or absence of IFN-⍺. Data significantly different from controls
[n = 3 for (A)–(C), n = 4 for (D); p < 0.05] are indicated by an asterisk (*).
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2.4 Discussion
In this study, we show that maternal exposure to a viral stimulus during formation of the
nascent placenta is associated with a robust antiviral response and hypoxia at the site of
placental development, concomitant with reduced placental and fetal growth trajectories.
We further found that TS cells express type I IFNR and respond to IFN-⍺ by increasing
IFN regulatory gene expression and decreasing expression of genes associated with the
TS cell stem state. TS cells also exhibit impaired differentiation potential in the presence
of IFN-⍺. Together, these results suggest that antiviral inflammation early in pregnancy
impairs proper TS cell function and causes latent placental development and fetal growth.
Viral infections during pregnancy can result in a variety of perinatal outcomes. In some
cases, a viral infection may have no apparent effect on the health of a fetus or newborn,
whereas in other cases, spontaneous abortion, FGR, or severe congenital anomalies may
result. The different outcomes likely relate to the type of virus, the time during pregnancy
when the infection is active, and whether the pathogen is transmitted to the fetus (such as
with toxoplasmosis, other, rubella, CMV, and HSV infections, which are major causes of
congenital anomalies) (Silasi et al. 2015). Aside from toxoplasmosis, other, rubella,
CMV, and HSV infections, the effect of viral inflammation on fetal and placental growth
and development is poorly understood. Consequently, there is currently no standard of
care for managing viral infections during pregnancy, despite the increased susceptibility
of pregnant women to severe illness and mortality from viral infections (Kourtis et al.
2014). In this study, we sought to investigate the effect of viral inflammation on
pregnancy outcome using the synthetic dsRNA molecule, PolyI:C. Because PolyI:C is a
TLR3 ligand and robust stimulator of antiviral inflammation (Palchetti et al. 2015), the
use of PolyI:C provides a means to elucidate the contribution of antiviral inflammation to
pregnancy outcome in the absence of a pathogen. Previous studies have reported adverse
pregnancy outcomes after administering PolyI:C to pregnant rodents, including
embryonic lethality (Buchrieser et al. 2019; Thaxton et al. 2013; Lin et al. 2006; Yockey
et al. 2018), preeclampsia-like symptoms (Chatterjee et al. 2012), preterm birth (Ilievski
et al. 2007), and neurodevelopmental impairments in offspring (Reisinger et al. 2015).
The novelty of our study is that we administered PolyI:C during early pregnancy prior to
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formation of the definitive placenta and then evaluated acute inflammation in the
conceptus as well as placental and fetal growth throughout pregnancy. Because
administration of PolyI:C to mice early in pregnancy results in embryonic lethality
(Buchrieser et al. 2019; Thaxton et al. 2013; Lin et al. 2006; Yockey et al. 2018), it was
surprising that, in our hands, fetal viability was unaffected when rats were exposed to a
similar dose per weight of PolyI:C, despite a robust antiviral response and hypoxia at the
placentation site. Species differences in PolyI:C-TLR3 signaling responses have been
reported (Lundberg et al. 2007), so these results may reveal differing susceptibility or
sensitivity to PolyI:C between mice and rats. The use of rats may thus provide an
advantage to study the effects of prenatal exposure to viral inflammation early in
pregnancy on long-term placental function, fetal development, and offspring health
without confounding embryonic demise. Our results that inflammation rather than viral
burden affects early placental development and pregnancy outcome are consistent with
other studies. For instance, exposure of pregnant immunocompetent mice to Zika virus
early in pregnancy, prior to formation of the definitive placenta, causes placentation
defects and adverse pregnancy outcomes despite rare detection of virus in the fetus or
placenta. Interestingly, these adverse effects were limited to infection during early
pregnancy and were less robust when the virus was administered at midpregnancy, when
the placenta is functional (Szaba et al. 2018). Thus, antiviral inflammation during early
pregnancy may be a strong independent contributor to deficient placentation and adverse
pregnancy outcomes regardless of pathogenic burden.
Proper fetal growth is an essential determinant of prenatal and perinatal health. Babies
born growth restricted have a decreased chance of surviving their first year and have a
higher risk of cardiovascular, metabolic, and neurodevelopmental sequelae in later life
(Sharma et al. 2016). FGR can be classified as symmetric (whole body) or asymmetric
(head sparing). Asymmetric FGR is often due to extrinsic events (e.g., placental
insufficiency, uterine anomalies) occurring late in pregnancy that cause more severe
growth impairments in abdominal organs than the head. Symmetric FGR, in contrast, is
usually attributed to an early embryonic event that causes all growth parameters to be
below normal for gestational age. We observed that fetal weight was symmetrically
decreased in later pregnancy when dams were exposed to PolyI:C during early gestation.
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We found no evidence of aberrant placental hemodynamics based on Doppler ultrasound
recordings; thus, PolyI:C-induced FGR is unlikely to be attributed to alterations in
placental blood flow dynamics. Therefore, viral inflammation reduced placental and fetal
growth but did not impair placental hemodynamics, which are phenotypes consistent with
symmetric FGR (Fleiss et al. 2019).
Viruses can be a major detriment to placental development. Viral infections have been
associated with increased trophoblast apoptosis, decreased trophoblast invasion,
production of proinflammatory responses, disruption of placental endocrine function, and
increased risk of obstetric complications (Griffiths and Baboonian 1984; Liu et al. 2015;
Chou et al. 2006; Arechavaleta-Velasco et al. 2006; Miner et al. 2016). Our findings
using PolyI:C suggest that antiviral inflammation is sufficient to impair placentation and
is consistent with other studies. For example, administration of PolyI:C to pregnant mice
elicits maternal decidual leukocyte activation, decidual necroptosis, and production of
TNF-α and IL-6 that induces STAT3 activation and endocrine disruption in placental
cells (Thaxton et al. 2013; Hsiao and Patterson 2011; Yu et al. 2017). Prenatal PolyI:C
exposure early in pregnancy also stimulates expression of IFN-induced transmembrane
proteins, which interferes with trophoblast syncytialization and labyrinth zone formation,
leading to embryo demise. Interestingly, mice lacking these transmembrane proteins are
protected from PolyI:C-induced placental maldevelopment and embryonic loss,
implicating placental maldevelopment as a critical determinant causing adverse
pregnancy outcomes during viral inflammation (Buchrieser et al. 2019). In rats, PolyI:C
administration at midgestation is associated with altered expression of amino acid and
drug transporters in the placenta, resulting in a corresponding change in amino acid
concentrations in the fetus (McColl and Piquette-Miller 2019; Petrovic and PiquetteMiller 2010). Term human placental explants also exhibit altered expression and function
of multidrug resistance transporters following challenge with PolyI:C (Lye et al. 2015).
In our study, we noted decreased expression of several maternally imprinted genes
associated with placental and fetal growth after maternal PolyI:C exposure, including
Sfrp2, Dlk1, and Mest. Sfrp2 encodes a cysteine-rich protein that acts as a regulator of
placental development through its modulation of the Wnt signaling pathway (Guilleret et
al. 2009). Dlk1 encodes a cell-surface transmembrane protein highly expressed in

96

placental villi and exhibits reduced expression in FGR (Wylie et al. 2000). Mest is
expressed mainly by the placenta. Mice lacking Mest exhibit FGR because of a severe
placental growth defect (Lefebvre et al. 1998), and decreased expression of Mest is
evident in human placentas during FGR (McMinn et al. 2006). Our results are consistent
with studies in which pregnant mice were challenged with a bacterial infection
(Campylobacter rectus) early in pregnancy, resulting in FGR associated with repression
of key developmental genes, including several imprinted genes (Bobetsis et al. 2010;
Bobetsis et al. 2007). Thus, it is possible that the latent fetal and placental growth
observed after PolyI:C exposure is at least partially due to altered expression of key
placental growth-promoting genes like Mest.
Recognition of dsRNA by pattern recognition receptors triggers an antiviral response that
features synthesis of type I (α, β) IFNs. Type I IFNs are a family of 13 cytokines that
bind to a single heterodimeric IFN-αR composed of two subunits, IFNAR1 and IFNAR2.
Binding of type I IFNs to IFNAR initiates downstream signaling cascades that regulate
activation and repression of hundreds of genes (Schreiber and Piehler 2015). The
products of these genes promote a cellular antiviral state designed to limit replication and
spread of viruses and other pathogens and can also alter cell proliferation, health, and
viability in a cell-type and environment-specific context. The importance of type I IFNs
for mediating systemic responses to viruses (and PolyI:C) in pregnant rodents is elegantly
demonstrated in Ifnar-/- mice (Yockey et al. 2018; Racicot et al. 2017; Cappelletti et al.
2017). Type I IFNs also alter stem cell traits in pluripotent and hematopoietic stem cells
(Pietras et al. 2014; Smith et al. 2018; Eggenberger et al. 2019), so we postulated that
type I IFNs impact TS cell behavior. We found that rat TS cells expressed high levels of
Ifnar1 and Ifnar2 and robustly responded to IFN-α by increasing expression of various
IFN-stimulated genes. IFN-α also decreased expression of genes associated with the TS
cell stem state and placental growth, including Mest, and impaired their differentiation
potential, as shown by reduced expression of Gcm1 and Prl3b1. Thus, similar to reports
with pluripotent and hematopoietic stem cells, type I IFN signaling may interfere with
signal transduction pathways that maintain TS cell stem traits and temporarily disrupt
normal TS cell function in the nascent placenta. Conversely, rat TS cells expressed low
levels of Tlr3, Ddx58, and Il6r, and no detectable changes in IFN-stimulated genes were
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observed after rat TS cells were exposed to PolyI:C, IL-6, or to another IFN
constitutively expressed at the placentation site, IFN-γ. These results are interesting
because human and murine trophoblasts respond directly to PolyI:C, IL-6, and IFN-γ
(Abrahams et al. 2006; Jones et al. 2009; Hu et al. 2008). Multiple cell types at the
maternal-placental interface are capable of recognizing pathogen-associated molecular
patterns, such as PolyI:C, and promote an antiviral state in part by producing type I IFNs.
Our data suggest that TS cells are unable to recognize PolyI:C and some other
inflammatory cytokines but possess the capacity to respond to type I IFNs. The narrow
scope of TS cell responsiveness to viral patterns and cytokines other than type I IFNs
may be a protective mechanism to avoid unwanted disruption of normal cellular
functioning or viability while still contributing to an aggregate antiviral state. As they
differentiate into specialized trophoblast lineages, trophoblasts may gain the capacity to
recognize and respond to a broader range of immune mediators to limit pathogen
replication and vertical transmission. Nonetheless, production of IFN-α in response to a
viral infection early in pregnancy may be a determinant of acute changes in TS cell
function, which could have long-lasting impacts on placental and fetal growth.
This study has several limitations. First, although humans and rats exhibit hemochorial
placentation featuring regions with analogous structure and function (Soares et al. 2012),
there are key differences in early placental development between these species.
Therefore, we cannot conclude whether viral inflammation early in pregnancy affects
human placental development in the same way as we observed for rat placentation. Of
note, women diagnosed with primary CMV infection between 11 and 15 weeks of
pregnancy exhibit progressively increased placental thickness, as demonstrated through
ultrasound examination (La Torre et al. 2006), rather than decreased placental size, as
would be suggested by our study. Potential explanations for this discrepancy are that
CMV infection was detectable only after the placenta was formed and functional. In our
study, the viral stimulus was provided during early placental development prior to
chorioallantoic fusion. Thus, the timing of viral stimulus may be an important
consideration. Moreover, the chronic CMV infection and relatively long duration of
pregnancy in humans may have facilitated either a progressive edematous and
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inflammatory response or a placental compensatory response, resulting in a thicker
placenta that would not be apparent in our postmortem analyses in rats.
A second limitation is that we cannot ascertain that altered TS cell function in response to
type I IFNs is directly responsible for the reduction in placental and fetal size after
maternal PolyI:C. In future studies, these experiments could be performed using a line of
rats in which the Ifnar gene is compromised by targeted genomic editing (Qaisar et al.
2017). Third, because PolyI:C was administered to dams systemically, we cannot
conclude whether the concentration of dsRNA at the maternal-placental interface in our
model represents the amount present within a typical virus infection. We attempted to
evaluate the presence of dsRNA at the maternal-placental interface by
immunofluorescence using a mAb (J2), but we were unable to detect robust staining.
However, the profile of antiviral factors induced at the maternal-placental interface that
was observed in our study is consistent with previous results that have used live viruses,
such as Zika and influenza A (Bayer et al. 2016; Steuerman et al. 2018; Sheridan et al.
2017), suggesting that the dose of PolyI:C used in our study elicits antiviral inflammation
at the maternal-placental interface that is comparable to inflammation present during a
virus infection. Exposure of pregnant rodents to PolyI:C is frequently used as a model of
brain maldevelopment and cognitive deficiencies in offspring (Reisinger et al. 2015),
which is consistent with the known association between viral infections during pregnancy
and increased risk of neurobehavioral impairments in humans (Kratimenos and Penn
2019). FGR is also an established risk factor for neurodevelopmental and behavioral
problems in childhood (Murray et al. 2015). Thus, our findings provide a new dimension
to the link between viral infections and FGR and raise the question of whether altered
placental and fetal growth trajectories are causally linked to long-term neurobehavioral
consequences. Our results may also help to stratify those pregnancies at risk for poor fetal
growth following exposure to a viral infection by evaluating expression of genes
associated with placental growth (e.g., Mest) so that targeted management strategies can
be implemented to alleviate long-term health sequelae.
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Chapter 3

3

Maternal Immune Activation Alters Fetal Brain
Development and Enhances Proliferation of Neural
Precursor Cells in Rats

Maternal immune activation (MIA) caused by exposure to pathogens or inflammation
during critical periods of neurodevelopment is a major risk factor for behavioral deficits
and psychiatric illness in offspring. A spectrum of behavioral abnormalities can be
recapitulated in rodents by inducing MIA using the viral mimetic, PolyI:C. Many studies
have focused on long-term changes in brain structure and behavioral outcomes in
offspring following maternal PolyI:C exposure, but acute changes in prenatal
development are not well-characterized. Using RNA-Sequencing, we profiled acute
transcriptomic changes in rat conceptuses (decidua along with nascent embryo and
placenta) after maternal PolyI:C exposure during early gestation, which enabled us to
capture gene expression changes provoked by MIA inclusive to the embryonic milieu.
We identified a robust increase in expression of genes related to antiviral inflammation
following maternal PolyI:C exposure, and a corresponding decrease in transcripts
associated with nervous system development. At mid-gestation, regions of the developing
cortex were thicker in fetuses prenatally challenged with PolyI:C, with females
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displaying a thicker ventricular zone and males a thicker cortical mantle. Along these
lines, neural precursor cells (NPCs) isolated from fetal brains prenatally challenged with
PolyI:C exhibited a higher rate of self-renewal. Expression of Notch1 and the Notch
ligand, delta-like ligand 1, which are both highly implicated in maintenance of NPCs and
nervous system development, was increased following PolyI:C exposure. These results
suggest that MIA elicits rapid gene expression changes within the conceptus, including
repression of neurodevelopmental pathways, resulting in profound alterations in fetal
brain development.

3.1 Introduction
Development of the brain is an intricately orchestrated process that commences early in
gestation and is particularly vulnerable to changes in the prenatal environment. There is
now substantial evidence that maternal infection during windows of susceptibility can
affect critical aspects of fetal brain development, leading to a wide range of neuronal
dysfunctions and behavioral outcomes in offspring (Gumusoglu and Stevens 2019). For
example, epidemiological evidence implicates maternal infection as a major risk factor
for neurodevelopmental disorders in offspring, including schizophrenia (Brown et al.
2009), autism-spectrum disorder (ASD) (Parker-Athill and Tan 2010), and epilepsy (Sun
et al. 2008), as well as neurodegenerative disorders including Alzheimer’s disease and
Parkinson’s disease (Carvey et al. 2003; Hoeijmakers et al. 2016). Altered brain
development is recapitulated in offspring born to pregnant mice and rats exposed to
different types of infections, resulting in a spectrum of behavioral abnormalities apparent
in adolescent and adult offspring (Boksa 2010). Despite considerable progress identifying
behavioral phenotypes in juvenile and adult offspring exposed prenatally to infection, the
impact of infection on neuronal development and brain structure, particularly during fetal
life, is not well understood.
Maternal immune activation (MIA) in the absence of a pathogen is sufficient to elicit
brain maldevelopment and behavioral abnormalities in offspring, indicating that the
maternal response to infection, rather than the infection itself, is a likely culprit. One of
the most recognized and established models of neurodevelopmental deficiencies resulting
from acute exposure to MIA involves prenatal exposure to polyinosinic:polycytidylic
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acid (PolyI:C) (Meyer and Feldon 2012). PolyI:C is a synthetic analog of double-stranded
RNA, which resembles the molecular pattern of certain viruses. PolyI:C induces the
generation of a cellular antiviral response, and stimulates the production of inflammatory
cytokines including type I interferons, interleukin (IL)-6, and IL-1β, all of which may
participate in MIA-induced neurodevelopmental impairment (Field et al. 2010; Smith et
al. 2007). PolyI:C therefore effectively mimics the acute cellular response to viral
infections and is advantageous as a model because the response is transient, and the
stimulus intensity and timing can be precisely controlled to evaluate the impact of MIA
during particular phases of brain development. Administration of PolyI:C to pregnant
mice or rats during early-to-mid gestation or late gestation has revealed differing levels of
sensitivity to fetal cytokines, corresponding to unique behavioral phenotypes later in life
(Meyer et al. 2008). These altered behaviors include deficits in social interaction,
attention, memory, and sensorimotor function that have construct and face validity
towards human neuropsychiatric disorders such as schizophrenia and ASD (Careaga et al.
2017), suggesting that MIA may interfere with structural and developmental
programming during prenatal brain development leading to behavioral changes in
postnatal life.
The cerebral cortex integrates sensory and motor information and is responsible for
shaping behavior, perception, higher-order thought, and reasoning in mammals. It
develops from a single layer of neuroepithelium that lines the ventricles. As early as
embryonic day 9 (GD 9) in rats, neural stem cells (NSCs) within the neuroepithelium
undergo symmetric divisions to provide the early NSC pool that is crucial for
determining cell number and adult brain size (Goldman-Rakic 1995). By GD 11, NSCs
start dividing asymmetrically to form neural precursor cells (NPCs), which then produce
neurons that migrate away from the ventricular zone to form the preplate, and subsequent
volley of neurons form the remainder of cortical layers. Recent evidence indicates that
cortical neurogenesis is orchestrated by highly complex signaling mechanisms involving
precise, temporally-regulated expression of transcription factors as well as the action of
signaling molecules belonging to the Notch and Wnt pathways (Martynoga et al. 2012).
Disruptions in maintenance of the NSC pool and cortical neurogenesis impact neuronal
number and brain size, and also result in malformations in layering (heterotopia) and
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neuronal connections. It is also important to note that in rats, cortical angiogenesis begins
at GD 10 and the blood-brain barrier is functional by GD 16. Consequently, early
developmental periods prior to neuronal migration on GD 11 is a potentially vulnerable
period for MIA-mediated abnormalities (Rice and Barone 2000).
In this study, we injected pregnant rats with saline or PolyI:C at GD 8.5 and generated a
transcriptional profile on whole conceptus tissue that revealed both the response of the
nascent uterine environment to MIA and changes in gene expression critical for
neurodevelopmental processes. We then evaluated cortical structure on GD 15.5 and
isolated neurospheres to assess the self-renewal capacity of NSCs and NPCs. We
discovered a robust antiviral inflammatory response following PolyI:C administration
that correlated with impaired progression of neurodevelopmental events. Surprisingly, we
also identified a “rebound effect” at mid-to-late gestation, in which cortical thickness was
increased suggesting an expanded NSC pool that correlated to increased NSC/NPC
proliferation capacity and altered expression of receptors and ligands regulating Notch
signaling – a pathway crucial for NSC proliferation and nervous system development.

3.2 Materials and Methods
3.2.1

Animals

Female (6-8 weeks old) and male Sprague Dawley rats were obtained from Charles River
Laboratories and maintained in a 12:12 hour light-dark cycle (lights on at 7:00 am) at
constant temperature/humidity and food and water available ad libitum. Females were
cycled by daily inspection of cells within the vaginal lavage and mated when in proestrus
with a fertile male. Gestational day (GD) 0.5 was defined as the day following mating if
spermatozoa were detected within the vaginal lavage. All experiments were in
compliance with guidelines outlined by the Canadian Council of Animal Care, using
protocols approved by the University of Western Ontario Animal Care Committee.

3.2.2

Injection protocol and tissue collection

Pregnant females were injected intraperitoneally on GD 8.5 with sterile saline (0.9%
NaCl) or an equal volume of saline containing 10 mg/kg PolyI:C sodium salt (Sigma-
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Aldrich). The 10 mg/kg dose of PolyI:C is based on our previous study (Baines et al.
2020), and other reports in which this dose of PolyI:C elicited an inflammatory response
and altered behavioral phenotypes in offspring (Bloise et al. 2017; Forrest et al. 2012).
For experiments evaluating the acute impact of PolyI:C on gene expression in the
conceptus (encompassing maternal decidua as well as nascent embryo and placenta),
dams were euthanized 6 h following saline or PolyI:C injection (early gestation). All
other tissue collections were performed on GD 15.5 (mid-to-late gestation; total
pregnancy duration in rats is ~22 days). Euthanasia was conducted using mild carbon
dioxide asphyxiation, followed by thoracotomy. For samples collected on GD 8.5, whole
conceptuses were isolated and snap-frozen in liquid nitrogen. For tissues collected on GD
15.5, embryos were collected, and whole brains were removed and fixed in 4%
paraformaldehyde for immunohistochemical analysis, or cortical tissue was minced and
processed for NPC and neurosphere culture.

3.2.3

RNA Sequencing

RNA was extracted from tissue by homogenizing in RiboZol (Amresco). The aqueous
phase was diluted with 70% ethanol and placed on RNeasy columns (Qiagen), treated
with DNase I, and purified. RNA integrity was assessed using an Agilent 2100
bioanalyzer (Agilent Technologies), and indexed libraries were generated following
rRNA reduction. Libraries were then sequenced with NextSeq High Output 75 cycle
sequencing kit (Illumina) at the London Regional Genomics Centre. Reads from *.fastq
files were aligned to the rat reference genome (Rnor_6.0.91) using CLCBio Genomics
Workbench (Qiagen version 10.1.2), and transcript abundance was expressed as reads per
kilobase of transcript per million mapped reads (RPKM). Analysis was restricted to
transcripts in which average RPKM was >0.1 among either saline or PolyI:C-exposed
conceptuses. Statistical significance was calculated by empirical analysis of digital gene
expression, followed by Bonferroni’s correction. Data are available on the Gene
Expression Omnibus (GSE145167). Gene ontology pathway analysis was completed
using DAVID Functional Annotation Bioinformatics (Huang et al. 2009).
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3.2.4

Quantitative RT-PCR

RNA was extracted from cells and tissues by lysing in RiboZol (Amresco) as directed by
the manufacturer. Complementary DNA was made from purified RNA using High
Capacity complementary DNA Reverse Transcription kit (ThermoFisher Scientific),
diluted 1:10, and used for quantitative RT-PCR. Complementary DNA was mixed with
SensiFAST SYBR green PCR Master Mix (FroggaBio) and primers (Table 1).
Amplification and fluorescence detection were conducted using a CFX Connect RealTime PCR system (Bio-Rad Laboratories). Cycling conditions included an initial holding
step (95℃ for 3 min), followed by 40 cycles of two-step PCR (95℃ for 10 s, 60℃ for 45
s), and a dissociation step (65℃ for 5 s, and a sequential increase to 95℃). The
comparative cycle threshold (ΔΔCt) method was used to calculate relative mRNA
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Table 3-1: List of Primers used for RT-PCR.
Gene

Accession
Number

Forward Sequence

Reverse Sequence

Actb

NM_031144.3

5’-AGCCATGTACGTAGCCATCC-3’

5’-CTCTCAGCTGTGGTGGTGAA-3’

Ccl5

NM_031116.3

5’-CCTTGCAGTCGTCTTTGTCA-3’

5’-GAGTAGGGGGTTGCTCAGTG-3’

Cxcl10

NM_139089.1

5’- TGTCCGCATGTTGAGATCAT-3’

5’-GGGTAAAGGGAGGTGGAGAG-3’

Dll1

NM_032063.2

5’-GCACGAGAAAACCAGAAAGC-3’

5’-TCTTCAAAGACCCAGGGATG-3’

Dll3

XM_006228611.3

5’- GACTCACAGCGCTTCCTTCT-3’

5’- TCTTCGGGATGATTCCAGTC-3’

Dll4

NM_001107760.1

5’- ACCTTTGGCAATGTCTCCAC-3’

5’- TTGGATGATGATTTGGCTGA-3’

Doc2b

NM_031142.1

5’-GAGCCAGCAAGGCAAATAAG-3’

5’-GTGTGGTTGGGTTTCAGCTT-3’

Eef2

NM_017245.2

5’-CGCTTCTATGCCTTCGGTAG-3’

5’-GTAGTGATGGTGCCGGTCTT-3’

Gapdh

NM_017008.4

5’- AGACAGCCGCATCTTCTTGT-3’

5’-CTTGCCGTGGGTAGAGTCAT-3’

Il1b

NM_031512.2

5’-AGGCTTCCTTGTGCAAGTGT-3’

5’-TGAGTGACACTGCCTTCCTG-3’

Jag1

NM_019147.1

5’- ATCGCATCGTACTGCCTTTC-3’

5’- GGCAATCCCTGTGTTCTGTT-3’

Jag2

NM_001375303.1

5’- TGCACTTTAACCGTGACCAA-3’

5’- AAAGACACAGCCACCTCCAC-3’

Notch1

NM_001105721.1

5’-GTTTGTGCAAGGATGGTGTG-3’

5’-CCTTGAGGCATAAGCAGAGG-3’

Notch2

NM_024358.2

5’- TCAATCGCTTCCAGTGTCTG-3’

5’- TGCAGATGCAGGTGTAGGAG-3’

Notch3

NM_020087.2

5’- CCCACAAGCCCTGTAGTCAT-3’

5’- TCACATTGATGACCCTGGAA-3’

Notch4

NM_001002827.1

5’- CACCTGCCTGAGGCTATCTC-3’

5’- GAGCTCTTCCAGAGGGCTTT-3’

Rn18s

NM_046237.1

5’-GCAATTATTCCCCATGAACG-3’

5’-GGCCTCACTAAACCATCCAA-3’

Rnf112

NM_138613.1

5’-CGCCAAGAAGGAGTTTGAAG-3’

5’-CAGAAGCGCATTGTGTAGGA-3’
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Rsad2

NM_138881.1

5’-GGGATGCTAGTGCCTACTGC-3’

5’-CTGAGTCTCCTTGGGCTCAC-3’

Sema5c

NM_017308.1

5’-ACTGTCTTTCCCCCTGTCCT-3’

5’-GTGGGGGCTCCTACACAGTA-3’

Ywhaz

NM_013011.3

5’-TTGAGCAGAAGACGGAAGGT-3’

5’-CCTCAGCCAAGTAGCGGTAG-3’

115

expression, using the geometric mean of Ct values obtained from amplification of five
genes (Rn18s, Ywhaz, Eef2, Gapdh, and Actb) as reference RNA.

3.2.5

Isolation of NPCs and neurosphere culture

Single-cell suspensions of cortical cells can be isolated from the embryonic telencephalon
and propagated as spherical NPC-containing masses called neurospheres (Campos 2004).
NPC culture was based on the method described by Ghosh et al., with modifications
(Ghosh and Greenberg 1995). Embryos were collected on GD 15.5, and DNA isolated
from tails using reagents from REDExtract-N-Amp DNA isolation kit (Sigma-Aldrich) to
evaluate sex of embryos, based on presence or absence of the Sry gene. Primers used for
Sry genotyping were 5’-TGGGAATGTATGCTGGCATA-3’ and 5’CCTCTCATGCCCAGAGTGAC-3’. Using a dissecting microscope, skin, skull, and
meninges were removed to access the cortex, then cortical tissue was removed and placed
in a dish containing fresh primary culture media (NeuroCult Proliferation Kit, Stem Cell
Technologies). Cells were gently dissociated, plated at a density of 120,000 cells/ml, and
incubated at 37ºC and 5% CO2 initially for 4 days. Under these conditions, cells
efficiently proliferated to generate neurospheres. To determine their proliferation
capacity, after three days in culture, neurospheres were treated with 10 mM 5-ethynyl-2’deoxyuridine (EdU) for 24 h, followed by immunohistochemistry as described below.
After four days, primary cortical NPCs were isolated from neurospheres. In brief,
neurospheres were mechanically dissociated, centrifuged, and resuspended in either
proliferation or differentiation medium. Cell viability was determined through trypan
blue exclusion, and 25,000 viable cells/ml were distributed into 24-well plates containing
sterile coverslips precoated with poly-D lysine (10 μg/ml) and laminin (10 μg/ml; both
from Sigma-Aldrich). For experiments in which male and female embryos were
individually analyzed, cells from each embryo were cultured in their own well until
genotyping was performed, then male or female cells were combined into a single well.
For all other experiments, cells from 3-5 embryos were combined. Cells plated for
proliferation experiments received NeuroCult proliferation medium, and cells plated for
differentiation experiments were cultured in NeuroCult differentiation medium (both
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from Stem Cell Technologies). Cells were cultured for 3 days prior to treatment with 10
mM EdU for 24 h, followed by immunofluorescence as described below.

3.2.6

Immunohistochemistry

Whole fetal brains were collected on GD 15.5 and placed in 4% paraformaldehyde
overnight. Brains were transferred to 30% sucrose for at least 24 h, and then embedded in
O.C.T. compound and stored at –80℃ until sectioning. Coronal cryosections were
obtained at 12 μm thickness. For neurosphere cryosectioning, media were carefully
removed from neurospheres after allowing them to settle to the bottom of a conical
centrifuge tube, and then 4% paraformaldehyde was added to the tube. Neurospheres
were transferred to 30% sucrose for at least 24 h, embedded in O.C.T. compound, and
cryosectioned at 10 μm thickness.
Sections of fetal brain and neurospheres were post-fixed for 10 min in 4%
paraformaldehyde, permeabilized in PBS containing 1% bovine serum albumin and 0.3%
Triton-X and blocked using 10% normal goat serum to reduce non-specific antibody
binding. Sections were immersed in primary antibodies as described below. The
following day, species-appropriate, fluorescent-conjugated secondary antibodies were
applied for 1 h, followed by Hoechst nuclear stain (ThermoFisher Scientific). For
detection of EdU, sections of EdU-treated neurospheres were probed with an Alexa488conjugated EdU monoclonal antibody (ClickIt EdU proliferation kit, ThermoFisher
Scientific), followed by Hoechst nuclear stain. Sections were then mounted using
Fluoromount G (SouthernBiotech), and fluorescence detected using a Nikon ECLIPSE Ni
series microscope equipped with a Ds-Qi2 camera. Confocal microscopy was performed
using a Zeiss LSM800 series confocal laser scanning microscope.

3.2.7

Immunofluorescence

Cell culture media were removed, and cells fixed in 4% paraformaldehyde. Detection of
EdU-positive cells was performed using an Alexa488-conjugated EdU monoclonal
antibody. Nuclei were subsequently counterstained using Hoechst nuclear stain.
Coverslips were then mounted, and fluorescence detected as described above. The
percentage of EdU-positive cells was calculated by dividing the number of EdU-positive
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cells by the total number of cells (as determined by detection of nuclei by Hoechst
staining), multiplied by 100.
For detection of various proteins, antibodies targeting Sox2 (1:100, 48-1400,
ThermoFisher Scientific), βIII-Tubulin (β3T; 1:1000, 60052, Stem Cell Technologies),
Pax6 (1:250, 42-6600, ThermoFisher Scientific), NeuN (1:200, MAB377, EMD
Millipore), Phospho-Histone H3 (1:800, 3377, Cell Signaling Technology), GFAP
(1:200, 12389, Cell Signaling Technology), and Notch1 (1:200, 4380, Cell Signaling
Technology) were diluted in PBS and applied overnight at 4ºC. The following day,
species-appropriate, fluorescent-conjugated secondary antibodies (AlexaFluor anti-mouse
488 and anti-rabbit 555, ThermoFisher Scientific) were applied for 1 h, followed by
Hoechst nuclear stain (ThermoFisher Scientific). Coverslips were then mounted, and
fluorescence detected as described above.

3.2.8

Western blotting

Protein expression was evaluated by western blotting. Total protein was isolated by
immersing cells in radioimmunoprecipitation assay lysis buffer (50 mM Tris, 150 mM
NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, pH 7.2) supplemented with
protease inhibitor cocktail (Sigma-Aldrich). A modified bicinchoninic acid assay (BioRad Laboratories) was used to measure total protein concentrations. Approximately 10
µg of cell lysates were mixed with 4× sample loading buffer (final concentration: 62.5
mM Tris pH 6.8, 2% SDS, 10% glycerol, 0.025% bromophenol blue, 50 mM
dithiothreitol), boiled for 10 min, and subjected to SDS-polyacrylamide gel
electrophoresis. Proteins were then transferred to polyvinylidene difluoride membranes,
blocked with 5% bovine serum albumin in TBS containing 0.1% Tween-20, and probed
with primary antibodies specific for phospho-histone H3 (1:1000, 3377, Cell Signaling
Technology), Notch1 (1:1000, 4380, Cell Signaling Technology), and β-actin (1:500, sc47778, Santa Cruz Biotechnology). Following incubation with species-appropriate,
infrared-conjugated secondary antibodies (Cell Signaling Technology), protein signals
were detected using a LI-COR Odyssey imaging system (LI-COR Biosciences).
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3.2.9

Statistical analysis

Statistical comparisons between two means were conducted using unpaired, two-tailed
Student’s t-tests, whereas statistical comparisons of three or more means were conducted
using analysis of variance, followed by Tukey’s post-hoc test. Sex-dependent effects
were compared using two-way analysis of variance followed by Sidak’s multiple
comparison. Assessment of changes in transcript abundance was conducted using nine
conceptuses collected from three dams per group. Data were independently validated
with an additional nine conceptuses from three dams per group. Fetal cortical thickness
was analyzed by obtaining images of the cortex from three distinct regions (anterior,
middle, posterior) separated from each other by approximately 100 μm, using at least ten
male and ten female brains collected from a total of three different litters per group. Total
cortical thickness, as well as thickness of each layer (Sox2+, β3T+), was measured in
three independent areas of each image using ImageJ (Schneider et al. 2012). Data are
presented as individual length measurements in μm ± SEM. For comparison of
proliferation capacity between neurospheres isolated from saline and PolyI:C-treated
dams, at least 1655 cells per dam prepared from four different litters per treatment were
used for analyses. Data are presented as percent EdU-positive cells per neurosphere ±
SEM. For comparing proliferation capacity in NPCs following disaggregation, five fields
of view were randomly imaged across two technical replicates, and cell numbers were
determined using an in-house automated cell-counting program (MATLAB) to obtain
total cell counts (based on the number of Hoechst-positive nuclei) and EdU-positive cells.
At least 300 cells per treatment obtained from 3 dams per group were counted. The
percent EdU-positive cells in each image was then obtained. All differences were
considered statistically significant when p < 0.05. Graphing and statistical analyses were
performed using GraphPad Prism 7.0.
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3.3 Results
3.3.1

Maternal PolyI:C exposure during early pregnancy induces
an antiviral response in the conceptus and alters expression
of genes associated with nervous system development

PolyI:C is a synthetic analog of dsRNA and has been used to stimulate cellular antiviral
responses in lieu of an active pathogen. In rodents (Smith et al. 2007) and primates (Rose
et al. 2017), exposure of dams to PolyI:C during early or mid-pregnancy elicits long-term
cognitive and behavioral deficits in offspring, suggesting that PolyI:C, or the antiviral
response incited by PolyI:C, interferes with normal brain developmental processes.
Transcriptome profiles have been generated using neonatal or postnatal brain tissue, days
or weeks following prenatal exposure to PolyI:C (Richetto et al. 2017; Weber-Stadlbauer
et al. 2017). However, acute gene expression changes in the conceptus (encompassing
decidua, embryo, and extraembryonic tissues) triggered by PolyI:C have not been
extensively characterized. Therefore, our first goal was to use RNASeq to profile global
gene expression changes in the conceptus following acute PolyI:C treatment. Overall,
from a total of 15,135 transcripts examined, exposure of dams to PolyI:C induced
significant changes in 1,032 transcripts in the conceptus (≥2-fold increased or decreased
compared to dams injected with saline, FDR p < 0.01). Of these, 771 genes were
upregulated, and 261 genes were downregulated (Figure 3-1). The 20 transcripts
exhibiting the highest increase and decrease following maternal PolyI:C exposure are
listed in Table 2 and Table 3, respectively. Among upregulated transcripts, maternal
PolyI:C exposure induced expression of interferon-stimulated genes (e.g. Isg15, 101.5fold; Ifit3, 140.5-fold; Mx1, 196.8-fold; Mx2, 108.2-fold), anti-viral molecules (e.g.,
Rsad2, 139.9-fold; Stat1, 9.5-fold; Stat2, 15.1-fold), and inflammatory chemokines (e.g.
Cxcl10, 196.3-fold; Cxcl11, 255.7-fold; Ccl2, 65.9-fold; Figure 3-1C, all FDR p < 0.01).
Interestingly, a considerable number of transcripts that were decreased after PolyI:C
exposure are associated with neurulation and neural development (e.g. Ranbp1, 13.4-fold;
Sema6c, 7.8-fold; Pnmal2, 12.1-fold; Nxph1, 4.5-fold; Figure 3-1C, all FDR p <0.01). To
validate results obtained from RNASeq on a separate cohort of samples, quantitative RTPCR was conducted on conceptuses exposed to saline or PolyI:C. Expression of Cxcl10,

120

Figure 3-1: Gene expression changes in the conceptus following maternal exposure
to PolyI:C.
(A) Volcano plot depicting number of unique transcripts expressed in the conceptus
following PolyI:C exposure relative to conceptuses exposed to saline. The x-axis
represents magnitude of fold-change (log2), and the y-axis shows P-value (log10).
Transcripts altered two-fold or more (false discovery rate p < 0.01) following PolyI:C are
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shown in red. (B) Pie chart showing number of transcripts upregulated and
downregulated in conceptuses exposed to PolyI:C compared to those exposed to saline.
(C) Heat map showing RPKM values (log2) of select transcripts in conceptuses following
maternal exposure to saline or PolyI:C. (D) Quantitative RT-PCR validation of select
transcripts in relation to values obtained using RNA-Seq. Data are normalized to values
obtained from saline-exposed conceptuses. All data are based on lysates from three
conceptuses pooled from each of three dams (nine conceptuses total) per treatment.

122

Rsad2, Ccl5, and Il1b was increased in conceptuses following maternal PolyI:C exposure,
and expression of Doc2b, Rnf112, and Sema6c was decreased, with fold changes
consistent with results obtained using RNASeq (Figure 3-1D).
Next, we performed gene ontology analysis to identify pathways that were significantly
altered in the conceptus following maternal PolyI:C exposure. Not surprisingly, pathways
that were upregulated after PolyI:C exposure included those associated with antiviral
pathways and inflammation. Examples of upregulated pathways include: negative
regulation of viral replication pathway (p = 8.2E-16, 17 genes), innate immune response
(p = 4.5E-19, 47 genes), and inflammatory response (p = 1.8E-24, 57 genes, Figure 32A). Intriguingly, pathways associated with decreased gene expression were related to
nervous system function and development, including central nervous system development
(p = 3.3E-02, 5 genes); axon guidance (p = 7.6E-03, 7 genes); and neuronal action
potential (p = 7.7E-04, 5 genes, Figure 3-2B). Thus, maternal PolyI:C exposure during
early pregnancy induces robust transcriptome changes in the conceptus, including
increased expression of genes associated with antiviral and inflammatory pathways and
reduced expression of genes associated with neurological development.

3.3.2

Maternal PolyI:C exposure during early pregnancy alters
cortical architecture in the fetus

Since offspring born to dams exposed to PolyI:C during early pregnancy are predisposed
to neurobehavioral impairments, and we found decreased expression of various genes
associated with central nervous system development following maternal PolyI:C
exposure, we sought to elucidate whether cortical architecture was altered in developing
fetal brains. Cortical neurogenesis begins around GD 11 in rats, peaks at E15, and slows
by E17 (Workman et al. 2013). Consequently, we measured cortical thickness, including
thickness of the cortical mantle (CM; delineated using the neuronal marker β3T) and
ventricular zone (VZ; identified using Sox2, which is highly expressed in NPCs, Figure
3A,B) in coronal sections of fetal brains on GD 15.5, one week following maternal saline
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Figure 3-2: Pathway analysis of unique gene signatures upregulated and
downregulated in the conceptus following maternal exposure to PolyI:C.
(A) Top 20 gene pathways upregulated in the conceptus following administration of
PolyI:C to pregnant dams. (B) Top 20 gene pathways downregulated in the conceptus
following administration of PolyI:C to pregnant dams. Pathway analysis was conducted
by inputting genes changed more than two-fold compared to conceptuses collected
following maternal exposure to saline, and with a false discovery rate < 0.01.
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Table 3-2: List of top 20 increased genes following maternal PolyI:C exposure.
Gene

Fold

Saline RPKM

PolyI:C RPKM

Ido1

Change
636.88

0

0.68

Skor1

398.92

0

0.18

Defb52

378.92

0

1.30

Tnf

364.57

0

0.29

RGD1305184

280.10

0.18

44.85

Cxcl11

255.69

0.41

91.90

Iqcf3

255.49

0

0.26

Gbp3

212.40

0.02

4.65

Mx1

196.83

2.06

358.59

Cxcl10

196.34

3.12

541.00

Gbp1

194.82

0.22

38.16

Ubp

38.16

0.86

142.26

Ifit3

140.50

2.35

291.69

Rsad2

139.88

1.13

137.84

Olr1735

134.79

0

0.68

Mx2

108.19

2.58

246.85

Isg15

101.53

1.71

154.19

Usp18

97.96

0.64

55.25

Cxcl9

96.43

2.84

243.99

Olr1734

89.75

0

0.42
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Table 3-3: List of top 20 decreased genes following maternal PolyI:C exposure.
Gene

Fold Change

Saline RPKM

PolyI:C RPKM

Ms4a6e

-1046.99

Change

1.28

0

LOC103690002

-15.47

2.84

0.16

Slco1a4

-13.43

1.30

0.09

Ddo

-13.43

0.12

0.01

RGD1561034

-9.23

0.87

0.01

Grcc10

-8.79

4.54

0.47

Clec4a

-8.52

0.43

0.04

Lancl3

-7.83

0.68

0.08

Sema6c

-7.76

0.16

0.02

Btnl9

-7.45

0.72

0.08

Myom2

-6.93

0.21

0.03

Muc16

-6.88

0.16

0.02

Abcg4

-6.77

0.61

0.08

Gria2

-6.71

0.63

0.08

Shc3

-6.25

0.32

0.05

Kcng1

-6.16

0.13

0.02

Scn7a

-5.81

0.39

0.06

Ldb2

-5.72

5.73

0.89

Etv1

-5.67

0.29

0.05

Rbp7

-5.57

2.37

0.38
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or PolyI:C treatment. Male fetuses prenatally challenged with PolyI:C showed an 8.3%
increase in total cortical thickness on GD 15.5 compared to saline-exposed male fetuses
(Figure 3-3C, p < 0.05). The increased cortical thickness in male fetuses was primarily
attributed to a thicker CM (20% increase in PolyI:C-exposed fetuses compared to saline,
Figure 3-3C, p < 0.05). The VZ also appeared to be increased in PolyI:C-exposed male
fetuses, but it was not statistically significant. Interestingly, thickness of the VZ in female
fetuses prenatally challenged with PolyI:C was increased by 10% (Figure 3-3C, p < 0.05),
whereas there was no change in thickness of the CM. Total cortical thickness appeared to
be thicker in females exposed to PolyI:C, but did not reach statistical significance (p =
0.08). Our results indicate that maternal PolyI:C exposure during early pregnancy caused
sex-specific alterations in cortical architecture at mid-to-late gestation, and in general was
associated with increased thickness of the developing cerebral cortex.

3.3.3

Increased proliferation of fetal NPCs following maternal
exposure to PolyI:C

Our results indicate that maternal PolyI:C treatment at early gestation results in altered
thickness of cortical layers in fetuses. This might be mediated through abnormal
functioning of NSCs/NPCs. Thus, for our next series of experiments, pregnant dams were
administered saline or PolyI:C on GD 8.5, and NPCs were isolated from fetal cortices on
GD 15.5 (Figure 3-4A). Cells isolated from fetal cortices expressed Pax6, Nestin, and
Sox2, and displayed morphology consistent with NPCs, including formation into
neurospheres within 4 days, at which point they were either fixed and cryosectioned, or
disaggregated and plated into monolayers. Interestingly, neurospheres isolated from
fetuses exposed prenatally to PolyI:C showed rapid growth and formed into larger
colonies, suggesting that they may have a higher proliferative index compared to
neurospheres isolated from fetuses collected from saline-treated dams (Figure 3-4B). To
examine the proliferative capacity of NPCs, we measured the percentage of cells within
neurospheres that incorporated EdU and found that neurospheres prepared from fetal
cortical tissue collected from PolyI:C-treated dams exhibited a 9.3% increase in EdU
incorporation compared to neurospheres prepared from saline-exposed fetuses (Figure 34C, p < 0.05). Furthermore, a greater percentage of neurospheres from fetuses collected
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Figure 3-3: Prenatal exposure to PolyI:C prompts changes in cortical architecture.
Dams were injected with either saline or PolyI:C on GD 8.5, and whole fetal brains were
collected one week later. (A) Schematic depiction of the layers of the rat fetal cortex at
GD 15.5. (B) Coronal sections of the cortex at GD 15.5 were stained for β3T (red) and
Sox2 (green) to delineate the CM and VZ, respectively. (C) Measurements showing total
cortical thickness and thickness of the CM and VZ in male and female fetuses. Graphs
represent means ± SEM. A star (☆) denotes the ventricle. Statistical analyses were
performed using two-way analysis of variance and Sidak’s multiple comparison. Data are
represented as mean ± SEM and asterisks denote statistical significance (*; p < 0.05; N ≥
10 fetuses per sex from at least three dams per group). Scale bar = 100 μm.
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Figure 3-4: Maternal exposure to PolyI:C increases proliferation potential of
neurospheres prepared from fetal cortices.
Pregnant rats were administered saline or PolyI:C on GD 8.5, and NPCs were isolated
from GD 15.5 fetal cortices for neurosphere culture. (A) Schematic depiction of
experimental protocol. (B) The two left panels show neurospheres produced from cortical
NPCs imaged using brightfield. The middle two panels show EdU incorporation in
cryosectioned neurospheres. The right two panels show immunofluorescence for
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phospho-histone H3 (P-HH3). In the middle and right panels, Hoechst is used to
counterstain nuclei. Scale bar = 100 μm. (C) Percent EdU positive cells in each
neurosphere were quantified from each treatment group. (D) Western blot analysis of PHH3 expression in neurospheres following 24, 48, and 72 h culture. β-actin was used as a
loading control. Statistical analyses were performed using Student’s t-test. Data are
represented as mean ± SEM. Data significantly different (p < 0.05) from controls are
indicated by an asterisk (*; 5-6 fetuses from each of 3 dams per treatment were used for
neurosphere generation).
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from PolyI:C-treated pregnancies had increased staining for phospho-histone H3 (PHH3), a marker of mitotically active cells, as shown using both immunofluorescence
(Figure 3-4B) and western blotting (Figure 3-4D).
When neurospheres are disaggregated and cells plated as monolayers, NPCs can be
maintained as a proliferative population expressing Nestin, Pax6, and Sox2, or induced to
differentiate into NeuN+ neurons and GFAP+ glia (Figure 3-5A). Thus, to determine the
proliferative capacity of NPCs using monolayer cultures, neurospheres prepared from
individual fetuses were disaggregated, sex determined through Sry genotyping, and male
or female NPCs combined and re-plated as monolayers. In NPCs prepared from GD 15.5
fetal brains one-week following maternal PolyI:C exposure, approximately 15% more
NPCs incorporated EdU regardless of whether they were derived from a male or female
fetus compared to NPCs from saline-exposed fetuses (Figure 3-5B and C, p < 0.05),
which is consistent with the increased proliferation of NPCs in neurospheres and thicker
cortical layers in fetal brains prenatally challenged with PolyI:C (Figures 3-3 and 3-4).
The increased EdU incorporation was also evident if cells were cultured in conditions
that favor differentiation (Figure 3-5D, p < 0.05). Additionally, we used NeuN to identify
cells that underwent differentiation into neurons. In NPCs prepared from fetal cortices
one week following maternal PolyI:C exposure, there was a 26.3% (p = 0.0003) and
20.2% (p = 0.0212) increase in NeuN-labelled cells in male and female NPCs,
respectively (Figure 3-5E). Although both male and female NPCs prepared from fetuses
exposed to PolyI:C have a higher differentiation potential compared to fetuses exposed to
saline, the effect was more robust in male fetuses. Collectively, these results show that
exposing pregnant rats to MIA during early pregnancy disrupts the normal proliferation
potential and behavior of fetal NPCs.
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Figure 3-5: NPCs isolated from fetal cortices challenged prenatally with PolyI:C
exhibit increased proliferation potential.
Pregnant rats were administered saline or PolyI:C on GD 8.5, and NPCs were isolated
from GD 15.5 cortices for neurosphere culture. Neurospheres from male or female
embryos were pooled, and then mechanically dissociated to form monolayers.
Monolayers were subsequently cultured in media to promote stem or differentiated states.
(A) Representative images of NPC monolayers cultured in proliferation conditions
stained for Pax6 (green) and Nestin (red) or cultured in differentiation conditions stained
for GFAP (green) and NeuN (red). Hoechst (blue) was used to counterstain nuclei. (B)
Representative images of EdU incorporation in NPCs prepared in proliferation conditions
from male and female cortices challenged prenatally with saline or PolyI:C one week
prior. (C) Percentage of male and female NPCs that incorporated EdU during culture in
proliferation conditions. (D) Percentage of male and female NPCs maintained in
differentiation media that incorporated EdU. (E) Percentage of male and female NPCs
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maintained in differentiation media immunoreactive for NeuN indicating their
differentiation capacity. Statistical analyses were performed using Student’s t-test. Data
are represented as mean ± SEM. Data significantly different (p < 0.05) from controls are
indicated by an asterisk (*; 2-3 fetuses per sex collected from at least 3 dams). Scale bar
= 50 μm.
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3.3.4

Altered expression of components of the Notch signaling
pathway in conceptuses following maternal exposure to
PolyI:C.

The Notch signaling pathway is intricately involved in shaping the cell number and
function of the vertebrate nervous system and is well known to facilitate binary cell fate
choices, including the regulation of NPC maintenance and differentiation (reviewed in
(Pierfelice et al. 2011)). In mammals, Notch signaling is controlled by cell-cell
interactions, with Notch receptors (Notch1-4) on one cell activated by ligands (Delta-like
(Dll)-1, Dll-3, Dll-4, Jagged (Jag)-1, and Jag-2) expressed on adjacent cells. Ligandreceptor interactions facilitate cleavage of the Notch intracellular domain, which
translocates to the nucleus to activate target genes influencing cell fate in the nervous
system. Since there are no intermediates between activation of Notch receptors in the cell
membrane and their target site in the nucleus, Notch signaling is principally regulated by
the expression of receptors, ligands and enzymatic activity at the cell membrane. In our
RNA-Seq analysis, we noted increased expression of Notch1 (2.2-fold, FDR p < 0.01)
and Dll1 (4.72-fold, FDR p < 0.01) in conceptuses following MIA, which prompted us to
evaluate expression of all receptors and ligands that participate in Notch signaling. Using
quantitative RT-PCR, we confirmed that following prenatal challenge with PolyI:C,
conceptuses exhibited increased expression of Notch1 and Dll1 compared to conceptuses
exposed to saline, with fold-changes comparable to results obtained using RNA-Seq
(Figure 3-6A, both p < 0.05). We also found reduced expression of Notch3 and Jag2
(51% decreased and 41% decreased, respectively, p < 0.05). Expression of Notch3 and
Jag2 appeared to be similarly reduced in our RNA-Seq analysis, but the p-values did not
reach our stringent cut-off (FDR p-value = 0.10 and 0.06, respectively). There was no
change in Notch2, Dll4, or Jag1 expression between saline or PolyI:C-exposed
conceptuses, whereas Notch4 and Dll3 levels were below the threshold for detection
(Cq>30 in both groups).
Notch1 is the prototypical Notch receptor implicated in maintaining NPC function. Since
we found increased Notch1 expression in conceptuses following MIA, we sought to
determine whether sustained Notch1 expression is evident in the developing fetal cortex,
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Figure 3-6: Maternal exposure to PolyI:C alters expression of Notch signaling
components in the conceptus.
(A) Transcript levels of Notch receptors (Notch1-4) and ligands (Dll1, Dll3, Dll4, Jag1,
Jag2) in conceptuses 6 h following maternal exposure to PolyI:C. Transcript levels were
normalized to levels in conceptuses from saline-exposed dams. NE = Not expressed
(below threshold of detection). (B) Immunofluorescence showing Notch1 expression in
GD 15.5 fetal cortices one-week following maternal exposure to saline or PolyI:C. β3T
was used to delineate the CM. Hoechst was used to stain nuclei. Note that Notch1 is
expressed throughout the cortices, but qualitatively increased expression and nuclear
accumulation of Notch1 is evident following prenatal challenge with PolyI:C. Scale bar =
10 μm. (C) Transcript levels of Notch1 expression in neurospheres collected from
cortices of GD 15.5 fetuses 6 h following maternal exposure to PolyI:C or saline. (D)
Cytoplasmic and nuclear levels of Notch1 in NPCs collected from fetal cortices one week
after maternal exposure to saline or PolyI:C. β-actin was used as a loading control for
cytoplasmic lysates; histone H3 was used as a loading control for nuclear lysates.
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Statistical analyses were performed using Student’s t-test. Data are represented as mean ±
SEM. Data significantly different (p < 0.05) from controls are indicated by an asterisk (*;
3 fetuses collected from each of 3 dams per treatment).
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one-week following maternal exposure to saline or PolyI:C. We found that NOTCH1 was
expressed in cells throughout the cortex, with more intense immunoreactivity in nuclei
located within the VZ in fetuses prenatally challenged with PolyI:C (Figure 3-6B). To
determine whether increased Notch1 expression was evident in NPCs following MIA, we
isolated NPCs from fetal cortices following maternal exposure to saline or PolyI:C one
week earlier, and generated neurospheres. Although there was no change in Notch1
mRNA expression in neurospheres collected from fetal brains one-week following
maternal exposure to PolyI:C, Notch1 protein was increased, particularly in nuclear
lysates (Figure 3-6C and D). Collectively, our results indicate that maternal exposure to
PolyI:C results in abnormalities in Notch signaling in the conceptus and fetal brain
(schematically depicted in Figure 3-7).

3.4 Discussion
Ample epidemiological and experimental evidence supports the notion that MIA during
early pregnancy may interfere with the development of the brain leading to potential
long-term neuropsychiatric and behavioral abnormalities. While many studies have
focused on long-term changes on brain development and/or behavioral outcomes
following MIA, molecular and structural changes in prenatal brain development are not
clear, and such changes may be central for postnatal consequences. In this study, we
identified significant changes to the transcriptome in conceptuses immediately following
MIA in rats, including increased expression of genes involved in inflammatory and
antiviral responses and suppression of genes involved in brain development. Increased
thickness of the VZ was evident in female fetuses one-week following MIA; total cortical
thickness and thickness of the CM were increased in male fetuses. Furthermore, NPCs
prepared from fetal cortices one-week following MIA exhibited enhanced proliferation in
vitro, which may contribute to increased thickness of the cerebral cortex and is likely
mediated by altered Notch signaling. Together, these results suggest that MIA during
early pregnancy causes rapid alterations in signaling pathways required for normal
neurogenesis, leading to profound and persistent changes in cortical development.
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Figure 3-7: Schematic depicting increased NPC proliferation mediated by Notch1
signaling following MIA.
MIA elicits increased expression of Notch1 and its ligand Dll1 in NPCs, which may
contribute to altered NPC proliferation and differentiation dynamics leading to changes in
cortical structure. NICD = Notch Intracellular Domain.
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Exposure of pregnant rodents or primates to the synthetic dsRNA mimetic PolyI:C is a
well-established tool for modelling MIA (Meyer 2014). Many viruses produce dsRNA as
part of their replication cycle. Eukaryotic cells have evolved the capacity to recognize
dsRNA through at least three receptors: toll-like receptor 3 (TLR3), retinoic acidinducible gene 1 (RIG1), and melanoma differentiation-associated protein-5 (MDA5),
which instigate an antiviral response to combat viral infection and propagation (Mian et
al. 2013). Since PolyI:C is sufficient to activate these receptors and trigger cellular
antiviral responses, the use of PolyI:C provides a means to investigate the impact of MIA
without confounding variability in the severity, spread, and duration of viral infections.
Molecular and cellular analyses conducted on brains of adult offspring challenged
prenatally with PolyI:C show profound and reproducible impairments that align with
behavioral phenotypes of clear relevance to neuropsychiatric disorders including ASD,
schizophrenia, and depression (Careaga et al. 2017; Malkova et al. 2012). Moreover,
behavioral abnormalities in offspring can be recapitulated by direct maternal treatment
with PolyI:C-induced cytokines (e.g. IL-6), whereas blocking key pathways prevents
neural and behavioral deficiencies following MIA (Smith et al. 2007; Murray et al. 2015;
Choi et al. 2016). In our study, we exposed dams to PolyI:C during early gestation (GD
8.5), which is a sensitive timepoint for neurogenesis in rats, and can also indirectly
impact brain development by disrupting formation and function of supporting organs like
the placenta (Baines et al. 2020; Hsiao and Patterson 2011). Although previous studies
have analyzed the transcriptome of the fetal brain following maternal PolyI:C exposure
(Garbett et al. 2012), our study is the first to characterize global transcriptome changes in
the whole conceptus (including the primordial nervous system and placenta as well as
maternal decidua, which is a likely source of cytokines deleterious for brain
development). A limitation of this approach was the inability to ascertain changes
happening specifically in the nascent central nervous system following MIA, however, it
did provide us the opportunity to identify molecules activated within the conceptus and
correlate these changes to pathways integral for brain development. In future studies, the
use of single cell transcriptomics may facilitate identification of cell type-specific
responses to MIA.
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Our study revealed broad antiviral and inflammatory responses triggered within the
conceptus rapidly following PolyI:C exposure. Among genes robustly upregulated
following maternal PolyI:C exposure, those conventionally associated with MIAassociated neurological impairments (e.g., Il6, Il1b, and interferon-stimulated genes)
were evident. A variety of other highly upregulated genes were identified in our analysis
that may have important relevance for nervous system development and embryogenesis.
For example, indoleamine 2,3-dioxygenase (Ido1) encodes a potent immunomodulatory
protein that catabolizes tryptophan – a critical amino acid for synthesis of
neuromodulators such as kynurenine and serotonin. High levels of IDO1 are associated
with depressive behavior in rats as well as pain and depression in humans (Kim et al.
2012). Increased expression of the genes encoding C-X-C motif chemokine (CXCL)-10
and CXCL11 occurs during central nervous system inflammation (McColl et al. 2004).
We also identified increased expression of a family of genes encoding interferon-induced
transmembrane proteins, which restrict cellular viral entry and spread, but may
exacerbate MIA and contribute to PolyI:C-induced embryonic lethality in mice
(Buchrieser et al. 2019). Thus, the conceptus competently produces a powerful immune
response that may be required to combat viral infections, but this response may have
consequences on processes essential for embryogenesis.
Previous studies have described an inverse relationship between inflammation and
expression of genes associated with brain development and function. For example, a
single intracerebroventricular injection of lipopolysaccharide into adult mice decreases
expression of genes associated with memory and learning (e.g., Egr1 and Arc) in the
cortex (Bonow et al. 2009). Systemic inflammation also reduces gene expression of
cholinergic components within various brain structures (Silverman et al. 2015),
homeostatic genes in microglia (Sousa et al. 2018), and pathways canonically associated
with nervous system development and function, including genes penetrant to ASD
(Oskvig et al. 2012; Lombardo et al. 2018). Consistent with these studies, our
transcriptomics analysis identified decreased expression of numerous genes including
Doc2b, Sema6c, Gria1, P2rx1, Scn10a, and Rnf112, that are associated with neural
induction, neurogenesis, and central nervous system development following maternal
PolyI:C exposure. Doc2b encodes a protein that contributes to release of
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neurotransmitters and synaptic transmission (Pang et al. 2011). Sema6c encodes the
transmembrane protein Semaphorin-6c, which plays an integral role in central nervous
system connectivity and formation of the peripheral nervous system (Masuda and
Taniguchi 2016). Altered levels of glutamate receptor 1, encoded by Gria1, is a risk
factor for schizophrenia (Parekh et al. 2018). P2X purinoceptor 1, encoded by P2rx1,
potentiates neurite outgrowth, while mutations in sodium voltage-gated channel alpha
subunit 10, encoded by Scn10a, has been implicated in neurological disorders like
multiple sclerosis and Pitt-Hopkins (Rannals et al. 2016). RING finger protein 112,
encoded by Rnf112, regulates neuronal differentiation during embryo development and
maintains neural function in adults. Mice lacking Rnf112 exhibit severe growth
retardation and impaired neurocognitive development characterized by deficiencies in
motor balance, learning, and memory (Tsou et al. 2017). Collectively, the rapid
repression of multiple genes critical for neurogenesis following MIA may interfere with
the normal progression of nervous system development and predispose to long-term
deficiencies in cognition and behavior. However, questions remain about specific
neurogenic pathways in the primordial nervous system that are sensitive to MIA, and
their relevance to long-term pathology in humans with neurobehavioral or cognitive
impairments.
Since we found that MIA represses expression of many genes associated with nervous
system development, we predicted that structural changes would be evident in the
cerebral cortex – the area of the brain responsible for higher order thought, perception,
and reason. Proper cortical development and expansion are dependent on coordinated
regulation of NPC proliferation and cell fate specification; accumulating evidence
indicates that these processes are disrupted following MIA. For example, MIA enhances
expression of cell cycle-related genes and alters NPC proliferation patterns, resulting in
increased cortical thickness and neuron density, brain overgrowth, regions of cortical
dysplasia, and layering defects (Choi et al. 2016; Ben-Reuven and Reiner 2021; Smith et
al. 2012; Le Belle et al. 2014). In this context, our findings of increased cortical thickness
and enhanced NPC proliferation in fetuses one-week following MIA support previous
findings and suggest endogenous dysregulation of NPC self-renewal and differentiation.
Although the thickness of the cerebral cortex in both male and female brains was
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increased by prenatal exposure to PolyI:C, structural changes exhibited a degree of
sexual dimorphism, with males displaying a thicker CM and females a thicker VZ. In line
with the increased CM thickness in male fetuses prenatally challenged with PolyI:C,
NPCs isolated from male fetuses also had a more pronounced tendency to differentiate in
vitro. The structural discrepancies between male and female brains following prenatal
challenge with PolyI:C may reflect distinct responses to inflammation, including a
heightened and prolonged surge of inflammatory cytokines such as IL-6 and IL-1β in
male brains, and increased susceptibility to apoptosis in female brains, which could
differentially predispose male and female offspring to distinct neuropsychiatric
phenotypes (Chavez-Valdez et al. 2019; Loram et al. 2012). Additionally, the duration of
time in which NPCs exhibit dysregulated proliferation following maternal inflammation
is not known. Whereas our study focused on changes occurring within one week of
PolyI:C exposure, a transient surge of maternal IL-6 given on E13.5 in mice is sufficient
to cause an expanded NPC population in two-month-old offspring, indicating that
dysregulated NPC behavior may endure long after in utero exposure to inflammation
(Gallagher et al. 2013). The ramifications of dysregulated NPC behavior and altered
corticogenesis are not fully established, but one possible repercussion is exhaustion of
NPC pools in older adult offspring (Storer et al. 2018). Another possible consequence is
that cortical structural defects resulting from aberrant NPC behavior may be an
etiological factor linking MIA with poor neurobehavioral outcomes in offspring. In
support of this possibility, increased brain volume, head circumference, and number of
cortical neurons are found in a subset of patients diagnosed with ASD (Courchesne et al.
2011; Pramparo et al. 2015).
The evolutionarily conserved Notch signaling pathway is a major contributor to cell fate
determination and patterning in the developing nervous system, including neurogenesis in
embryonic brains, maintenance of NPC populations, and specification of glia (Pierfelice
et al. 2011). Mice lacking Notch1, Dll1, or Rbpj (which encodes a key nuclear component
of the canonical Notch pathway) exhibit early embryonic lethality with compromised
nervous system development, including rapid depletion of NPCs and precocious neuronal
differentiation (Imayoshi et al. 2010; Hitoshi et al. 2002), suggesting that signaling
through Notch1 and Dll1 is critical for proliferation and maintenance of NPCs. The role
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of Notch3 in NPC biology is less clear. Notch3 is expressed in NPCs, but mice lacking
Notch3 are viable, and their brain development appears normal (Krebs et al. 2003). In
some studies, Notch3 is found to promote NPC proliferation similar to Notch1; other
studies have reported Notch3 antagonizes Notch1, thereby inhibiting NPC proliferation
and stimulating differentiation of NPCs (Rusanescu and Mao 2014). Intriguingly, we
observed increased expression of Notch1 and Dll1, and decreased expression of Notch3
in conceptuses following MIA. Consistent with our findings, elevated expression of
several Notch signaling components (e.g. Notch1, Dll1) is evident in inflammatory
conditions such as rheumatoid arthritis and systemic lupus erythematosus, and de novo
production of Notch ligands and receptors is increased following activation of TLR
pathways (Shang et al. 2016). Moreover, direct infection of human NPCs with Zika virus
is sufficient to induce Notch signaling; proper differentiation and improved viability of
Zika-infected NPCs is restored using a Notch pathway inhibitor, DAPT (Ferraris et al.
2019). We therefore propose that dysregulated expression of Notch signaling components
following MIA may contribute, at least in part, to the sustained increase in NPC
proliferation and increased thickness of cortical layers during fetal development.
In conclusion, we have uncovered a comprehensive profile of gene expression changes in
the rat conceptus following an early gestational exposure to PolyI:C and correlated these
changes to sustained dysregulation of cortical structure and NPC function. PolyI:C and
other immunogens (e.g., lipopolysaccharide) elicit strong, short-lived innate immune
responses, and have an advantage of controlling the onset and severity of MIA within
defined periods of embryogenesis. A limitation of these models is that they may not fully
recapitulate the broad and potentially long-lasting immune response characteristic of live
pathogens. Despite this limitation, many distinct types of bacterial and viral infections
predispose to neuropsychiatric deficiencies in humans at various stages in pregnancy, and
behavioral phenotypes are comparable in rodents challenged prenatally with PolyI:C,
lipopolysaccharide, and active pathogens (e.g., influenza A) (Arsenault et al. 2014). This
suggests that maternal immune responses provoked by distinct pathogens and
immunogens may converge to impact development of the primordial nervous system,
with implications for long-term cognitive function and behavioral phenotype. In future
studies, it will be enticing to dissect the impact that MIA exerts on pathways vital for
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nascent nervous system development, such as dysregulated expression of Notch signaling
components, which may underlie the pathogenesis of neurodevelopmental disorders
caused by distinct stimuli. For example, in another rodent model that elicits behaviors
reminiscent of ASD, inhibition of excessive Notch signaling alleviates ASD-like
behaviors in offspring (Zhang et al. 2019). Therefore, this pathway-specific approach
may yield new therapeutic strategies that selectively target the molecular underpinnings
of abnormalities in cortical development and offspring behavior following prenatal
exposure to immunogens.
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Chapter 4

4

Gene Expression Profiling of Decidua from Interleukin15 Deficient Rats Reveals Osteopontin as a Natural
Killer Cell-Specific Marker

Uterine Natural Killer (uNK) cells are the most prevalent immune cells within the uterus
during early pregnancy. These cells are thought to contribute to the regulation of
decidualization and placentation, but their functions remain poorly characterized.
Previously, we use targeted genomic to edit the Interleukin-15 (Il15) locus in rats,
resulting in a frameshift mutation in Il15. Since IL15 is required for NK cell survival,
these Il15-deficient (IL15Δ/Δ) rats exhibit a severe deficiency of NK cells including uNK
cells, which caused robust changes in placental morphology including precocious
trophoblast invasion. Therefore, we hypothesize that uNK cells produce factors during
early pregnancy that control the depth of placentation. This study aimed to profile gene
expression differences in the conceptus between wild-type (WT) and IL15Δ/Δ rats during
early pregnancy to identify regulatory factors produced by uNK cells involved in
controlling placental invasion. Global transcript changes in the conceptus were assessed
between pregnant IL15Δ/Δ and WT Sprague-Dawley Holtzman rats at gestational day
(GD) 9.5 using Clariom S gene expression profiling. There were 257 genes differentially
expressed between WT and IL15Δ/Δ rats. Notably, we detected a significant decrease in
Prf, which encodes the uNK cell marker perforin, and Spp1, which encodes osteopontin
(OPN) in IL15Δ/Δ rats. Using immunohistochemistry, OPN was localized to the uterine
glands, decidua, and primitive placenta at GD 9.5 in WT rats. Conversely, IL15Δ/Δ rats
had strong OPN expression in the uterine glands, but no detectable OPN in the decidua.
Isolated uNK cells from GD 9.5 decidua expressed Spp1 mRNA; OPN and perforin
staining were co-localized in vitro and in vivo, strongly indicating that OPN is produced
by uNK cells. This study provides the first comprehensive characterization of rat uNK
cells and identifies OPN as a uNK cell marker in rats. These findings will ultimately
provide a deeper understanding of uNK cell biology and how uNK cells contribute to
placental development.
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4.1 Introduction
Decidualization involves morphological and functional changes to the uterine
endometrium in preparation for an implanting embryo. Decidualization facilitates
implantation of a blastocyst and is critical for proper regulation of placentation, which in
humans requires deep invasion of trophoblasts into the maternal endometrium and inner
myometrium. The decidua basalis contains a variety of specialized cell-types that have a
vital role in regulating the extent to which trophoblasts can invade towards the maternal
myometrium (Godbole et al. 2011; Zhu et al. 2009; Lash et al. 2006; Smith et al. 2009).
In particular, during early pregnancy there is a marked infiltration and proliferation of
immune cells at the decidual-placental interface (Jabrane-Ferrat 2019). Uterine natural
killer (uNK) cells are the predominant immune cell population of the decidua in both
humans and rodents, comprising over 70% of uterine leukocytes during early pregnancy
(Jabrane-Ferrat 2019). These cells are thought to be important for placental and decidual
development (Cerdeira et al. 2013). For example, uNK cells are found in close proximity
to the uterine spiral arteries (the feeder vessels of the placenta) prior to trophoblast cell
invasion, thereby contributing to the regulation of trophoblast invasion (Robson et al.
2012; Chakraborty et al. 2011). Studies primarily using transgenic mice devoid of NK
cells indicate a contribution of uNK cells to the widening of the spiral arteries during
pregnancy to accommodate the increased blood flow to the placenta required for rapid
fetal growth in late gestation (Moffett and Colucci 2014). The role of uNK cells at the
maternal-placental interface in other species with hemochorial placentation, such as rats
and humans, is controversial since invading trophoblast cells emanating from the placenta
are primarily responsible for spiral artery remodelling in these species (Gaynor and
Colucci 2017). It is possible that uNK cells have conserved functions in initiating spiral
artery remodelling, and that invasive trophoblasts are required for complete arterial
transformation in these species.
Interleukin-15 (IL-15) is a cytokine required for NK cell development and survival and is
produced by several tissues including: the heart, appendix, testes, skeletal muscle, lungs,
placenta, and peripheral blood mononuclear cells (Huntington et al. 2007; Patidar et al.
2016; Grabstein et al. 1994). IL-15 also plays a role in regulating the activation of innate
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immune cells in response to certain stimuli such as viral infections (Carson et al. 1995;
Ma et al. 2000). To examine the role of uNK cells as regulators of decidualization and
placentation, several mouse studies have exploited deleted the gene encoding IL-15 or its
receptor to generate NK cell-deficient animals. Consistently, IL-15-deficient mouse
models feature uterine abnormalities that result from an absence of uNK cells, including a
hypocellular decidua and failed spiral artery remodelling, and have been instrumental in
furthering our understanding regarding uNK cell function during pregnancy (Ashkar et al.
2003; Barber and Pollard 2003; Mori et al. 2016). However, since a deeply invasive
trophoblast is not a feature of mouse placentation, these models have been less
informative about the functional role of uNK cells in the regulation of trophoblast
invasion during placentation.
To gain insight into the role of uNK cells in the regulation of trophoblast invasion and
placentation, we previously generated an IL-15 mutant (IL15Δ/Δ) rat model (Soares et al.
2018; Renaud et al. 2017). Rats, like humans, have a deeply invasive trophoblast, so the
generation of IL15Δ/Δ rats provided for us an opportunity to study the regulatory role of
uNK cells in trophoblast invasion and placentation. IL15Δ/Δ rats have a severe deficiency
of uNK cells, and exhibit placental morphological changes including an expanded
junctional zone (the portion of the rodent placenta from which invasive trophoblasts
arise) at midgestation. Additionally, these rats present with widened spiral arteries with
increased internal luminal diameter compared to wild-type (WT) rats due to precocious
trophoblast invasion (Renaud et al. 2017). These findings are consistent with other
studies using asialo GM1 antibody-mediated NK cell depletion in rats (Chakraborty
2011). Therefore, we hypothesize that uNK cells produce regulatory factors that promote
decidualization and negatively regulate the depth of trophoblast invasion. In this study,
we performed gene expression profiling of rat WT and IL15Δ/Δ uteri on GD 9.5, a time
period when uNK cells are prevalent in the decidua and the placenta is in a nascent state,
to better characterize transcriptional signatures of rat uNK cells and identify gene
expression differences that may account for the robust changes in placental development.
We found a variety of differentially expressed transcripts in uteri between WT and
IL15Δ/Δ dams, notably Spp1, which encodes the multifunctional phosphoprotein
osteopontin (OPN). Additionally, we identified uterine glands and uNK cells as the
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primary sources of OPN in the GD 9.5 rat conceptus. Further, we were able to
successfully isolate and culture rat uNK cells which expressed significant levels of OPN.
Collectively, our findings highlight robust gene expression differences between WT and
IL15Δ/Δ deciduas in rats including many factors expressed by uNK cells and suggest that
OPN may be a critical uNK cell-derived factor capable of dampening trophoblast
invasion.

4.2 Materials and Methods
4.2.1

Animals

WT male (8-10 weeks old) Holtzman Sprague-Dawley rats were obtained from Envigo
and bred with in-house generated WT or IL15Δ/Δ Holtzman Sprague-Dawley females (68 weeks old). NK cell isolation experiments were conducted with WT Sprague-Dawley
animals (Charles River). All animals were maintained in a 12 h light: 12 h dark cycle
with water and food available ad libitum. Females were cycled by daily inspection of
cells within the vaginal lavage and mated with a fertile male when in pro-estrus. Cells
were identified under a microscope as outlined by Goldman et al. (Goldman et al. 2007).
Gestational day (GD) 0.5 was defined as the day immediately following mating if
spermatozoa were detected within the vaginal lavage. All protocols involving the use of
rats were approved by the University of Western Ontario Animal Care and Use
Committee.

4.2.2

Tissue Collection

To obtain tissue for immunohistochemical or molecular analysis, pregnant dams were
sacrificed on GD 9.5 using mild carbon dioxide inhalation until respiratory failure,
followed by thoracotomy. Whole GD 9.5 conceptuses (containing decidua, placenta, and
embryo) were isolated and placed in sterile saline for uNK cell isolations. For
immunohistochemistry, whole conceptuses were fixed in 10% neutral buffered formalin
for paraffin-embedded sections, or tissues were snap-frozen in liquid nitrogen and stored
at −80℃ for RNA and protein extraction.
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4.2.3

Clariom S Gene Expression Array

RNA was isolated from snap-frozen conceptuses (encompassing maternal decidua as well
as nascent embryo and placenta), of WT and IL15Δ/Δ rats at GD 9.5. RNA was collected
by homogenizing whole conceptuses in RiboZol (VWR; 3 dams of each WT and mutant,
3 conceptuses from each dam), followed by collection of the aqueous phase which was
applied to RNeasy columns (Qiagen) with DNase I (Qiagen). Purified RNA (30 µg per
sample) was submitted to Hamilton Health Sciences Centre (Hamilton, ON, Canada) for
transcriptome analysis on a GeneChip Scanner 3000 using the Clariom S rat array
(Thermo Scientific). Samples were normalized using the Signal Space TransformationRobust Multiarray Analysis data normalization algorithm to reduce background and data
files were generated and processed for analysis using Transcriptome Analysis Console
Software 4.0 (ThermoFisher Scientific) to analyze global expression patterns of genes.
Gene ontology pathway analysis was completed using DAVID Functional Annotation
Bioinformatics (Huang et al. 2009).

4.2.4

Quantitative RT-PCR

To confirm the validity of the array results at the transcript level and in a larger number
of conceptuses, quantitative RT-PCR (qRT-PCR) was performed. RNA was extracted
from cells and tissues by lysing in RiboZol (Amresco) as directed by the manufacturer.
Purified RNA was used to make complementary DNA using High-Capacity
complementary DNA Reverse Transcription kit (ThermoFisher Scientific), diluted 1:10,
and used for qRT-PCR. Complementary DNA was mixed with SensiFAST SYBR green
PCR Master Mix (FroggaBio) and primers detailed in Table I. To amplify DNA and
detect fluorescence, a CFX Connect Real-Time PCR system (Bio-Rad Laboratories) was
used. Cycling conditions involved an original holding step (95℃ for 3 minutes), followed
by 40 cycles of two-step PCR (95℃ for 10 s, 60℃ for 45 s), and a dissociation step
(65℃ for 5 s, and a sequential increase to 95℃). The comparative cycle threshold (ΔΔCt)
method was used to calculate relative mRNA expression, using the geometric mean of Ct
values obtained from amplification of four genes (Rn18s, Ywhaz, Actb, and Gapdh) as
reference RNA.

157

4.2.5

Protein Extraction and Western Immunoblot

Total tissue protein was isolated by homogenizing snap frozen GD 9.5 conceptuses in
radioimmunoprecipitation assay lysis buffer (50 nM Tris, 150 nM NaCl, 1% Nonidet P40, 0.5% sodium deoxycholate, 0.1% SDS, pH 7.2) supplemented with protease inhibitor
cocktail (Sigma-Aldrich), then sonicated (Sonic Dismembrator Model 100, Thermo
Fisher Scientific). To measure total protein concentrations, a modified bicinchoninic acid
assay (Bio-Rad Laboratories) was used according to the manufacturer’s instructions.
Approximately 25 µg of tissue lysates were mixed with 4✕ reducing loading buffer
(62.5 nM Tris, pH 6.8, 10% glycerol, 2% SDS, 50 nM DTT, and 0.025% bromophenol
blue). Samples were boiled for 5 minutes and then subjected to SDS-polyacrylamide gel
electrophoresis. Proteins were transferred to a nitrocellulose membrane, blocked with 3%
BSA in TBS that contained 0.1% Tween-20, and then probed with primary antibodies
specific for OPN (AKm2A1, 1:500, Santa Cruz Biotechnology), Perforin (PRF; TP251,
1:1000, Torrey Pines Biolabs), and GAPDH (5174, 1:1000, Cell Signaling Technology).
Following incubation with species-appropriate, infrared-conjugated secondary antibodies
(Cell Signaling Technology), protein signals were detected using a LI-COR Odyssey
imaging system (Li-COR Biotechnology). Resulting bands were analyzed using ImageJ
software, where band intensities of target proteins were normalized to corresponding
GAPDH signals.
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Table 4-1: Forward and reverse primers used for quantitative RT-PCR
amplification.
Gene

Accession

Forward Sequence

Reverse Sequence

Number
Rn18s

NM_046237.1

5’-GCAATTATTCCCCATGAACG-3’

5’-GGCCTCACTAAACCATCCAA-3’

Actb

NM_031144.3

5’-GCCATGTACGTAGCCATCC-3’

5’-CTCTCAGCTGTGGTGGTGAA-3’

Ccl5

NM_031116.3

5’-CCTTGCAGTCGTCTTTGTCA-3’

5’- GAGTAGGGGGTTGCTCAGTG-3’

Crym

NM_053955.2

5’-GCTGTTGGAGCCAGTAGACC-3’

5’-TCAGCCCCTGACAACAGAAC-3’

Eomes

XM_039082697.1

5’-TTCACCCAGAATCTCCCAAC-3’

5’-TGGAAGGCTCATTCAAGTCC-3’

Gapdh

NM_017008.4

5’-AGACAGCCGCATCTTCTTGT-3’

5’-CTTGCCGTGGGTAGAGTCAT-3’

Prf1

NM_017330.2

5’-GGCACTCAAGGAACCTTCC-3’

5’-CTCAAGCAGTCTCCTACC-3’

Spp1

NM_012881.2

5’-AGACTGGCAGTGGTTTGCTT-3’

5’-TGTAATGCGCCTTCTCCTCT-3’

Vim

NM_031140.1

5’-ATGCTTCTCTGGCACGTCTT-3’

5’-TGGCAGCCACACTTTCATAC-3’

Ywhaz

NM_013011.3

5’-TTGAGCAGAAGACGGAAGGT-3’

5’-CCTCAGCCAAGTAGCGGTAG-3’
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4.2.6

Immunohistochemistry

GD 9.5 whole conceptuses were collected, fixed in 10% neutral buffered formalin,
embedded with paraffin, and sectioned at 5 µm thickness. Serial sections were
deparaffinized in Histoclear (National Diagnostics) and rehydrated using increasing
dilutions of ethanol washes. Formaldehyde crosslinks were fragmented by placing slides
in Reveal Decloaker (Biocare Medical) at 95℃ for 20 minutes. Following rehydration,
endogenous peroxidases were blocked by treating tissues with 0.3% hydrogen peroxide in
methanol. Sections were then permeabilized using 0.3% Triton-X and 1% BSA in PBS
and blocked with 10% normal goat serum (Life Technologies). Sections were immersed
in primary antibodies specific for OPN (0.5 µg/ml, Santa Cruz Biotechnology) or PRF
(2.5 µg/ml, Torrey Pines Biolabs), overnight at 4℃. Subsequently for chromogenic
staining, sections were incubated with species-appropriate biotinylated secondary
antibodies, followed by Vectastain (MJS Biolynx). Colour was developed using 3-amino9-ethylcarbazole (AEC) red (Vector Laboratories), counterstained with hematoxylin
(Sigma Aldrich) and mounted with Fluoromount-G mounting medium (Southern
Biotech). For fluorescent staining, sections were incubated with species-specific Alexa
488– or Alexa 555–conjugated secondary antibodies followed by DAPI nuclear stain
(ThermoFisher Scientific. Sections were imaged using a Nikon ECLIPSE Ni series
microscope equipped with a Ds-Qi2 camera.

4.2.7

uNK Cell Isolation

Deciduas were removed from GD 9.5 implantation sites under a dissection microscope
and extraembryonic ectoderm and ectoplacental cones were removed. Isolated decidual
tissue was minced and then placed in gentle collagenase/hyaluronidase in DMEM
(StemCell Technologies) for 2 hours at 37℃ on a gentle shaker as per the manufacturer’s
instructions. Digested tissue was passed through a 100 μm cell strainer and the resulting
single cell suspension was layered onto Lymphoprep™ (StemCell Technologies) and
subjected to density-gradient centrifugation as per manufacturer’s instructions. Isolated
mononuclear cell layer was washed, and cells were counted for flow cytometry or plated
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for cell culture experiments. For cell culture, isolated mononuclear cells were
resuspended in RPMI supplemented with 1% FBS and 10 ng/ml rat recombinant IL-15
(PeproTech) and plated. For coculture experiments cells were placed directly into
incubators for 24 h. For separation conditions, resuspended cells were incubated for 2
hours at 37℃. After 2 hours, cells in suspension were removed from those adhered and
placed in separate wells or analyzed by flow cytometry. For all conditions, after 24 hours
(plus 6 h and 12 h for separation experiments) RNA was isolated from both adhered and
suspended cells for expression of NK cell markers.

4.2.8

Immunofluorescence

After resuspension, a small number of isolated mononuclear cells were isolated and fixed
in 4% paraformaldehyde. Following fixation, cells were smeared on gelatin-coated
microscope slides. Cell smears were permeabilized using 0.3% Triton-X and 1% BSA in
PBS and blocked with 10% normal goat serum (Life Technologies). Slides were then
immersed in primary antibodies specific for OPN (0.5 µg/ml, Santa Cruz Biotechnology)
and PRF (2.5 µg/ml, Torrey Pines Biolabs) overnight. Slides were then incubated with
Alexa 555–conjugated anti-rabbit secondary (Invitrogen), Alexa 488–conjugated antimouse secondary (Invitrogen) antibodies, and DAPI (ThermoFisher Scientific) prior to
mounting with Fluoromount-G. Images were acquired using a Nikon ECLIPSE Ni Series
microscope equipped with a Ds-Qi2 camera.

4.2.9

Flow Cytometry

Following isolation, freshly resuspended cells or suspended cells plated for two hours
were subsequently diluted to 1 x 106 cells per ml and incubated for 30 minutes with PEconjugated mouse anti-rat anti-CD161 (BD Biosciences) or PE-conjugated mouse IgG1
(κ isotype control; BD Biosciences), and then fixed and permeabilized using BD
Cytofix/Cytoperm Fixation/Permeablization Kit (BD Biosciences) as per manufacturer’s
instructions. Fixed cells were then analyzed using a Cytomics FC500 flow cytometer
with CXP software (Beckman Coulter).
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4.2.10

Statistical Analysis

Unless indicated otherwise, statistical significance was analyzed by Student’s t-test when
comparing two groups, and Analysis of Variance followed by a Tukey’s post-hoc test
when comparing three or more groups. Differences were considered statistically
significant when p ≤ 0.05. GraphPad Prism 8.0 was used for all graphing and statistical
analysis. All animal experiments were conducted with a minimum of three dams. The
specific number of dams and conceptuses analyzed is indicated in the figure legends, with
“N” representing the number of dams and “n” representing the number of conceptuses
used in each cohort of samples.

4.3 Results
4.3.1

Altered Gene Expression in Decidua of IL15Δ/Δ Rats

Our previous study utilizing IL15Δ/Δ rats found an expanded junctional zone, extensive
trophoblast invasion into spiral arteries and enhanced dilation of spiral arteries associated
with a lack of uNK cells compared to WT rats (Renaud et al. 2017); however, the
mechanisms underlying these changes have yet to be elucidated. We set out to examine
global gene expression changes between WT and IL15Δ/Δ rats, which would allow us to
determine candidate genes that may be driving changes in decidualization and
placentation in response to the absence of IL-15. Moreover, since IL15Δ/Δ rats do not
possess uNK cells, this approach may uncover genes expressed specifically by rat uNK
cells. Thus, we used a microarray analysis to profile global gene expression changes on
GD 9.5 between WT and IL15Δ/Δ conceptuses. Overall, from a total of 23,418 transcripts
examined, there were significant ( ≥ 2-fold increased or decreased compared to WT, p ≤
0.05) differences in the expression of 257 genes between IL15Δ/Δ and WT conceptuses
(Figure 4-1A, B). Of these, 91 transcripts were upregulated more than 2-fold in IL15Δ/Δ
rats, and 156 transcripts were downregulated more than 2-fold (Figure 4-1B). Transcripts
upregulated in IL15Δ/Δ deciduas include those associated with neurotransmission and
central nervous system development (e.g., Gria4, 3.92-fold; Crym, 3.61-fold) and various
glycoproteins involved in implantation or inflammatory responses (e.g., Zp2, 31.18-fold;
Orm1, 24.17-fold; Prom1, 5.26-fold). Unsurprisingly, many of the downregulated genes
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Table 4-2: List of top 20 increased genes in IL15Δ/Δ animals.
Gene

Fold Change

WT Reads (log2)

IL15Δ/Δ Reads (log2)

Zp2

31.18

3.27

8.23

Hp

6.84

8.42

11.19

Gria4

3.92

5.23

7.2

LOC102553649

3.61

7.87

9.72

Crym

3.61

5.13

6.98

Olr1220

3.36

4.34

6.09

Olr1468

3.29

2.92

4.63

Chpt1

3.17

12.26

13.93

Olr1081

3.09

3.15

4.78

Olr84

2.98

2.32

3.9

LOC685828

2.93

6.98

8.53

LOC100911939

2.93

3.33

4.88

Olr1237

2.93

3.33

4.88

Olr1237

2.93

3.33

4.88

Fis1

2.91

8.62

10.16

Samt4

2.87

2.84

4.36

Hormad1

2.82

4.25

5.75

Qpct

2.72

7.83

9.27

Vom2r10

2.72

3.36

4.81

Olr1063

2.67

4.55

5.97
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Table 4-3: List of top 20 decreased genes in IL15Δ/Δ animals.
Gene

Fold Change

WT Reads (log2)

IL15Δ/Δ Reads (log2)

Gzmc

-1798.9

15.71

4.9

Prf1

-318

13.13

4.82

LOC100911163

-140.18

11.64

4.51

Gzmb

-80.41

11.12

4.79

Gzmbl2

-75.92

11.32

5.08

Nkg7

-49.08

8.74

3.13

Il2rb

-42.81

9.34

3.92

Spp1

-23.94

12.21

7.63

Fcrl6

-18.35

8.44

4.24

Cd96

-13.34

7.42

3.68

Ccl5

-7.97

6.93

3.94

Eomes

-7.86

8.27

5.29

Laptm5

-5.57

9.17

6.69

Mcpt10

-5.39

8.07

5.64

LOC100910060

-5.36

5.54

3.12

Plek

-5.19

5.42

3.04

Lcp1

-5.17

10.04

7.67

Clnk

-5.16

6.0

3.63

Mcpt8

-4.86

8.35

6.06

Sh2d1b

-4.49

5.56

3.4
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encoded proteins associated with inflammatory processes and immune cell (namely NK
cell) development (e.g., Gzmc, 1798.9-fold; Prf1, 318-fold; Gzmb, 80.41-fold).
Gene ontology analysis identified downregulated pathways in IL15Δ/Δ conceptuses
including immune response (p = 4.2E-6, 12 genes), immune system process (p = 3.3E-4,
10 genes), and leukocyte cell-cell adhesion (p = 3.0E-5, 5 genes, Figure 4-1C).
Interestingly, pathways associated with upregulated genes were related to neurological
processes and sensory perceptions including chemical stimulus (p = 1.2E-3, 13 genes)
and olfaction (p = 2.5E-3, 12 genes, Figure 4-1D). To further confirm microarray results,
qRT-PCR was conducted to detect a subset of these transcripts using conceptuses
collected from a separate cohort of WT or IL15Δ/Δ dams. Compared to WT rats, the
relative expression of Crym was significantly (p ≤ 0.05) increased in IL15Δ/Δ rats. The
relative expression of the genes encoding the NK cell associated proteins eomesodermin
(Eomes) and chemokine ligand 5 (Ccl5) were significantly decreased (p ≤ 0.05, N ≥ 5, n
≥ 13) (Figure 4-1E). Thus, conceptuses from IL15Δ/Δ rats exhibit robust gene expression
Changes, including reduced expression of many genes associated with NK cell
development and function.

4.3.2

IL15∆/∆ Rats Do Not Possess Uterine Natural Killer Cells

Since IL-15 is required for NK cell development, our next goal was to confirm the
absence of uNK cells in conceptuses collected from IL15Δ/Δ rats. First, we conducted
qRT-PCR on GD 9.5 conceptuses collected from WT and IL15Δ/Δ dams (N ≥ 5, n ≥ 13
for each group) to detect Prf, the gene that encodes the pore-forming cytolytic protein
PRF, which is highly expressed in NK cells and cytotoxic T lymphocytes. Since
cytotoxic T lymphocytes are typically rare in the decidua (Erlebacher 2013; Yang et al.
2019), we concluded that Prf expression can be used as a proxy for NK cells. Not
surprisingly, Prf transcript expression was significantly downregulated (35-fold, p ≤
0.05) in conceptuses from IL15Δ/Δ rats (Figure 4-2A), which is consistent with results
from our microarray analysis. To confirm these changes at the protein level, we
performed western blotting, and observed an 86% decrease in PRF protein levels in
IL15Δ/Δ conceptuses compared with WT conceptuses (Figure 4-2B). To confirm the
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Figure 4-1: Gene expression changes in conceptuses isolated from WT and IL15Δ/Δ
rats.
Volcano plot of genes significantly (p ≤ 0.01) upregulated or downregulated in
conceptuses from IL15Δ/Δ rats compared to WT rats. (B) Pie chart showing number of
transcripts upregulated and downregulated in conceptuses from IL15Δ/Δ rats compared to
WT rats. (C) Top 10 gene pathways downregulated in conceptuses from IL15Δ/Δ rats.
(D) Top 10 gene pathways upregulated in conceptuses from IL15Δ/Δ rats. Pathway
analysis was conducted by inputting transcripts changed more than 2-fold with a p ≤ 0.01
in IL15Δ/Δ rats compared to WT rats into DAVID Bioinformatics Resource. (N = 3, n = 9
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for each group). (E) Quantitative RT-PCR was used to compare the relative expression of
select transcripts in GD 9.5 conceptuses from IL15Δ/Δ rats compared to WT rats. N = 9, n
≥ 13 per group. Results represent means ± SEM. Data significantly different from
controls (p ≤ 0.05) are indicated by an asterisk (*).
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localization of PRF, and thus NK cells, we conducted immunohistochemistry on WT and
IL15Δ/Δ conceptuses, staining for PRF on GD 9.5. At GD 9.5, WT rats had increased
PRF staining in the decidua basalis (DB), including moderate staining proximal to the
ectoplacental cone (EPC, which contributes to formation of the placental junctional
zone), whereas no staining was observed in the decidua of IL15Δ/Δ rats (Figure 4-2C).
Quantifying the number of PRF positive cells highlighted a significant 98.5% decrease in
PRF positive cells in the DB (Figure 4-2D) and 97.2% decrease in PRF positive cells in
proximity to the EPC (Figure 4-2E) in IL15Δ/Δ rats compared to WT controls (p ≤ 0.05,
N ≥ 5, n = 7 for each group). Collectively, these results demonstrate that deciduas from
IL15Δ/Δ have greatly reduced numbers of uNK cells in the decidua and near the nascent
placenta.

4.3.3

IL15∆/∆ Rats Have Decreased Osteopontin Expression

OPN has previously been implicated in the homeostasis and function of NK cells
(Leavenworth et al. 2015). Moreover, decreased levels of OPN have been reported in
cases of placenta accreta, a condition characterized by deficient decidualization and over
invasive placentation (Özer et al. 2018). As Spp1, the gene encoding OPN, was one of the
most significantly downregulated genes in our gene expression analysis, we further
evaluated expression and localization of Spp1 in deciduas of WT and IL15Δ/Δ rats.
Expression of Spp1 was significantly decreased (2.45-fold) at the RNA level in GD 9.5
IL15Δ/Δ implantation sites compared to WT (Figure 4-3A, p ≤ 0.05, N ≥ 5, n ≥ 13 for
each group). Interestingly, four conceptuses from IL15Δ/Δ rats (out of a total of X) had
comparable levels of Spp1 as WT. These same four conceptuses had robustly
downregulated PRF (Figure 3) indicating that these results were not due to an unexpected
influx of NK cells, so we reasoned that the Spp1 in these four conceptuses may be due to
contamination of samples by uterine glands. Indeed, it has been reported that OPN is
secreted by uterine glands in various species (Johnson et al. 2003; Chaen et al. 2012;
Burton et al. 2002; Qi et al. 2014), and following immunohistochemistry for OPN,
staining was readily apparent in both WT and IL15Δ/Δ uterine glands (Figure 4-3B,G).
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Figure 4-2: IL15Δ/Δ rats are devoid of PRF-containing uNK cells on GD 9.5.
(A) Quantitative RT-PCR comparing Prf levels between conceptuses from WT and
IL15Δ/Δ rats (N ≥ 5, n ≥ 13). (B) Western blot showing decreased PRF levels in
conceptuses from IL15Δ/Δ rats compared to conceptuses from WT rats. GAPDH was
used as a loading control. The histogram on the right shows results from densitometric
analysis comparing PRF levels relative to GAPDH (n = 4 per group) (C)
Immunohistochemistry showing PRF localization in conceptuses on GD 9.5 (N = 9, n =
12 per group). Please note the lack of PRF detection in IL15Δ/Δ deciduas. Scale bar in
whole conceptus, 250 µm. Scale bar in higher magnification images, 50 µm. (D, E)
Quantification of PRF-positive cells in WT and IL15Δ/Δ conceptuses (N ≥ 5, n = 7 per
group) in the decidua (D) and near the EPC (E). Results represent means ± SEM. Data
significantly different from controls (p ≤ 0.05) are indicated by an asterisk (*).
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Figure 4-3: Decreased expression of decidual OPN in IL15Δ/Δ rats.
(A) Relative gene expression of Spp1 in WT versus IL15Δ/Δ conceptuses on GD 9.5 (N ≥
5, n ≥ 13). (B) Images showing OPN localization in uterine glands of WT and IL15Δ/Δ
conceptuses on GD 9.5. (C) Western blot showing levels of OPN in lysates from GD 9.5
conceptuses of WT and IL15Δ/Δ rats. GAPDH was used as a loading control. The
histogram on the right shows results from densitometric analysis comparing OPN levels
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relative to GAPDH (n = 6 per group). Uncropped images of western blots are provided in
Figure S2. (D) Immunohistochemical images of OPN staining in WT versus IL15Δ/Δ
conceptuses. (E) Higher magnification images of OPN staining in the decidua (DB) of
WT versus IL15Δ/Δ conceptuses. (F) Higher magnification image of OPN staining in the
ectoplacental cone (EPC) of WT versus IL15Δ/Δ conceptuses. Please note that OPN
staining is observed in sections of WT decidua, but not in IL15∆/∆ decidua (N = 9, n =
12). Scale bar in D, 250 µm. Scale bar in E and F, 50 µm. (G) Quantification of OPN+
cells in WT and IL15Δ/Δ conceptuses (N ≥ 5, n = 7 per group). Results represent means ±
SEM. Data significantly different from controls (p ≤ 0.05) are indicated by an asterisk
(*).
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We next sought to determine whether changes in OPN expression were detectable at the
protein level. Western blotting was performed using tissue lysates of whole GD 9.5
conceptuses collected from WT and IL15Δ/Δ rats. Compared to WT conceptuses, a 37%
decrease in OPN was observed in IL15Δ/Δ conceptuses (Figure 4-3C, N = 3, n = 6 for
each group, p ≤ 0.05). To determine localization of OPN expression on GD 9.5,
immunohistochemical detection of OPN was used. Sections of conceptuses collected
from IL15Δ/Δ rats showed no OPN staining in or around the developing placenta (Figure
3D-F). In comparison, WT conceptuses had pronounced OPN staining both in the
decidua basalis (DB) and near the ectoplacental cone (EPC). After counting the number
of OPN-positive cells present in the decidua and glands of conceptuses from WT and
IL15Δ/Δ rats (N ≥ 5, n = 7 for each group), a significant decrease was seen in the levels of
OPN staining in the DB (99.5% decrease) including near the EPC (95% decrease), while
levels remained similar between the two groups in uterine glands (Figure 4-3G),
indicating that any changes in OPN expression observed at the RNA or protein levels are
likely due to changes in the decidua and not the uterine glands. To determine if OPN colocalizes with PRF and is therefore likely produced by uNK cells, we co-stained for PRF
and OPN in GD 9.5 conceptuses and observed positive staining for both in WT
conceptuses (Figure 4-4). Thus, OPN is expressed by uNK cells and it may play a role in
modulating uNK cell functions.

4.3.4

Isolated uNK cells express OPN

While uNK cells have previously been isolated from both humans and mice, isolation of
uNK cells in rats has yet to be reported (Paffaro et al. 2003; Timonen and Saksela 1980).
Here, we demonstrate a protocol to isolate and culture NK cells from GD9.5 deciduas of
pregnant rats. Isolated mononuclear cells were plated for 2 hours to allow the
heterogenous population of cells time to separate by adherence. After 2 hours, cells were
separated into suspended versus adherent populations. Adherent cells consistently
exhibited reduced expression of genes encoding the NK cell markers perforin (Prf1),
killer cell lectin-like receptor subfamily b 1F (Klrb1f), and Ccl5 over 24 hours (Figure
5a). Compared to adherent cells, suspended cells expressed significantly (p ≤ 0.05) higher
levels of Ccl5, Klrb1f, Prf1 and Spp1, which continuously increased over time in culture.
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(Figure 4-5A). Culturing suspended cells with adherent cells for 24 h yielded
significantly higher expression levels of NK cells markers Ccl5 (31.52-fold), Prf1 (5.83fold), and Klrb1f (18.77-fold) as well as Spp1 (11.17-fold) in suspended cells compared
to adherent (Figure 4-5B). Interestingly, the transcript expression of Vim, a gene
encoding vimentin, a protein found within decidual stromal cells (Glasser and Julian
1986), was significantly decreased (2.9-fold) in suspended cells compared to adherent
controls (Figure 4-5B). Collectively, these results indicate enrichment of NK cells within
the population of suspended cells isolated from GD 9.5 decidua, as compared to those
adhering to tissue culture plastic.
Further confirmation of the presence of NK cells can be accomplished by analyzing the
expression of CD161 (Arase et al. 1997). When evaluating surface expression of CD161
in decidual mononuclear cells, approximately 7.24% were positive for CD161 (Figure 46A). After allowing adherent cells to attach for 2 h and collecting the suspended cells, we
successfully enriched the population of CD161+ cells to approximately 25% (Figure 46B). Comparatively, allowing isolated decidual mononuclear cells to attach for 2 h
allowed us to significantly enrich the population of CD161 + cells by 18.34% (Figure 46C). Immunofluorescence conducted on suspended cells for the NK cell secreted protein
PRF allowed us to visualize that a large number of these cells were likely uNK cells. PRF
positive cells also co-stained for the expression of OPN indicating a colocalization of
OPN expression and PRF in isolated uNK cells. Collectively, results from these
experiments indicate that a population of uNK cells can be successfully isolated from rat
deciduas and maintained in culture for at least 24 h. Furthermore, these results indicate
that isolated rat uNK cells from GD 9.5 deciduas express OPN.
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Figure 4-4: Co-localization of OPN in WT GD 9.5 conceptuses.
Co-localized staining for PRF (green) and OPN (red) in a representative GD 9.5
conceptus. PRF staining was used to detect uNK cells in the decidua basalis (DB) and
ectoplacental cone (EPC). Images taken at 40x magnification and scale bars represent 50
μm.
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Figure 4-5: Isolated suspended cells express NK cell markers and Spp1.
(A) 24-hour time course of relative gene expression for Ccl5, Klrb1f, Prf1, and Spp1 in
suspended and adherent cells isolated from GD 9.5 deciduas (N=4). (B) Relative gene
expression of Ccl5, Klrb1f, Prf1, Spp1, and Vim in adherent and suspended cells cultured
together for 24 hours (N=5). Results represent means ± SEM. Data significantly different
from controls (p ≤ 0.05) are indicated by an asterisk (*).
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4.3.5

Isolated uNK cells express OPN

While uNK cells have previously been isolated from both humans and mice, isolation of
uNK cells in rats has yet to be reported (Paffaro et al. 2003; Timonen and Saksela 1980).
Here, we demonstrate a protocol to isolate and culture NK cells from GD9.5 deciduas of
pregnant rats. Isolated mononuclear cells were plated for 2 hours to allow the
heterogenous population of cells time to separate by adherence. After 2 hours, cells were
separated into suspended versus adherent populations. Adherent cells consistently
exhibited reduced expression of genes encoding the NK cell markers perforin (Prf1),
killer cell lectin-like receptor subfamily b 1F (Klrb1f), and Ccl5 over 24 hours (Figure
5a). Compared to adherent cells, suspended cells expressed significantly (p ≤ 0.05) higher
levels of Ccl5, Klrb1f, Prf1 and Spp1, which continuously increased over time in culture.
(Figure 4-5A). Culturing suspended cells with adherent cells for 24 h yielded
significantly higher expression levels of NK cells markers Ccl5 (31.52-fold), Prf1 (5.83fold), and Klrb1f (18.77-fold) as well as Spp1 (11.17-fold) in suspended cells compared
to adherent (Figure 4-5B). Interestingly, the transcript expression of Vim, a gene
encoding vimentin, a protein found within decidual stromal cells (Glasser and Julian
1986), was significantly decreased (2.9-fold) in suspended cells compared to adherent
controls (Figure 4-5B). Collectively, these results indicate enrichment of NK cells within
the population of suspended cells isolated from GD 9.5 decidua, as compared to those
adhering to tissue culture plastic.
Further confirmation of the presence of NK cells can be accomplished by analyzing the
expression of CD161 (Arase et al. 1997). When evaluating surface expression of CD161
in decidual mononuclear cells, approximately 7.24% were positive for CD161 (Figure 46A). After allowing adherent cells to attach for 2 h and collecting the suspended cells, we
successfully enriched the population of CD161+ cells to approximately 25% (Figure 46B). Comparatively, allowing isolated decidual mononuclear cells to attach for 2 h
allowed us to significantly enrich the population of CD161 + cells by 18.34% (Figure 46C). Immunofluorescence conducted on
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Figure 4-6: Isolated suspended cells express the NK cell-surface marker CD161.
(A, B) Flow cytometry for isolated uNK cells confirms the presence of the NK cell
marker CD161 on 8.25% of cells (A). (B) After plating for 2 h cells in suspension were
stained for CD161 and the population of CD161 positive cells was enriched to 28.5%.
(C) Percent values for CD161 positive cells with and without plating adherent cells for
enrichment of suspended cell population. (D) uNK cells isolated from GD9.5 deciduas
express both PRF and OPN. Arrows indicate cell positive for PRF and OPN staining.
Images taken at 40x magnification and scale bars represent 50 μm.
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suspended cells for the NK cell secreted protein PRF allowed us to visualize that a large
number of these cells were likely uNK cells. PRF positive cells also co-stained for the
expression of OPN indicating a colocalization of OPN expression and PRF in isolated
uNK cells. Collectively, the results from these experiments indicate that a population of
uNK cells can be successfully isolated from rat deciduas and maintained in culture for 24
hours. Furthermore, these results indicate that isolated rat uNK cells from GD 9.5
deciduas express OPN.

4.4 Discussion
Proper placental and decidual development is critical for healthy pregnancy outcomes;
failure of these processes results in adverse pregnancy outcomes such as preeclampsia
and PA (Sahu et al. 2019; Garrido-Gomez et al. 2017; Goh and Zalud 2016). While
various cell types play a critical role in placentation, uNK cells are thought to play a key
role in the regulation of placental development. Although several studies have examined
the role of uNK cells on various aspects of pregnancy, most studies have been conducted
using mouse models (Barber and Pollard 2003; Fu et al. 2017; Bany et al. 2012). The use
of mice has provided invaluable insight into the potential functions of uNK cells;
however, unlike placental development in humans and rats, placentation in mice is
inherently shallow (Ain et al. 2003). Thus, the importance of uNK cells in species that
exhibit deep placentation and extensive trophoblast invasion, such as in humans, is not
well understood. Since IL-15 is required for the maturation of NK cells and as one of the
few labs possessing an IL-15 deficient rat model, this study complements findings from
mouse studies and provides unprecedented insight into the potential contribution of IL-15
and uNK cells in controlling placental trophoblast invasion. This has important
translational significance for pregnancy complications associated with dysregulated
trophoblast invasion such as preeclampsia and PA.
In this study, we conducted the first comprehensive characterization of rat uNK cells,
identifying significant transcriptomic changes in conceptuses from IL15Δ/Δ rats
compared to WT rats on GD 9.5. There were 257 genes that had significantly (> 2-fold
up/down regulated and p ≤ 0.05) changed expression between WT and IL15Δ/Δ
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conceptuses. Genes that were upregulated in IL15Δ/Δ rats compared to WT rats were
typically associated with functional pathways such as neurological processes and sensory
pathways. One possibility is that upregulated genes between IL15Δ/Δ and WT rats may
be associated with neurological and/or sensory pathways but have other functions in the
decidua or during pregnancy. One example of this is the gene Crym, which encodes a
heat shock protein called crystallin. Although functions of crystallin have been studied
mostly in the context of central nervous system and lens development (Slingsby and
Wistow 2014), upregulated levels of phosphorylated crystallin have been found in rat and
mouse deciduas, with the proposed role of protecting decidualization against stress
conditions (Iwaki et al. 1990; Zuo et al. 2014). Moreover, knocking down crystallin
increases stromal cell death and inhibits decidualization under stress conditions (Zuo et
al. 2014). Taken together, the upregulation of crystallin in IL15Δ/Δ rat conceptuses may
therefore indicate that a lack of uNK cells results in a form of decidual stress similar to
the effects seen following hypoxia exposure (Zuo et al. 2014). Additionally upregulated
was Gria4, a gene that encodes the glutamate receptor 4 protein (GRIA4). While GRIA4
has primarily been implicated in neurotransmission and variations in Gria4 expression
leads to cognitive impairments, GRIA4 has been observed within the trophoblast and has
been implicated in the context of pathogenic pregnancies (Martin et al. 2017; Yeung et al.
2016; Sagata et al. 2010; Uhlén et al. 2015). Genes that were significantly downregulated
in IL15Δ/Δ rat conceptuses compared to WT included Prf1, Ccl5, Eomes, Gzmb and
Il2rb, which have all been implicated in NK cell function (Gordon et al. 2012; Kim et al.
2011; Maghazachi et al. 1996; Fernandez et al. 2019), supporting the notion that the
absence of uNK cells is the key difference between WT and IL15Δ/Δ rat deciduas.
The gene Prf1 encodes perforin (PRF), a pore-forming cytolytic protein found in both T
cells and NK cells (Kägi et al. 1994). Since the decidua lacks a prominent T-cell
population, we utilized PRF as a marker of uNK cells, which was consistently decreased
at both the transcript and protein level in IL15Δ/Δ rats (Head et al. 1994; Parr et al. 1990).
Specifically, the absence of PRF observed in the decidua confirmed that IL15Δ/Δ rats are
indeed devoid of uNK cells, as previously reported (Renaud et al. 2017). Comparably,
studies that have knocked out or mutated either IL-15 or the IL-15R in mice, confirm that
IL-15 function is required to maintain uNK cell populations (Barber and Pollard 2003;
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Kennedy et al. 2000) and PRF staining is also absent in these deciduas (Herington and
Bany 2007). Akin to what was seen in our study, uNK cells in mice are mainly localized
to the decidua (Croy et al. 2003). In humans however, uNK cells are thought to directly
interact with trophoblast cells in the decidua, controlling the depth of extravillous
trophoblast invasion into spiral arteries (Hanna et al. 2006; Soares et al. 2014), but
whether this is the same case in rats remains unknown. In the present study. We
demonstrated that PRF is present at the ectoplacental cone, the location of trophoblast
cells and the nascent placenta, which may indicate that interactions between uNK cells
and trophoblast cells are occurring. This is supported by previous studies demonstrating
that on GD 8.5 in mice (which approximates to GD 9.5 in rats), trophoblast cells at the
ectoplacental cone are surrounded by a large number of uNK cells, some of which
infiltrate into the cone (Madeja et al. 2011). Future studies can aim to explore this
relationship and determine if uNK cell deficiency alters trophoblast invasion or function
throughout pregnancy.
One of the most robustly downregulated genes in decidua from IL15Δ/Δ rats was Spp1,
the gene encoding the protein OPN. OPN is a prime candidate as a potential regulator of
the degree of placental invasion, due in part to its known role as a regulator of cell
invasion (Wu et al. 2015; Huang et al. 2017; Qi et al. 2014) and its altered expression
patterns in PA (Özer et al. 2018; Long et al. 2019). A well-characterized role for OPN is
as a matricellular protein that is both produced and secreted into the extracellular space
(Viloria and Hill 2016) to modulate cell function through interacting with molecules such
as structural matrix proteins and integrins (i.e., αvβ3) (Bornstein 2009; Lessey et al.
1994). In pregnancy, OPN is thought to bind to integrins to mediate events including
implantation, early blastocyst attachment trophoblast invasion and proliferation in
various species (Wu et al. 2015; von Wolff et al. 2004; Johnson et al. 2014; Qi et al.
2014; Zhou et al. 2016). In cases of PA in humans, elevated expression levels of the
integrin αvβ3 are observed in complicated placentas compared to normal controls,
particularly in extravillous trophoblast cells regions (Weitzner et al. 2021). Since OPN
plays are role in regulating cell adhesion, reduced OPN levels may decrease the ability
for trophoblasts to adhere to their appropriate location at the end of their migration (Zhou
et al. 2016). Therefore, a lack of OPN could result in the ability for trophoblast cells to
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migrate more freely, causing the excessive invasion observed at mid-gestation in IL15Δ/Δ
rats.
Since most downregulated genes in IL15Δ/Δ conceptuses are associated with NK cell
function, it is logical that uNK cells are the main cellular source of decidual OPN and the
absence of uNK cells in IL15Δ/Δ rats is the reason for reduced Spp1 expression. In our
study, decreased Spp1 mRNA levels were consistently detected in IL15Δ/Δ conceptuses,
although in a few cases notably high Spp1 mRNA expression was observed, which we
attribute to possible contamination with uterine glands which showed equally high OPN
staining in both WT and IL15Δ/Δ conceptuses. Together, these results indicate that uNK
cells are the likely cellular source of decidual OPN, which may be important for
controlling placentation, and reveal the potential use of OPN as a uNK cell-specific
marker. Since OPN was highly expressed in uterine glands and its remained unchanged
between WT and IL15Δ/Δ rats, our results indicate that there are at least two different
sources of OPN production (glandular and uNK cell-derived) in mid-gestation rat uteri.
To determine if uNK cells are the source of decidual OPN, we isolated uNK cells from
the deciduas of WT animals. Isolation and culture of uNK cells has been successfully
completed in both human and mouse models and while in rats peripheral NK cells have
been collected from placentas, the isolation of uNK cells has yet to be reported
(Koopman et al. 2003; Hanna et al. 2006; Yadi et al. 2008; Paffaro et al. 2003; Shields et
al. 2018). Previous isolation of human uNK cells note the expression of various NK cells
markers including CD56, NKP46, and KIR2DL1, plus the expression of granzymes A
and B (Vacca et al. 2006). Here, we report isolated rat uNK cells express transcripts for
the NK cell markers Ccl5, Klrb1f, and Prf1 as well as the marker for OPN (Spp1), as well
as provide evidence of uNK cells as the main source of OPN in the GD 9.5 rat decidua.
Further supporting this, OPN was localized specifically to areas populated by uNK cells,
and staining of OPN co-localized with the uNK cell marker PRF. Furthermore, isolated
rat uNK cells expressed CD161, PRF, and OPN, further implicating uNK cells as the
primary cellular source of decidual OPN. In mice, intracellular OPN has been found in
peripheral NK cells and implicated in IL-15 signaling, therefore it is logical that it is
logical that conceptuses from IL15Δ/Δ rats lack both PRF and OPN in uNK cells
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(Leavenworth et al. 2015). Therefore, it is likely that uNK cells are the cellular source of
decidual OPN which regulates placentation and reveals the potential use of OPN as a
uNK cell-specific marker.
OPN has been implicated in inflammatory environments, and while it exists as a
component of the extracellular matrix, it also functions as a soluble cytokine (Lund et al.
2009). In humans, isolated decidual tissues indicate that there is a correlation to the
number of uNK cells to the levels of secreted OPN, indicating a relationship between
uNK and OPN and the possible role OPN plays in recruiting uNK cells to the pregnant
uterus (Qu et al. 2008). Combined with our findings that PRF and OPN are co-localized,
it is possible that the secreted and intracellular forms of OPN work together to
respectively recruit and maintain uNK cells during pregnancy. Consistent with this
possibility, OPN in mice promotes the expansion of common lymphoid progenitor cells,
which give rise to NK cells (Kanayama et al. 2017). Determining the subcellular
distribution of OPN in uNK cells to define the expression of secreted versus intracellular
Spp1 isoforms is needed to confirm the localization and type of OPN expression in these
cells.
In the present study, we successfully isolated a population of uNK cells from pregnant rat
deciduas. The co-expression of OPN and PRF as well as the expression of CD161 on the
surface of these cells; however, the identity of these cells remains unknown. To enrich
our population of uNK cells, isolated MNC were allowed to adhere for 2 hours to
separate decidual stromal cells and macrophages (adherent) from uNK cells found in
suspension, methods similar to those used in human uNK cell isolation (Koopman et al.
2003). Separating out suspended cells from those that had adhered, allowed the
population of uNK cells to express more NK cells markers and OPN over time (ptime ≤
0.05 for Ccl5, Klrb1f, Prf1, and Spp1). Due to normalization of RNA values prior to
transcript level analysis, it is not known if isolated uNK cells are proliferating over 24
hours in cell culture, however these findings warrant further investigation. Additionally,
it was observed that levels of NK cell markers had a larger relative expression when cells
were cultured directly with those that adhered in a co-culture system. Previous NK cell
cultures indicate the increased expression of various cytokines and growth factors (i.e.,
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Vegfc, Cxcl10, Cxcl11), when co-cultured with trophoblast cells or endothelial cells,
warranting further investigation into the cytotoxicity of uNK cells and interactions
between adherent and suspended cells in a co-culture method (Gong et al. 2014; Lash et
al. 2011). While our adherent enrichment strategy increased the number of CD161+ cells
by ~18%, future experiments are needed to further enrich isolated uNK cell population
and determine the identify of additional present cells. Upon further enrichment, future
experiments on the interaction of uNK cells and trophoblast cells will allow for genetic
manipulation techniques like shRNA and CRISPR to decrease the expression of OPN and
determine its importance in uNK cell proliferation and survival as well as trophoblast
invasion.
This study has several limitations. First, the population of uNK cells throughout
pregnancy is dynamic, additional experiments over the course of rat pregnancy would
clarify the expression of OPN over time and provide an indication of its role in placental
and decidual development. For example, determining if levels of OPN peak at the same
time or prior to the commencement of certain decidualization processes (i.e., spiral artery
remodelling may indicate a potential involvement of OPN in guiding these changes. This
is further warranted by previous studies demonstrating that human decidual samples
collected from later weeks during first trimester (weeks 8-9) pregnancies had
dramatically increased expression of OPN compared to samples collected from earlier in
the first trimester (weeks 4-5) (Qu et al. 2008). Second, we cannot ascertain that altered
OPN expression in IL15Δ/Δ rats is directly a result of a lack of uNK cells. While we were
able to use IL15Δ/Δ rats to identify a significant lack of both OPN and uNK cells, the use
of single cell transcriptomics may help facilitate the identification of cell-specific OPN
production in the decidua.
In summary, we have conducted a comprehensive profile of gene expression changes in
the rat conceptus between WT and IL15Δ/Δ rats. We further determined that OPN is
likely expressed by uNK cells, and we speculate that it may play a role in controlling
processes related to placentation and decidualization. Due to the known role of OPN in
promoting cell adhesion, reduced OPN levels may decrease trophoblast adhesion
resulting in their ability to migrate more freely, leading to the excessive invasion seen at
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mid-gestation. The effect of hyper-invasive trophoblasts has long been studied in PA,
with emerging studies linking decreased OPN in placentas to the diagnoses of PA (Illsley
et al. 2020; Miller et al. 1997; Özer et al. 2018). Thus, our findings provide a new aspect
to investigate the association between decreased OPN levels and PA, allowing future
studies to utilize isolated uNK cells for functional assays. Collectively, our results
provide insight into the roles of IL-15, and more specifically uNK cells in pregnancy,
which could ultimately aid in understanding mechanisms underlying common pregnancy
complications so that targeted therapies can be implemented to alleviate long-term
complications for both mothers and their babies.
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Chapter 5

5

Discussion

5.1 Discussion and Significance of Research
Maternal immune cells can be found in close proximity and interacting with placental
cells throughout gestation and can secrete various cytokines and growth factors
suggesting an important role in regulating placental development. The overall hypothesis
of my thesis is that maternal immune activation during pregnancy will disrupt normal
placental and fetal growth and development. With this work, I have advanced our
knowledge of the detrimental impact that MIA can have on the development of the
placenta and fetal brain. The main findings that support my hypothesis and further
advance this knowledge are that:
1.

Administration of MIA during early gestation results in aberrations in placental

and fetal neurodevelopment.
2.

OPN is produced by uNK cells, which as a multifunctional cytokine could

modulate trophoblast invasion and placental development.
In this work, I have provided insight into the possible mechanisms by which MIA impairs
placental development. This placental maldevelopment possibly occurs through the
increased expression of type I interferons and their ability to impair differentiation of
trophoblast stem cells. Additionally, MIA can lead to alterations in NPC cell proliferation
and cortical thickness which may result aberrant activation of Notch signaling pathways.
Finally, the presence of uNK cells at the placental-fetal interface results in the presence
of decidual OPN, a secreted protein that may possibly regulate development of the
placenta.

5.1.1

Administration of MIA during early gestation results in
aberrations in placental and fetal neurodevelopment

In chapters 2 and 3, I administered PolyI:C during early gestation in rats as a model of
MIA to analyze the downstream consequences on placental development and fetal
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growth. MIA due to PolyI:C exposure altered placental and fetal growth trajectories
(Chapter 2), and neurodevelopment in offspring (Chapter 3).
MIA during early gestation results in a rapid and extensive proinflammatory response in
implantation sites (Chapter 2), which was further confirmed by transcriptome analysis 6
hours after administration of maternal PolyI:C exposure (Chapter 3). Whole viruses (like
Zika and Coxsackie) pose additional obstacles due to the occurrence of symptoms of
infection (i.e., fever and lethargy) compared to MIA models. Therefore, since PolyI:C is
capable of eliciting MIA in the absence of a viral infection, my work suggests that
changes in placental morphology could result from an antiviral response, rather than the
pathogen itself. In animal models, sterile inflammation is sufficient to recreate many of
the features found in various obstetric complications such as: embryonic loss, preterm
birth, and preeclampsia (Scharfe-Nugent et al. 2012; Gomez-Lopez et al. 2016), further
implicating MIA as a cause of pregnancy complications. Since PolyI:C is frequently used
as a model of MIA-induced neurocognitive deficits, we wanted to explore the possibility
that PolyI:C affected placental development, since the placenta provides oxygen and
nutrients needed for healthy brain development. While I detected a robust immune
response in the pregnant uterus near the developing placenta based on increased
expression of several well-established antiviral genes, it was unclear whether the immune
response at this site was propagated directly due to accumulation of PolyI:C or indirectly
because of cytokines induced in other tissues. In an attempt to address this issue, I
collected tissue at several time points (GD 8.5, 13.5, & 18.5) following maternal
exposure to PolyI:C and performed immunohistochemistry on implantation sites and/or
placentas using a J2 monoclonal antibody, which detects for dsRNA (Millipore Sigma,
MABE1134). Unfortunately, the staining was inconclusive, so this remains an
unanswered question. Despite the lack of positive staining of dsRNA, I determined that
the expression of pro-inflammatory cytokines and chemokines within the uterus provides
strong evidence of an anti-viral, type I interferon response near the developing placenta.
Therefore, upon confirmation of a maternal antiviral response, I sought to determine if
these effects impaired placental development. I found that MIA during early gestation in
rats resulted in smaller placentas and fetuses. Additionally, I found that type I interferons
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impaired rTS cell differentiation in vitro, which is consistent with other reports
(Devendra et al. 2005; Longhi et al. 2009; Farina et al. 2010).
The finding that MIA during early gestation decreased placental size at midgestation are
consistent with Zika and Coxsackie infections that result in damage to the placental
barrier and growth retardation in offspring (Euscher et al. 2001; Miner et al. 2016).
Furthermore, work with West Nile virus illustrates the vulnerability of trophoblast cells
to infection by viruses after implantation and prior to formation of the definitive placenta,
suggesting a window of susceptibility to viral insults (Julander et al. 2006). This work
complements previous studies which indicate the placenta has a window of susceptibility
to insults between GD 6.5 and GD 9.5 in rats, which resulted in aberrant placental
morphology (Rosario et al. 2008). In a similar manner, our MIA model, which utilizes
PolyI:C administration during early placental development (GD 8.5) occurs in the middle
window of susceptibility to insults which creates a suboptimal in utero environment for
the progression of a healthy pregnancy.
Using RNA sequencing (Chapter 3), I discerned that PolyI:C caused a substantial
increase in expression of inflammatory genes at the implantation site. Additionally, many
downregulated genes were involved in CNS development, but since whole tissue
homogenates were used, the identity of the cells causing these changes changing genes
remains unknown. To identify the effects of MIA on the developing fetal brain more
clearly, single cell RNA-sequencing could be used in future experiments, in which single
cells are isolated from the cerebral cortex at GD 15.5 following maternal exposure to
PolyI:C or saline. This heterogenous population of cells could then be single-cellbarcoded and sequenced, allowing for clustering and analysis of expression of various
genes at single cell resolution. Thus, NPCs within various stages of differentiation can be
determined, and the identity of cells expressing potentially interesting genes such as
Notch1 can be identified.
Taken together, these results demonstrate the negative impact of MIA on placental
development and fetal growth. Maternal PolyI:C injection results in a rapid and robust
increase in inflammation near the site of the developing placenta during early gestation
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that further results in placental impairments and reduced fetal growth. Additionally,
decreased fetal brain weights were correlated with altered NPC proliferation in MIA
animals compared to controls. Therefore, early gestation MIA results in long term
consequences on placental morphology and fetal development that warrants further
investigation to understand the link between aberrations in normal development of the
placenta and neurological impairments in offspring (Figure 5-1).

5.1.2

OPN is produced by uNK cells, which as a multifunctional
cytokine could modulate trophoblast invasion and placental
development

Knockout of Il15 in rats results in the complete loss of NK cells and specifically uNK
cells as previously reported (Renaud et al. 2017). While IL15 deficiency appears not to
affect the number of T cells, B cells, or macrophages, it is possible that survival or
presence of various subsets of these immune cells are altered, which warrants further
investigation (Renaud et al. 2017). Previous studies utilizing NK cell deficient rat and
mouse models consistently demonstrate impairments in uterine vascular development
with spiral arteries featuring narrow lumens and thick vascular walls (Renaud et al. 2017;
Mazurier et al. 1999; Wang et al. 1994; Kennedy et al. 2000). Although these findings in
mice and rats indicate an important role for uNK cells initiating and contributing to
pregnancy-dependent changes in the uterine environment, it is important to note that uNK
cells are not required for pregnancy success or fetal development.
A common finding in both rat and mouse studies utilizing IL-15 deficient animals is the
increased depth of trophoblast invasion into the maternal uterine tissue. These findings of
hyper-invasive trophoblasts in animal models are consistent with the life-threatening
obstetric complication, placenta accreta (PA). PA is a serious complication in human
pregnancies in which invasive trophoblasts invade too deeply into the uterus due to a
decidual deficiency and thereby increasing the risk of severe maternal hemorrhage during
labour (Publications Committee, Society for Maternal-Fetal Medicine and Belfort 2010).
Interestingly, recent studies have found decreased levels of uNK cells in PA suggesting
that uNK cells play a role in preventing the deficient decidualization and deep placental
invasion, characteristic of the disease (Colucci 2019; Laban et al. 2014).
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Figure 5-1: Proposed relationship between impairments in placental development
with neurodevelopmental impairments observed in offspring.
Administration of PolyI:C to pregnant dams at GD 8.5 results in reduced placental
development and fetal growth at GD 13.5. Inflammatory responses generated by PAMP
(TLR3, RIG1, or MDA5) activation impaired the differentiation of rTS cells which form
the definitive placenta. PolyI:C-exposed fetuses also had increased proliferative capacity
of NPCs on GD15.5, although it is unclear whether these responses are due directly to
MIA or indirectly due to impaired placental development.

198

This work implicates the production of OPN by uNK cells. Moreover, OPN is secreted
from uterine glands as a component of histiotroph to supply early nutrition for the fetus
and as such it has an essential role in implantation and reproduction (Nomura et al. 1988).
Consistent with reports in mouse models, my work indicates the presence of OPN, an
extracellular structural protein, in rat uNK cells (Chapter 4). While OPN was
significantly downregulated at the mRNA level and undetectable via
immunohistochemistry within the decidua in IL15Δ/Δ rats, immunblotting results indicate
the presence of OPN at reasonably high levels in both WT and IL15Δ/Δ animals. Despite
the knowledge that OPN is produced by uterine glands as histotrophic nutrition for the
developing embryo, it is possible that the lack of uNK cell-produced OPN is being
compensated for by the presence of other OPN producing cells like DSC or innate
lymphoid cells that are not IL-15 dependent (von Wolff et al. 2004). Future studies can
be done to determine the possible additional sources of OPN in the decidua, by isolating
decidual tissue from surrounding tissues for protein analysis.
NK cells have long been hypothesized to play a role in trophoblast invasion and
trophoblast-mediated spiral artery remodelling. While some reports indicate that
chemokines and growth factors produced by uNK cells enhance trophoblast invasion
(Hanna et al. 2006; Xiong et al. 2013; Lash et al. 2010), other reports indicate that factors
produced by uNK cells inhibit trophoblast invasion (Hu et al. 2006; Lash, Otun, et al.
2006). Consistent with the latter reports, IL15Δ/Δ rats exhibit hyper-invasive
trophoblasts, indicating a restrictive effect by uNK cells on trophoblast invasion and
trophoblast-mediated spiral artery remodelling (Renaud et al 2017). Since my findings in
Chapter 4 indicate that uNK cells produce OPN, it is possible that OPN produced and
secreted by uNK may play a role in regulating invasion and migration of trophoblast
cells. Over invasive trophoblasts pose both obstetric risks and serious long term health
risks to a mother, like those observed in disorders such as placenta accreta (Tantbirojn et
al. 2008). Compared to healthy term placental tissues, placentas from percreta cases
exhibit significantly reduced OPN expression (Özer et al. 2018), and in vitro work
implicates decreased OPN expression with impaired trophoblast growth and invasion
(Zhou et al. 2016). Furthermore, in humans decreased uNK cell numbers has been
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associated with the development of placenta accreta (Laban et al. 2014). Therefore, it is
possible that uNK cell secreted OPN regulates trophoblast invasion, and the depth of
placental attachment into the myometrium can be exacerbated in pregnancies lacking
sufficient uNK cell numbers due to decreased OPN expression.

5.2 Limitations & Future Directions
Following the results observed in chapter 3, I sought to determine the contribution of
uNK cells to the PolyI:C-induced antiviral response in the pregnant uterus. The initial
strategy was to use an immunodepletion strategy using injection of anti-asialo-GM1
antibodies into pregnant rats (ThermoFisher). Use of asialo-GM1 antibodies was able to
successfully deplete uNK cells as determined by qPCR and immunohistochemistry,
which was associated with impaired immune response to PolyI:C and significant changes
in immune responses between control animals and immunodepleted animals were not
observed (Appendix A). Following up on these experiments, on GD 9.5 I exposed
pregnant IL15Δ/Δ or WT dams to PolyI:C and another potent MIA stimulant, LPS, at
doses previously shown to cause complete embryonic loss. In both IL15Δ/Δ or WT rats,
neither PolyI:C nor LPS caused even partial embryonic loss, even when used at
concentrations twice as high (Appendix B; Figure B-3). Since WT and IL15Δ/Δ rats are
on a Sprague-Dawley Holtzman background, we attributed this lack of response to strain
differences in the immune responses of these rats. It has previously been observed in
mice (Sellers et al. 2012) and rats (Becker 2016) that there are varying immune responses
between strains, however immune responses during pregnancy between Sprague-Dawley
and Sprague-Dawley Holtzman rats has yet to be studied. It has also been noted that
various rat strains have differing basal levels of immune cells within the blood, as well as
varying levels of viral titers following adenovirus infection (Li et al. 2003). Together, our
results along with previous work indicate possible strain differences in immune responses
to pathogens or MIA models and these effects during pregnancy warrant further
exploration. Unfortunately, because of this limitation we were unable to ascertain the
contribution of NK cells in MIA-induced placental and brain maldevelopment.
While human and mouse uNK cells have previously been isolated and characterized
(Lash et al. 2011; Koopman et al. 2003; Felker and Croy 2017), the isolation of uNK

200

Figure 5-2: Proposed experimental methodology for co-culture of isolated decidual
cells.
Gestational day 9.5 rats are sacrificed using mild-carbon dioxide inhalation and
implantation sites are removed. Deciduas are isolated from the implantation sites and
following removal of the primitive placenta and embryo, cells are dissociated and
separated on a density gradient. Mononuclear cells are collected following differential
centrifugation and cells are plated for 2 hours at 37°C to enrich the suspended population.
Following plating, uNK cells can be separated as suspended cells in the cell culture
medium, while DSC and macrophages remain adhered to the tissue culture plastic.
Invasion assays will be conducted using rTS cells in the upper chamber and the bottom
chamber can be filled with isolated cells prior to plating, following plating enrichment, or
with conditioned media collected from separated cells.
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cells from rat decidua provides an opportunity to further our understanding of
mechanisms and roles of uNK cells in pregnancy. Therefore, because of the impact of
uNK cells in regulating trophoblast invasion observed in IL15Δ/Δ rats (Renaud et al.
2017), as well as the decreased expression of OPN, the possibility of the relationship
between these two features necessitates more investigation. To further assess the impact
of uNK cell secreted OPN on placental development, it would be interesting to co-culture
isolated rat uNK cells with rTS cells. My method of isolating uNK cells resulted in a
higher number of CD161+ cells following an adhering enrichment protocol, however
further enrichment would allow for clearer results. Future studies could further enrich an
isolated population of mononuclear cells with biotinylated CD161 beads (ThermoFisher)
to allow for positive selection of CD161+ uNK cells. Nevertheless, based on my
experience, isolated uNK cells can be kept in culture for approximately 72 hours,
although they appear to decline in number (as measured by the quantity of RNA and
integrity of cells in culture; data not shown) after 24 hours. In transwell chambers, rTS
cells can be plated above an extracellular matrix such as Matrigel (Corning) or Cultrex
(R&D Systems) with enriched uNK cells or uNK cell conditioned media plated below the
transwell (Figure 5-2). Based on the hyperinvasive trophoblast observed in IL15Δ/Δ rat
placentation, I predict that rTS cell cultured in the presence of uNK cells or uNK cell
conditioned media will have restricted trophoblast invasion compared to those cultured in
control conditions. This model would allow us to determine how uNK cells modulate rTS
cell differentiation and invasion. Additionally, we could quantify the amount of OPN
secreted by isolated rat uNK cells throughout gestation using an enzyme-linked
immunosorbent assay, which will help inform future experiments in which a specific
dose of recombinant rat OPN can be applied to rTS cells to evaluate the resulting effects
on differentiation and in invasion. Together, these experiments will further implicate
uNK cells as a source of decidual OPN, as well as the role of uNK cell-derived products
(including OPN) on the differentiation and invasive capacity of rTS cells.
To further evaluate the role of OPN in placental development, our lab is in the process of
acquiring OPN deficient rats from the University of Glasgow. To discern the importance
of decidual OPN, tissues will be isolated from pregnant Spp1Δ/Δ or WT rats throughout
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gestation and stained for changes in the extent of trophoblast invasion and placental
morphology. Furthermore, isolated uNK cells from Spp1Δ/Δ rats will be cultured for 24
hours, RNA and protein from isolated cells will be isolated and used for gene expression
and an enzyme-linked immunosorbent assay (ELISA) of OPN, and uNK cells from OPN
deficient rats will be cultured in invasion assay chambers to determine the role of uNKderived OPN on rTS cell invasion. Together, this work will further evaluate both the role
of OPN on placental development and trophoblast invasion as well as the relationship
between uNK cells and decidual OPN.
While the use of PolyI:C as a model of MIA allows for an understanding of the basic
mechanisms of viral infections, it has some limitations in its translatability to viral
infections. While PolyI:C does cause similar immune responses in the pregnant mouse
compared to influenza A infection, the responses in all cytokines are not comparable
(Jacobsen et al. 2021). Specifically, the administration of PolyI:C results in a rapid and
robust increase in proinflammatory cytokines (i.e., IL-6 & TNFα) in the maternal serum,
however administration of influenza A takes longer to generate a similar immune
response (Jacobsen et al. 2021). Therefore, it is important to take the activation time and
degree of symptoms into consideration when utilizing PolyI:C. Furthermore, the use of
PolyI:C to mimic the activation of TLR3 as seen during infection with dsRNA viruses
does not factor in the additional immune cascades and side effects that live pathogens can
initiate. For example, in addition to temperature changes, rats infected with influenza
exhibit signs of respiratory distress, weight loss, and increased respiration (Ottolini et al.
2005), while the pathogen itself can activate TLR3, TLR7, TLR8, and RIG1 (Lund et al.
2004; Le Goffic et al. 2007; Le Goffic et al. 2006). In rats, the number of studying
influenza A during pregnancy is limited, however increases in maternal cytokines like
IFN-γ and IL-4 have been previously observed (Gu et al. 2011). These influenza-induced
maternal cytokines in rats, paired with the impairments of placental development in mice
exposed to influenza (Liong et al. 2020; Van Campen et al. 2020), warrant further
investigation into the effects of whole pathogens like influenza, on the development of
the placenta in rats. As influenza A is a respiratory virus, intranasal inoculation is most
analogous to the primary route of infection in humans. Furthermore, work with intranasal
influenza A infection in mice displays a prominent cytokine storm in the mother which
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can reach the placenta (Liong et al. 2020; Van Campen et al. 2020). Therefore, to
determine the effect of viral infection on development of the rat placenta, I propose
infection with influenza A through intranasal inhalation to GD 9.5 pregnant rats.
Following maternal early-gestation exposure to influenza A, placentas will be collected at
mid and late-gestation for histological analysis to observe change in placental
morphology. Additionally, doppler ultrasound microscopy will be performed on
influenza A exposed dams compared to controls to determine if viral infection during
early pregnancy will impair functionality of the definitive placenta. Furthermore, to
explore the impact of viral stimuli on the developing cortex, additional experiments will
be performed where NPCs will be isolated from fetuses from influenza A treated
pregnancies compared to controls. NPCs will be cultured as previously described, and the
effect of influenza A on the proliferative and self-renewal capacity of NPCs will be
analyzed. The expression of NOTCH1 and its ligands will also be analyzed at the gene
and protein level. I predict that influenza A infection during early pregnancy will result in
impairments in placental development, however less robust effects on NPC
differentiation and proliferation due to the longer incubation period of the virus and an
increased window before a cytokine response is observed in the mother (Jacobsen et al.
2021). With the prevalence of SARS-CoV-2, additional future work assessing the impact
of maternal COVID19 exposure would prove beneficial; however, these experiments are
currently limited by the availability of feasible animal models (Reviewed by: Shou et al.
2021). Rat models have yet to be developed, which like mice have an incompatible ACE2
receptor to SARS-CoV-2 S protein and therefore would require the use of a rat-adapted
SARS-CoV-2 strain or human-expressing ACE2 rats.
Since influenza has been observed to result in placental abnormalities in the placentas of
infected dams (Van Campen et al. 2020; Littauer et al. 2017), it is possible that early
gestation exposure can alter the growth trajectories due to MIA. To determine the effect
of influenza A on the uterine immune environment I propose the use of intranasal
inoculation of influenza A to pregnant WT SD dams during early gestation
(approximately GD 7.5), I then plan to collect uNK cells from deciduas at GD9.5 as
described above. Collecting uNK cells exposed in utero to influenza A may alter the
expression of NK-cell like surface receptors. Reports of the ability of influenza to infect
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NK cells themselves (Mao et al. 2009), as well as respond to infection through the
NKp46 receptor in humans (Arnon et al. 2004) indicates a possibility of uNK cells to
respond to influenza A infection near the developing placenta. Therefore, secreted antiviral cytokines and granzymes from uNK cells can also be determined using ELISAs (IL6, IFN-γ, Granzyme B) in response to influenza A infection compared to vehicle controls
to further determine the role of uNK cells in the in utero immune response to viral
infections. Isolated influenza A exposed uNK cells can additionally be cultured in
invasion chambers with rTS cells as described above to understand the effect of viral
infections on immune-mediated trophoblast invasion. With this work, I predict that
influenza A infection will result in an increase in MIA at the maternal-fetal interface and
an increase in the expression of uNK cell markers. Furthermore, I expect that uNK cells
isolated from infection exposed dams will impair the ability of trophoblast invasion due
to the increased secretion of pro-inflammatory cytokines. Together, these studies will
further emphasize the detrimental effects of infection and maternal inflammation during
early pregnancy on the development of the placenta and the fetal brain.
Single-cell work in the human decidua describes the presence of three major populations
of uNK cells, each with distinct expression of immunomodulators and chemokines
(Vento-Tormo et al. 2018). Previous work with supernatants from isolated human uNK
cells, shows the increased proliferation of placental explants cultured in uNK conditioned
media (Lash et al. 2010); however, the effects on early placental development remain
unknown. Therefore, to further elucidate the effects of human uNK cells on placental
development, I propose the isolation of human uNK cells as previously described (Lash,
Schiessl, et al. 2006), to be cultured in transwell chambers with human TS (hTS) cells.
Like rTS cells, hTS cells have the ability to differentiate into various trophoblast
lineages, therefore assessment of the stem and differentiation capacity of hTS when
cultured will indicate the effect of uNK secreted factors on early placental development. I
predict that presence of uNK cells will result in the preferential differentiation of hTS
cells into an invasive lineage.

5.3 Conclusions and Significance
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Development of the placenta is a tightly regulated process in which aberrations in the
maternal immune system can alter the intra-uterine environment and result in
impairments in trophoblast differentiation. The overall conclusions of these studies are
that in utero exposure to maternal inflammation during early gestation results in a
significant decrease in the size of the junctional zone and decreased fetal growth.
Additionally, reduced placental and fetal size also correlate to impairments in fetal
neurodevelopment, with an increase in the proliferative capacity of NPCs from the cortex
at mid-gestation. Furthermore, a lack of uNK cells during pregnancy is associated with
decreased levels of OPN, which could contribute to the altered placental morphology in
these rats. Our knowledge of the impact of MIA during pregnancy has been further
advanced by this work. Collectively, this work expands on both the regulatory and
protective roles of the maternal immune system during pregnancy and how aberrations in
normal immune processes can lead to impairments in placental and fetal growth and
development.
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Appendix A
Appendix A: Fetal weights and lengths following immunodepletion.

Figure A-1: Fetal weight and length following immunodepletion with anti-asialo
GM1 and treatment with PolyI:C or saline.
When treated with PolyI:C, fetuses collected untreated animals show a significant
decrease in fetal weight and length. Normal rabbit serum (NRS) exposure, a control for
anti-asialo GM1 treatment resulted in a more severe growth restricted phenotype in pups
compared to both untreated and anti-asialo GM1 litters. Results represented as means ±
SEM (N = 3).
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Appendix B
Appendix B: MIA in IL15Δ/Δ rats.

Figure B-1: Comparison of fetal development at mid-gestation in IL15Δ/Δ animals.
(A) Litter sizes and number of resorptions collected from GD 13.5 WT or IL15Δ/Δ dams
had no significant differences. Both fetal weights (B) and fetal length (C) were not
significantly different between genotypes. Results represented as means ± SEM (N = 3).
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Figure B-2: Effect of early-gestation PolyI:C exposure on fetal growth in 1L15Δ/Δ
transgenic animals.
Fetal length (A) and fetal weight (B) at GD 13.5 in SDH pups showed no impairments
following maternal PolyI:C exposure as compared to saline controls in either genotype.
Results represented as means ± SEM (N = 3).
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Figure B-3: LPS does not affect fetal viability between maternal IL-15 genotypes.
Maternal treatment with 50ng/mL of LPS did not affect viability or the number of
resorptions despite maternal genotype. Results represented as means ± SEM (N = 3).
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Appendix C
Appendix C: Animal ethics approval
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